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 Abstract 
The Secreted End of a Transcription Factor Promotes Sensory Axon Growth 
Ethan Price McCurdy 
 
During neural development, axons rely on extracellular cues to reach their target 
regions. Although extracellular signaling is one of the principal determinants for the 
growth of developing axons, only a small handful of known signaling cues has been 
identified. The existence of some 86 billion neurons of different subtypes, which 
ultimately form numerous functional circuits in the human nervous system, means an 
enormous number of extracellular cues would be required during development. Current 
views hold that even if more extracellular cues were to be discovered, they would never 
number large enough to account for the complexity of the human nervous system. 
Rather, intracellular signaling pathways and other cell-intrinsic mechanisms expand the 
ways in which a neuron can respond to extracellular cues by tuning the degree of 
responsiveness to them.  
Cell-intrinsic signaling pathways also give axons the ability to actively control 
their own development. These pathways can operate independently of the extracellular 
environment or even independently of the cell body, where the majority of protein 
synthesis takes place. For example, the local translation of proteins in the axon gives it 
autonomous control to immediately respond to changing demands in the environment. 
Local translation also occurs in other cell types, but the compartmentalized control over 
growth is especially important for neurons since the axon can extend up to a meter away 
from the cell body. In addition to local translation, axonally derived transcription factors, 
which can be locally synthesized in or localized to the axon, provide another means to 
control axon development. Axonally derived transcription factors act as physiological 
 sensors and relay information about events happening in the periphery back to the cell 
body in order to effectuate a global response.  
It has recently been shown that transcription factors belonging to the OASIS 
family are activated by proteolysis in axons. Following their activation by proteolytic 
cleavage, the transcriptionally active N-terminus of these factors is transported to the cell 
body to activate global transcriptional pathways. For at least one OASIS family member, 
CREB3L2, this cleavage event simultaneously produces the C-terminus, which is 
capable of undergoing secretion. The secreted C-terminus of CREB3L2 acts as an 
accessory ligand for the activation of Hh pathways in chondrocytes.  
The generation of two bioactive proteins from one transcription factor, a 
transcriptionally active portion and a secreted portion, raised the question of whether 
there was a local function for OASIS transcription factors in axons. Through my 
research, I identified a mechanism in which DRG axons secrete the C-terminus of 
CREB3L2, which promotes axon growth in a paracrine manner. CREB3L2 is a 
transcription factor whose translation is induced by physiological ER stress. For 
CREB3L2 to be active, it must be cleaved by S2P, which I found is expressed in 
developing axons. Following proteolysis of CREB3L2 by S2P, the secreted C-terminus 
of CREB3L2 promotes the formation of Shh and Ptch1 complexes along axons. I found 
that upon depletion of the secreted CREB3L2 C-terminus, binding of Shh to the Ptch1 
receptor is diminished. Returning the CREB3L2 C-terminus to the cultures exogenously 
was sufficient to rescue the formation of these complexes. These results highlight an 
intrinsic role for Shh signaling in developing DRG axons. Moreover, these results 
demonstrate how ER stress machinery is recruited to axons and promotes axon 
outgrowth. Finally, these results illustrate a novel, neuron-intrinsic mechanism by which 
developing axons actively regulate their own growth.  
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Chapter 1. Outline of Thesis and Contributions 
The results of my thesis describe a novel mechanism in which developing axons 
take an active and autonomous role in promoting their own growth. In Chapter 2, I 
review the foundation of this project as it relates to the field at large and expand on the 
topics of axon growth, ER stress, and the three major players in the mechanism 
described in this thesis: S2P, CREB3L2, and Hh. In Chapter 3, I review the materials 
and methods that were used.  
The results of my research are presented in Chapter 4, which comprises a 
manuscript that is currently under review. The experiments and analyses throughout this 
thesis were designed and carried out by myself, unless otherwise noted. However, I am 
particularly grateful for the assistance of Kyung Min Chung, who provided the data in 
Chapter 4, Figures 4A and 4B. I am also grateful for the assistance of Carlos Benitez-
Agosto, who quantified the results of the PLA performed in Chapter 4, Figure 7D. In 
Chapter 5, I discuss the significance of my project and its major conceptual advances, 
and I present the future directions that follow the work presented in this thesis.  
In addition to the principal chapters that make up the majority of my thesis, I have 
included a coauthored publication in the appendix (Villarin et al., 2016). In this report, we 
identified the local translation of two dynein cofactors, Lis1 and p150Glued in developing 
DRG axons and found that Lis1 and p150Glued are translated in axons differentially in 
response to low, threshold, or high levels of exogenous NGF. The translation of these 
cofactors was found to modulate the speed of the retrograde motor protein, dynein, and 
determine the size of cargo that can be transported by dynein from the axon to the cell 
body. We believe that the local translation of these proteins allows axons to rapidly 
respond to changing demands in the axonal environment. One of my contributions to this 
project was examining the local and global rates of protein synthesis in response to NGF 
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using the puromycylation assay. I also assisted with the immunostaining of markers for 
protein synthesis (Appendix, Figures 1e-1g).  
While working on this publication, we identified a candidate motif on the RNA-
binding protein, APC, which is bound to microtubules, as a binding site for Lis1 mRNA 
transcripts (Pafah1b1). To confirm that Pafah1b1 was bound to APC in DRG neurons, I 
performed RNA immunoprecipitation with APC to detect the association of Pafah1b1 
transcripts by RT-PCR, using LNA to functionally block any association of Pafah1b1 with 
the purported binding motif. Using this approach, I confirmed that Pafah1b1 was bound 
to APC at this site (Appendix, Figure 7b), which provided evidence that APC serves as a 
hotspot for local synthesis and functionally organizes transcripts such as Lis1 for 
immediate translation. Finally, I provided assistance with identifying the active GSK3β 
apoptotic signal in the absence of NGF signaling (Appendix, Figure 5c) as well as 
performing some of the quantifications of various TUNEL and calcein AM assays 
throughout the report. 
 This publication marked the end of my involvement with this particular project as I 
sought to explain different experimental questions during the remainder of my graduate 
studies. However, this project was the starting point for my work with DRGs and the 
study of cell-intrinsic mechanisms in developing neurons. In (Villarin et al., 2016), I used 
molecular approaches and microfluidic devices to examine local translation, cell viability, 
and transport in primary neuronal cultures. One of the points this paper underscores is 
the role for cell-intrinsic mechanisms that inform the neuron to act in a certain way in 
response to changing conditions in the environment. This conceptual framework and 
focus on cell-intrinsic regulation continued to be informative for how I approached and 
thought about my own project that is presented in this thesis. 
  3 
Chapter 2. General Introduction  
 During my graduate studies, I discovered that intramembranous S2P activates the 
ER stress transducing transcription factor CREB3L2 in sensory axons by proteolysis. 
The cleavage by S2P liberates the CREB3L2 C-terminus, which is secreted from the cell 
into the extracellular environment. Once secreted, the CREB3L2 C-terminus forms a 
complex with the chemoattractive morphogen Shh and promotes the association of Shh 
with the Ptch1 receptor along axons. Through the formation of these complexes, the 
CREB3L2 C-terminus promotes sensory axon growth downstream of S2P activity. Of 
note, a role for S2P or CREB3L2 in promoting axon growth has not been described 
previously. This introduction provides a background for the topics of axon growth; the 
role of transcription factors during neural development; ER stress pathways, with 
particular attention to the ER stress-related proteins S2P and CREB3L2; and Hh 
signaling. At the time of writing this thesis, S2P activity has not been directly examined in 
neurons. One of the primary conceptual advances of this project is the identification of a 
novel growth-promoting pathway in developing sensory neurons that proceeds 
downstream of ER stress factors. 
 Reports on axon growth have predominantly focused on external cues in the 
environment of the axon, such as the tropic factors regulating axon guidance. By 
comparison, the cell-intrinsic pathways that underlie axon growth have received less 
attention. The following section begins by discussing some of the canonical signaling 
cues that regulate developing axons. This is followed by a discussion on how 
intracellular signaling by transcription factors allows for numerous axonal responses to a 
limited number of extracellular signaling cues. Our lab has had a long-standing interest 
in the role of transcription factors during development and, more recently, about how 
local mechanisms enable cell-autonomous behavior. In the subsequent sections, I 
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discuss the topic of ER stress and the extent to which our current understanding of the 
stress response is complicated by neuronal morphology. Following the section on ER 
stress, I discuss S2P, CREB3L2, and Hh in more detail and propose a mechanism 
connecting their activities in developing axons. I conclude with a summary of the role 
that I identified for S2P and CREB3L2 for promoting axon growth in a neuron-intrinsic 
manner during neuronal development. 
 
2.1 Axon growth 
 The axon is the longest process of a neuron, and it is responsible for the 
transmission of information from one cell to the next after mature synapses are formed. 
During neural development, chemical and tactile extracellular cues, as well as 
intracellular signaling pathways, control the highly coordinated process of axon growth. 
Although Santiago Ramón y Cajal had captured the immense beauty and complexity of 
neuritic projections by the late 19th century, no one knew with any certainty how the 
developing axon was able to reach its correct target until pioneering work in the visual 
system led Roger Sperry to propose one of the most influential developments in modern 
neuroscience. Sperry’s “chemoaffinity hypothesis” argued that attractive chemical 
signaling directs the axons of developing neurons toward their target regions (Sperry, 
1963). In contrast to this theory of chemical guidance, Paul Weiss argued for another 
prevailing theory at the time, proposing that nerve growth was mostly unspecific (Weiss, 
1936) and instead relied principally on contact-mediated guidance (Weiss, 1945). 
Although parts of the physical theory put forward by Weiss have gained more ground in 
recent years (Franze, 2013), Sperry’s hypothesis, that attractive chemical cues direct 
axon growth, has been more influential for how researchers have thought about axon 
guidance over the last few decades. However, expanding on his theory, it is now 
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understood that axon growth is also shaped by repulsive guidance cues in addition to 
attractive guidance cues. Both attractive and repulsive guidance cues are secreted from 
neurons and other supportive, non-neuronal cells and act in a long-range or short-range 
manner. 
 For a time the identity of these chemical cues was unknown. Eventually, work 
performed in the developing spinal cord led to the identification of the attractive guidance 
cues. Two of the most notable examples of attractive guidance cues are netrin (Kennedy 
et al., 1994) and Hh (Charron et al., 2003). Early work in DRG neurons and chick brains 
also led to the isolation of one of the best-studied repulsive guidance cues, semaphorin 
3A (Luo et al., 1993). Every guidance cue has a corresponding receptor (or receptors) 
that transduces the signal and evokes a stereotyped response from developing neurites. 
In total, over the last thirty years, there have been several major families of guidance 
cues and receptors described in the brain: Netrin and DCC, Slit and Robo, Semaphorin 
and Plexin/Neuropilin, Ephrin and Eph, Wnt and Frazzled, and most recently, Draxin and 
DCC (Dickson, 2002; Raper and Mason, 2010; Stoeckli, 2018). 
 Categorizing guidance factors into strict functional or spatial classes can be 
difficult. For example, semaphorins were at first considered to be strictly repulsive (Luo 
et al., 1993). However, it was later found that members of the class-3 (Sema3) 
semaphorin family could also have an attractive effect on cortical neurons (Bagnard et 
al., 1998) and olfactory neurons (de Castro et al., 1999). While these observations 
initially seemed incompatible, it was later found that Sema3 members exert attractive or 
repulsive effects on axons depending on the components of the receptors that are 
recruited (Chauvet et al., 2007; Wolman et al., 2004). Additionally, semaphorins can 
have unique guidance-independent functions. For example, Sema3A can induce 
apoptosis in DRG neurons by acting through the receptor PlexinA3 (Ben-Zvi et al., 
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2008). In terms of their distribution, both semaphorins and slits can act as short-range 
cues or they can be secreted and act as long-range cues (Renzi et al., 2000; Schwarting 
et al., 2000; Simpson et al., 2000). Research in recent years has also uncovered new 
roles for developmental pathways that had previously seemed all but axiomatic. For 
example, one of the conventions in the field of axon guidance held that netrin-1 derived 
from the floorplate acted as a long-range cue to attract commissural neurons (Kennedy 
et al., 1994). However, it was recently shown that long-range signaling by netrin-1 is 
dispensable and that netrin-1 derived from progenitor cells in the ventricular zone directs 
commissural axon growth towards the floorplate by promoting cell adhesion (Dominici et 
al., 2017; Varadarajan et al., 2017). 
 While the precise function for many of these guidance factors remains the subject 
of debate, it is clear that both short- and long-range factors coordinate to guide axon 
growth along a tightly controlled developmental timeframe. It is also evident that the 
functions of most guidance factors are conserved throughout the nervous system, as 
highlighted in a recent review on axon guidance (Stoeckli, 2018).  
 
2.1.1 Trophic factors and the transcriptional response 
 In addition to the tropic cues that serve principally to control axon guidance, there 
are a number of trophic factors that promote axon growth and neuronal viability. For 
DRG neurons, one of the most studied trophic factors is NGF, which binds the receptor 
TrkA. The binding of NGF induces the dimerization and autophosphorylation of TrKA, 
leading to its activation (Greene and Kaplan, 1995). After it is activated, TrkA-NGF is 
endocytosed into the cell (Grimes et al., 1996). The endocytosis of activated receptors is 
a conserved feature of neurotrophin signaling (Ginty and Segal, 2002). While developing 
DRG neurons require low levels of NGF to survive (Crowley et al., 1994; Smeyne et al., 
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1994), NGF will also stimulate axon outgrowth (Campenot, 1977; Gundersen and 
Barrett, 1979; Hengst et al., 2009). It has been demonstrated that retinal ganglion  
 
neurons deprived of supportive trophic factors can survive if the transcriptional programs 
mediating apoptosis are shut off; however, they will not grow neurites (Goldberg et al., 
2002). This is because some of the chief effects of trophic factors are to activate local or 
transcriptional programs that remodel the cytoskeleton, or upregulate the production of 
components required for the expansion of the plasma membrane at the growth cone 
(Bonni and Greenberg, 1997; Chen et al., 2006; Dent et al., 2011; Gracias et al., 2014; 
Extracellular signals
•Guidance cues   





•Local translation   














Figure 2.1: Schematic of a developing neuron. Extracellular signals are detected by 
receptors along the growth cone or axon. If a transduced signal is bound for the cell body, 
intracellular cargo is transported within the axon in a retrograde direction by dynein along 
microtubule scaffolding. In the cell body, a transcriptional or translational response 
produces materials that are exported to the periphery by an anterograde motor protein from 
the kinesin family. Intracellular cargoes can be mRNA, proteins, or vesicles, such as 
mitochondria. 
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Hengst et al., 2009). For example, trophic factors can upregulate components of 
exocytic vesicles (Pfenninger, 2009) or modify F-actin dynamics in the growth cone 
(Dent et al., 2011).  
 The primary roles of trophic factors are to promote both the viability and growth of 
neurons (Raper and Mason, 2010). Trophic factors accomplish this by activating a 
number of intracellular mechanisms downstream of binding to their receptors. For 
example, it has been shown that brain-derived neurotrophic factor (BDNF) stimulates the 
filopodial dynamics of chick retinal ganglion axons through a Rho GTPase-dependent 
mechanism (Chen et al., 2006; Gehler et al., 2004). Similarly, the local application of 
NGF to chick DRGs induces the polymerization of F-actin in growth cones and 
protrusions of the plasma membrane (Marsick et al., 2010). These studies illustrate how 
trophic factors induce local changes in the growth cone that are required for growth cone 
mobility, such as cytoskeletal remodeling. Other pathways downstream of trophic factors 
require active communication between the axonal periphery and the cell body. For 
example, the activation of TrkA by NGF induces the local synthesis of the transcription 
factor CREB in the growth cone, which is required for cell survival (Cox et al., 2008). 
However, in order to activate a transcriptional response, transcription factors like CREB 
that are produced at the growth cone in response to trophic factors must be transported 
from the axonal periphery to the nucleus (Figure 2.1).  
 The transport of locally derived signals is accomplished by the motor protein 
dynein as well as its cofactors. Dynein and its cofactors carry signaling components, 
such as transcription factors, in a retrograde manner towards the cell body along 
microtubule tracks (Reck-Peterson et al., 2018). Trophic factors can also regulate the 
mechanical and kinetic aspects of the retrograde transport itself. For example, at least 
two dynein cofactors, Lis1 and p150Glued, are differentially translated in sensory axons in 
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response to the stimulation or withdrawal of NGF, which leads to changes in the speed 
of dynein and regulates the size of the cargo it can carry (Villarin et al., 2016).  
 After a transcription factor arrives in the nucleus and generates a transcriptional 
response, members of the kinesin family carry these cargoes in an anterograde manner 
back to the axonal periphery (Hirokawa et al., 2010). These cargoes can be the 
translated protein from the transcriptional response, the mRNA itself (which can be 
translated on-site at the periphery), essential components of the membrane such as 
cholesterol or fatty acids, and organelles. There is ongoing transport of proteins and 
mRNA between the cell body and neuritic compartments, which helps provide for the 
biological capacity for sustained axon growth (Pfenninger, 2009). The constitutive 
transport of materials to and from the periphery and cell body is concurrent with the local 
pathways that are activated at the growth cone to modify filopodial dynamics. This 
means that as supplies are being brought to the periphery for membrane expansion, 
local structural changes in the cytoskeleton are being activated to stabilize physical 
growth. Hence, trophic cues rely on both local and long-distance cell-intrinsic pathways 
to keep neurons alive and produce the mechanical changes enabling growth (Dent et al., 
2011). 
 
2.1.2 Axon fasciculation 
 Extending axons grow together as bundles or fascicles, which assists with their 
growth and prevents inapposite branching that would result in faulty neural connections. 
The tendency of axons to grow in bundles or fascicles was recognized in early studies 
as the “blueprint hypothesis” (Singer et al., 1979) and later elaborated upon as the 
“labeled pathways” hypothesis using developing grasshopper CNS neurons (Raper et 
al., 1983). Another early surface-mediated mechanism for fasciculation that was 
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identified in invertebrates involved the transmembrane receptor integrin (Baum and 
Garriga, 1997; Hoang and Chiba, 1998). In one study, it was shown that while axon 
length was not impaired by mutations to the ina-1 (integrin) allele, there were clear and 
severe defects in axon fasciculation (Baum and Garriga, 1997).  
 In vertebrates, the role of integrin is more important for neuronal migration 
(Dulabon et al., 2000), synaptic maturity (Huang et al., 2006), or mediating responses to 
guidance cues, as was shown for Semaphorin 7A (Pasterkamp et al., 2003). 
Interestingly, Semaphorin 3A also appears to promote fasciculation when signaling 
through neuropilin-1 (Huber et al., 2005), and it was recently shown that the guidance 
cue Draxin binds netrin-1 and DCC to promote axon fasciculation (Liu et al., 2018). 
These reports demonstrate how classical guidance cues can also promote fasciculation 
in vertebrates. 
 In vertebrates and invertebrates, glycoproteins on the surface of axons, such as 
members of the cadherin family or other cell-adhesion proteins like L1CAM, promote 
fasciculation via homophilic interactions between axons (Dodd and Jessell, 1988). 
Intracellular pathways also regulate axon fasciculation. For example, the adhesion 
proteins NFPC (NF-protocadherin) (Leung et al., 2013) and ALCAM (Thelen et al., 2012) 
are both locally translated in growth cones. It has also been shown that the bidirectional 
Ephrin/Eph pathway in developing axons provides an active way for axons to participate 
in their own fasciculation. This cell-intrinsic control comes as a result of the activities of 
Ephrin and Eph, both of which can act as either ligand or receptor (Cowan and 
Henkemeyer, 2002; Holland et al., 1996).  The EphrinB-EphB2 interaction has been 
described as a way that axons can promote their own fasciculation in a cell-autonomous 
manner (Chilton, 2006) and understanding how axons can communicate and regulate 
their own fasciculation remains an area of interest (Wang and Marquardt, 2013). 
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 The following section discusses some of the other essential cell-intrinsic 
mechanisms that underlie the growth of developing axons. For example, local translation 
has been shown to modulate the response of developing axons to extracellular signaling 
cues (Campbell and Holt, 2001; Leung et al., 2013; Piper et al., 2005; Yao et al., 2006a). 
However, other intracellular signaling pathways can control elements of axon growth in a 
cell-autonomous capacity, including many transcription factor families (Moore and 
Goldberg, 2011). The role of transcription factors during neural development will also be 
examined; in particular, I will discuss how transcription factors localized to the axon can 
act as biological sensors for intracellular and extracellular changes. 
 
2.2 Transcription Factors 
 While estimates vary, it is thought that there are approximately 86 billion neurons 
in the human brain (Azevedo et al., 2009). During neural development, axons traverse 
enormous distances, recognize and respond to intermediate targets, establish precise 
circuits, and regulate neuronal survival by deciphering competing signals and complex 
signaling gradients. As was discussed in a recent review (Stoeckli, 2018), the number of 
guidance cues that have been identified (or most likely will be identified) cannot account 
for the astounding complexity required to produce a mature and functional nervous 
system. And yet it happens anyway – a small subset of extracellular chemical or tactile 
cues produces numerous and diverse responses at precise points during development. 
 One of the explanations for how neurons can decode relatively few guidance cues 
into complex decision-making is due to the activity of transcription factors (Polleux et al., 
2007). Transcription factors bind DNA at unique regions and transcribe the genetic code 
contained within DNA into mRNA. The biological response contained in the mRNA can 
be immediately translated into protein or shipped to a different part of the cell for on-
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demand production at a later time. These transcriptional programs are activated at 
distinct times during neuronal development. To an extent, the transcriptional response 
tells developing axons to follow a preordained plan, regardless of the extracellular 
signaling that is encountered. Because of transcriptional pathways, there is always a 
turnover of receptors, ligands, and intracellular proteins that modulates the response of a 
developing neuron to the extracellular factors that are available to it.  
 Hence, a guidance cue encountered by a neuron can have an attractive or 
inhibitory effect at different developmental checkpoints, such as the response to Shh by 
pre- and post-crossing commissural axons, respectively (Bourikas et al., 2005; Yam et 
al., 2012). The more convincing of these studies demonstrated that the switch towards 
repulsion by post-crossing axons was controlled by increasing levels of 14-3-3 proteins 
in commissural axons over time (Yam et al., 2012). Increased 14-3-3 protein expression 
causes a decrease in the activity of protein kinase A, which in turn regulates growth 
cone turning (Kent et al., 2010). Of course, this type of cell-intrinsic control is not limited 
to Hh. At the optic chiasm, the transcription factor Zic2 regulates the expression of the 
EphB1 receptor on growth cones of developing retinal ganglion cells (Lee et al., 2008b). 
EphB1 is responsible for mediating the repulsion of ipsilateral axons away from 
ephrinB2, which is expressed at the chiasm midline (Herrera et al., 2003; Williams et al., 
2003). The upregulation of EphB1 depends on Zic2, which provides cell-intrinsic control 
for establishing normal binocular vision (Lee et al., 2008b).  
 Transcriptional programs also underlie cell survival. For example, developing 
DRGs require the trophic factor NGF to survive. Cell death in the absence of NGF is 
mediated in part by exerting control at the transcriptional level for the pro-apoptotic 
protein, BAX, whose expression decreases throughout DRG development (Vogelbaum 
et al., 1998). BAX knockout in mice protects against cell death of developing DRGs that 
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are null for either NGF or TrKA (Patel et al., 2000). Hence, NGF is critical for the viability 
of DRGs because of the transcriptional regulation of pro-apoptotic signaling pathways 
throughout development. 
 The activation of transcriptional programs that regulate developing neurons can 
also be driven by extracellular cues and changes in neuronal activity. For example, the 
induction of transcriptional pathways during development (including neurogenesis) 
occurs downstream of a number of extracellular molecules, including Hh (Wilson and 
Stoeckli, 2013), Frazzled/DCC (Neuhaus-Follini and Bashaw, 2015), and Slit/Robo 
(Borrell et al., 2012). Existing neuronal connections can also be refined by transcription 
factors as a result of neuronal activity. For example, calcium-driven activity induces the 
transcription factor NeuroD2 in cortical neurons, which in turn is required for the 
maturation of thalamocortical synapses (Ince-Dunn et al., 2006). All of these cases 
demonstrate the importance of transcription factors for the developing nervous system 
and provide evidence for how complex neuronal connections are formed using only a 
small pool of guidance factors. 
 
2.2.1 Axonally derived transcription factors 
 Axons can span immense distances between the cell body and their target 
regions. For example, axons of motor neurons can extend up to a meter away from the 
cell body (Twelvetrees et al., 2012). To maintain communication with the rest of the 
neuron, axons integrate extracellular signaling cues encountered in the local 
environment, such as around the growth cone, and relay that information to the cell body 
by retrograde transport. The signals derived from the periphery inform the cell body of 
the axonal environment and give the cell the information it needs to respond, for 
example through the generation of a robust transcriptional or translational response. 
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Often the sensors that locally recognize and activate these transcriptional pathways are 
axonally derived transcription factors, either locally synthesized in or localized to the 
axon, and they are essential for how the axon senses changes in the environment. For 
example, in addition to local kinase activity, downstream signaling by NGF/TrkA at 
sensory growth cones is mediated by the axonal transcription factor CREB (Cox et al., 
2008; MacInnis and Campenot, 2002; Mok et al., 2009; Riccio et al., 1997, 1999). 
 CREB was the first locally synthesized transcription factor identified in mammals 
(Cox et al., 2008). This report identified a functional role for axonally derived 
transcription factors by showing that NGF-dependent synthesis and retrograde transport 
of axonal CREB is essential for cell survival. Since then there have been several notable 
studies demonstrating physiological roles for axonally derived transcription factors, 
including for ATF4 (Baleriola et al., 2014), STAT3 (Ben Yaakov et al., 2012; Selvaraj et 
al., 2012; Walker et al., 2018), SMAD1/5/8 (Ji and Jaffrey, 2012), and Luman/CREB3 
(Ying et al., 2014, 2015). Of note, these transcription factors can all be locally translated 
in the axon. It is also known that axons contain a number of mRNA transcripts that code 
for transcription factors (Gumy et al., 2011; Ji and Jaffrey, 2014; Taylor et al., 2009). 
Over the last few years, several reports have established that the axonal activation of 
transcription factors is a conserved response to nerve injury (Ben Yaakov et al., 2012; 
Ohtake et al., 2018; Ying et al., 2014). Following injury, for example after nerve crush, 
axonally derived transcription factors are activated locally and transported to the cell 
body to promote transcriptional programs that are required for survival and recovery. For 
sensory neurons, both the axonal UPR and metabolic cholesterol pathways appear to be 
regulated by axonal Luman/CREB3 (Ying et al., 2015). 
 The retrograde transport of axonal proteins to the cell body is a means for 
communicating information encountered in the axonal periphery to the rest of the 
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neuron. However, transcription factors localized to or produced in the periphery can also 
carry out their functions locally. For example, while the transcription factor STAT3 is 
activated in hippocampal axons exposed to Aβ1-42, it is not transported to cell bodies 
following its activation, suggesting that there may be a conserved local function for this 
transcription factor in the cases of injury and disease (Ben Yaakov et al., 2012; Walker et 
al., 2018). It has been shown that STAT3 helps stabilize microtubules in the axons of 
motor neurons of progressive motor neuronopathy mouse models (Selvaraj et al., 2012). 
One possibility then is that STAT3 is locally required for maintaining axonal structure by 
stabilizing microtubules in the face of a degenerative insult from Aβ1-42 (Walker et al., 
2018) or nerve damage (Ben Yaakov et al., 2012). 
 
2.2.2 The axonal secretory pathway 
 During my graduate studies, I discovered that the C-terminus of the transcription 
factor CREB3L2 is locally secreted from sensory neurons. Neurons themselves are 
highly secretory cells. Mature neurons secrete neurotransmitters into the synaptic cleft 
via synaptic vesicles (Sudhof, 2004) and the ectodomains of many transmembrane 
proteins are shed into the extracellular environment by proteases, including those 
belonging to the ADAM family (Kuhn et al., 2016; Weber and Saftig, 2012). The ADAM 
family has also been shown to promote the growth of sensory axons (Sanz et al., 2017). 
It has previously been shown that transcription factors can enter the secretory pathway 
as well. Notably, the secreted homeodomain transcription factor engrailed-2 functions as 
a guidance cue for axons (Brunet et al., 2005; Maizel et al., 1999, 2002). In neurons 
there is a link between cellular stress and secretion. For example, components of the 
secretory pathway are activated downstream of the unfolded protein response, which 
induces the expression of members of the Golgi-associated GRASP family (Ziel et al., 
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2019), and can mediate unconventional protein secretion (Giuliani et al., 2011; Kinseth 
et al., 2007). The activation of the secretory pathway can be pathologic, such as the 
secretion of the structural protein tau by cortical neurons (Mohamed et al., 2014), which 
is thought to exacerbate neuronal pathology. However, the secretion of proteins can also 
be beneficial; for example, during neurogenesis it has been shown that acute stress in 
the hippocampus drives the secretion of growth factors from astrocytes, which enhances 
cell proliferation (Kirby et al., 2013). In the peripheral nervous system, exosomes 
released by Schwann cells are incorporated into DRG axons and promote sensory nerve 
regeneration after injury (Lopez-Verrilli et al., 2013). The relationship between cell stress 
and the secretory pathways in neurons is in line with the convention that secretory cells, 
which require considerable rates of protein translation and folding, are prone to ER 
stress (Hetz, 2012). Some of the other functions of secreted proteins that have been 
identified include cell-cell interactions, protein folding (e.g. the HSP70 chaperone, which 
is active in the stress response), protein metabolism, and to a lesser extent, 
maintenance of structure (Schubert et al., 2009).  
 Axons contain mRNAs that code for secretory proteins (Gumy et al., 2011) in 
addition to the machinery for an active secretory pathway, including components of the 
Golgi apparatus (González et al., 2016; Merianda et al., 2009). The presence of these 
transcripts indicates that axons possess an active and compartmentalized secretory 
system. In evidence of an axonal secretory pathway, it has been shown that axons that 
were transfected with a viral construct encoding a glycoprotein and separated from their 
cell bodies could locally translate and transport the folded glycoprotein to the axonal 
surface (Brittis et al., 2002). Notably, in the dendritic or axonal compartments, neuritic 
growth can be enhanced or diminished by targeting local components of the secretory 
pathway (Aridor and Fish, 2009; Horton et al., 2005). Several years ago it was shown 
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that the axonal membrane protein NMP35, which is locally translated in axons and 
immediately enters the axonal secretory pathway, promotes the growth of sensory axons 
(Merianda et al., 2013). Together these results illustrate that axons contain an active 
secretory system, but the outstanding question is how that system actually works.  
 Ordinarily when a protein is bound for the secretory pathway, it is folded in the ER 
lumen and encapsulated in vesicles that pass through the cis-face of the Golgi 
apparatus and into a series of membrane stacks known as the trans-Golgi network 
(TGN). The purpose of the TGN is to sort the vesicles and target them to the correct part 
of the cell, such as the cell surface (Guo et al., 2014). However, since axons do not 
contain Golgi stacks and therefore do not have a trans-Golgi network, there is still 
speculation as to how proteins reach the axonal surface. While studies have noted the 
presence of Golgi components in axons (González et al., 2016; Merianda et al., 2009), 
currently there are not enough convincing studies that these Golgi components are truly 
active and functionally contribute to the secretory pathway. In the absence of 
conventional secretory machinery, one compelling explanation for axonal secretion is 
Type IV processing, which would allow for Golgi-independent transport of axonal 
proteins from the ER directly to the cell surface (Rabouille, 2017). In the absence of 
Golgi, proteins can be targeted to the membrane either by encoding a signal peptide or 
containing a sequence that has features allowing for leaderless secretion (Bendtsen et 
al., 2004; González et al., 2018; Rabouille, 2017). Interestingly, it has been shown in rat 
hippocampal neurons that limiting ER-to-Golgi transport diminished the supply of 
membrane proteins to dendrites, which impaired their growth, but did not have a 
corollary effect on the supply of membrane to or growth of axons (Ye et al., 2007). This 
strongly suggests that axons have a Golgi-independent way of transporting biological 
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materials to the cell surface and points to an alternative secretory pathway that is unique 
to the axonal compartment. 
 Members of the OASIS family of transcription factors, which possess a 
transcriptionally active and secreted domain, are expressed and functional in axons 
(Ying et al., 2014, 2015). It has been shown that the C-terminal portions of the OASIS 
family members CREB3L2, OASIS, and CREB4, are secreted into the extracellular 
environment (Saito et al., 2014). Since members of the OASIS family are activated 
during ER stress, the relationship between stress and the secretion of these factors in 
neurons is not surprising. However, their roles in neurons are not fully understood. 
During my graduate studies, I discovered that CREB3L2 is expressed and secreted from 
axons of developing DRG neurons. As I will discuss in the results of Chapter 4, the 
secreted C-terminus of CREB3L2 promotes Shh signaling and axon growth of 
developing DRGs. While I did not study the mechanism of transport to the cell surface, 
Type IV secretion proceeds downstream of the stress response and ER stress is what 
leads to the activation and cleavage CREB3L2. This would make a compelling case that 
the Type IV pathway underlies CREB3L2 secretion in axons.  
 The link between ER stress and the secretory pathway is of particular interest in 
neurons. In the following section, I discuss the role of ER stress and the activation of the 
major ER stress pathways as well as the OASIS family. 
 
2.3 ER Stress 
 As an organelle, the endoplasmic reticulum (ER) is a large, tubular network that is 
comprised of both smooth and rough ER, the latter being decorated with ribosomes. It 
has numerous, vital functions in the cell, including (but not limited to): protein synthesis, 
folding, and secretion, as well as vesicle trafficking, calcium storage, and the synthesis 
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of lipids (Schwarz and Blower, 2016). The ER tubules, or cisternae, are comprised of 
two lipid bilayers separated by a cavity called the lumen, which is the site of folding for 
newly synthesized proteins. The ribosomes studding the rough ER are located on the 
cytosolic side of the membrane; hence a transmembrane protein in the ER can have a 
luminal or cytosolic interface.  
 The ER can be thought of principally as a homeostatic organ. The disruption of 
protein synthesis or accumulation of unfolded proteins can trigger the titular unfolded 
protein response (UPR), and disruption of calcium storage or lipid metabolism will trigger 
a wave of ER stress pathways (Hetz, 2012). The general goal of activating these 
pathways is to return the cellular state to that of homeostasis. However, numerous 
diseases display underlying ER stress (Hetz and Saxena, 2017), and a sustained ER 
stress response is ultimately detrimental to cell health and terminates in apoptosis. 
Apoptosis can be a normal process, such in the skin between human fingers and toes 
during embryogenesis, or it can be devastating, for example the apoptosis of post-mitotic 
neurons of the hippocampus as a result of AD. 
 Because of their highly polar and unique morphology, neurons present a 
particularly interesting case for studying ER stress. The later sections of this thesis 
discuss the ER stress proteins S2P and CREB3L2. This section begins with ER stress 
as a general topic and transitions to the major and minor pathways of ER stress and the 
UPR. Later on I will discuss ER stress in neurons and unconventional roles for ER 
stress. 
 
2.3.1 The main branches of ER stress 
 Following the translation of a polypeptide that is bound for the secretory pathway 
or trans-Golgi network, either in the cytosol or at the surface of the rough ER, the 
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polypeptide is translocated into the lumen of the ER (Rapoport, 2007), where it must be 
folded with the aid of chaperones. As an exception, if the polypeptide is a 
transmembrane protein, it is cotranslationally inserted into the ER membrane (Wessels 
and Spiess, 1988). There are three principal UPR pathways that sense the status of 
folded proteins in the lumen: IRE1, PERK, and ATF6. The first of these pathways to be 
discovered was IRE1, when the gene Ire1 was identified as being critical for viability in 
yeast following ER stress induced by tunicamycin or βMe (Cox et al., 1993).  
 In mammals, IRE1α is a transmembrane sensor with a kinase domain in its 
cytoplasmic side and a unique fold made up of β-sheets in its luminal domain, which 
allows IRE1 monomers (IRE1α and IRE1β in mammals) to dimerize (Credle et al., 2005; 
Zhou et al., 2006). Under steady-state folding conditions, the ER chaperone BiP keeps 
IRE1 monomers in an inactive state. However, when this balance is shifted and unfolded 
proteins accumulate in the lumen, BiP preferentially binds to unfolded proteins (Bertolotti 
et al., 2000; Oikawa et al., 2009) and disengages from IRE1α, allowing IRE1α/β to 
homodimerize. This dimerization event leads to its autotransphosphorylation by the 
kinase domains of IRE1 (Korennykh et al., 2009), which turns on the RNase activity of 
IRE1α (Lee et al., 2008a; Li et al., 2010). This activity leads to the cleavage of full-length 
XBP1 and generation of the XBP1-s (spliced) transcription factor (Hetz, 2012). Active 
XBP1-s is translocated to the nucleus where it upregulates target UPR genes in order to 
restore cellular homeostasis. 
 Like IRE1, PERK is kept in an inactive state by BiP until unfolded proteins 
accumulate in the lumen (Bertolotti et al., 2000), upon which it dimerizes and activates 
its own branch of the UPR by phosphorylating eIF2α. The consequence of eIF2α 
phosphorylation is the suppression of the global translation of proteins. Ordinarily, eIF2α, 
methionyl initiator tRNA (tRNAiMet ), and GTP form a ternary complex that delivers 
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initiator tRNA to the ribosome. Each successive round of translation initiation requires 
that eIF2α be recharged with GTP by eIF2B before it can form a complex with the next 
tRNAiMet (Webb and Proud, 1997). However, p-eIF2α binds and inhibits eIF2B, thereby 
halting translation with the exception of a few transcripts such as ATF4 (Harding et al., 
2000; Vattem and Wek, 2004). 
 Shutting down translation has a twofold effect: it helps the stressed cell conserve 
on energy and nutrients while the selective translation of transcripts such as ATF4 
regulates the expression of genes that restore protein homeostasis or eventually induce 
apoptosis (Harding et al., 2003; Wortel et al., 2017). For example, the latter case has 
been shown to occur in Alzheimer’s disease (Baleriola et al., 2014). Conversely, it has 
also been reported that ATF4 can be protective in Parkinson’s disease by positively 
regulating cellular levels of parkin (Sun et al., 2013). 
 The third major branch of the UPR, ATF6, belongs to the bZIP family of 
transcription factors (Figure 2.2). ATF6 shares several structural similarities to the 
OASIS family, which includes CREB3L2 (BBF2H7), Luman (CREB3), OASIS 
(CREB3L1), CREBH (CREB3L3), and CREB4 (CREB3L4), all of which have a defined 
role related to ER stress (Asada et al., 2011). Each member is a single-pass 
transmembrane protein whose N-terminus projects into the cytosol and whose C-
terminus projects into the ER lumen. The bZIP region in the N-terminus encodes a basic 
leucine-zipper domain that mediates the transcriptional activity of ATF6 and the OASIS 
family. The presence of the bZIP region allows each member to bind DNA as a homo- or 
heterodimer (Reinke et al., 2013; Rodríguez-Martínez et al., 2017). Like IRE1 and 
PERK, BiP is bound to ATF6 on its luminal domain and senses the presence of unfolded 
proteins in the cytosol. However, ATF6 must also be activated by intramembrane 
proteolysis, which is also the case for the OASIS family. 
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Figure 2.2: Relative sizes of human ATF6 and members of the OASIS family. (A) The bZIP 
domain of each protein is depicted in blue and the transmembrane domain is depicted in red. Note 
that the luminal domain of ATF6 is nearly 150 amino acids longer than the largest luminal domain 
of the OASIS family (OASIS, followed by CREB3L2). The size of each entry and position of the 
bZIP and transmembrane domains are reported from the UniProt protein database: ATF6 
(P18850, CCDS1235), CREB3L2 (Q70SY1, CCDS34760), Luman (O43889, CCDS6588), OASIS 
(Q96BA8, CCDS53620), CREBH (Q68CJ9, CCDS12121), and CREB4 (Q8TEY5, CCDS1056). 
Appearance of (A) is based on (Asada et al. 2011). (B) Alignment of the bZIP domain for ATF6 and 
members of the OASIS family. There is a higher degree of conservation in the basic region 
(approximately the first 30 amino acids) than the leucine-zipper (the last 30 amino acids). While 
the basic region recognizes DNA sequences, the leucine-zipper mediates dimerization with other 
transcription factors. The diversity within this region underlies the capacity of each member to form 
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 Initially, ATF6 and the members of the OASIS family are synthesized as full-length, 
inactive precursors residing in the ER membrane. However, upon the induction of ER 
stress, ATF6 and the OASIS family members are cleaved by site-1 and/or site-2 
protease, which liberates the soluble, active transcription factor contained in the N-
terminal portion of the protein (Brown et al., 2000; Rawson, 2013). After its release into 
the cytosol, the activated N-terminus translocates to the nucleus to upregulate UPR 
genes aimed at restoring the cell to homeostasis. As an interesting example of crosstalk 
between the three major ER stress pathways, ATF6 also induces the transcription of 
Xbp1, which is then spliced by IRE1α (Yoshida et al., 2001). 
 
2.3.2 ER stress in neurons 
 There is a compartmentalization of function between the neuritic (dendritic, axonal) 
and somatic regions of a neuron. Moreover, the organelles are not distributed equally 
across these compartments. Because of their polarization, the conventional picture of 
ER stress becomes more complicated in neurons. Does ER stress function in axons like 
it does in other cellular contexts; are there additional or fewer layers of regulation? While 
both smooth and rough ER surround the nucleus in the neuronal cell body, the 
specialized axonal compartment of the neuron contain only long tracts of smooth ER 
(Wu et al., 2017). Despite their immense projection from the cell body and the fact that 
they only contain smooth ER, axons produce proteins locally by the process of local 
translation (Batista et al., 2017; Campbell and Holt, 2001; Hengst et al., 2009; Villarin et 
al., 2016; Wu et al., 2005; Yao et al., 2006a). With respect to ER, the site of axonal local 
translation can differ from dendritic local translation since dendrites contain rough ER in 
their initial segment in addition to the smooth ER distributed throughout the dendritic 
branches (Ramírez and Couve, 2011). However, both dendrites and axons contain 
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ribosomal mRNA and floating ribosomes that mediate local translation (Bodian, 1965; 
Koenig and Martin, 1996; Koenig et al., 2000). Not only are ER stress factors locally 
translated in axons, but the UPR can be activated in axons as well (Ohtake et al., 2018; 
Oñate et al., 2016). Some members of the OASIS family are locally translated in axons, 
such as CREB3/Luman, whose translation was shown to be required for axonal 
regeneration following nerve injury (Ying et al., 2014). In unpublished work, our lab has 
also found that CREB3L2 is locally translated in axons in response to Aβ1-42 (Appendix, 
Figure 5.1).  
 There have been several recent reports showing that beneficial ER stress 
underlies a number of physiological events in neurons. For example, the PERK-
dependent phosphorylation of eIF2α during neural development controls local translation 
in axons in response to semaphorins (Cagnetta et al., 2019). XBP1 has also been 
shown to regulate BDNF expression in the hippocampus. Specifically, mice with a 
conditional XBP1 knockout in neurons have impaired memory formation (Martínez et al., 
2016). It has also been reported recently that the cytoskeletal protein filamin A interacts 
with IRE1α in a non-canonical mechanism that is necessary for cell migration of cortical 
neurons (Urra et al., 2018). All of these examples point to the critical role of ER stress 
pathways during normal neuronal physiology. However, ER stress also underlies the 
regenerative capacity of neurons. For example, in order for there to be axon 
regeneration of sensory neurons following injury, the OASIS family member 
CREB3/Luman must be axonally translated and activated (Ying et al., 2014, 2015). 
Because they are synthesized as inert transmembrane precursors, the axonal activity of 
OASIS family members reflects the fact that they must be properly folded and inserted 
into the axonal ER. Moreover, it also requires that there is a local switch to change them 
from being inert factors into active signaling molecules. 
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 How are axonally derived transcription factors such as ATF6 or the OASIS family 
activated? Earlier it was mentioned that these factors are inert in the ER membrane until 
they are cleaved by the proteases S1P and/or S2P. However, there has not been a 
thorough examination of these proteases in neurons. The following section will expand 
on the role of one of these proteases, S2P, which is known to generate the 
transcriptionally active portion of ATF6 and members of the OASIS family. 
 
2.4 Site-2 Protease 
 S2P is a metalloprotease that is essential for the regulation of lipid and ER stress 
metabolic pathways. One of the early breakthroughs that led to the identification of S2P 
came from the identification of a mutant Chinese hamster ovary (CHO) line, M19, which 
was unable to grow without the addition of exogenous cholesterol and unsaturated fatty 
acid to the cells (Hasan et al., 1994). In the same study, it was found that M19 cells had 
defective expression of HMG-CoA reductase, an enzyme that catalyzes rate-determining 
components of cholesterol biosynthesis and that is transcriptionally regulated by SREBP 
(Goldstein and Brown, 1984). However, (Hasan et al., 1994) reported that the growth of 
M19 in sterol-deficient media could be rescued following the transfection of total human 
genomic DNA, prompting interest to isolate the mutated gene that was unable to 
regulate cholesterol metabolism in M19. At the same time, research efforts were already 
underway to identify the proteases that cleave SREBP, which was known to regulate 
cholesterol synthesis and lipid metabolism (Duncan et al., 1997; Hua et al., 1996; Sakai 
et al., 1996).   
 The SREBP family (SREBP-1a, -1c and SREBP-2) controls intracellular levels of 
lipids, fatty acids, and cholesterol. When lipid or cholesterol levels are low, SREBP is 
activated and upregulates transcriptional targets such as fatty acid synthase and HMG-
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CoA reductase (Brown and Goldstein, 1997; Horton et al., 2003). Prior to the 
identification of S2P, the DNA-binding capacity of the active SREBP transcription factor 
and its role in regulating fatty acid metabolism was already known (Bennett et al., 1995; 
Briggs et al., 1993; Hua et al., 1993; Yokoyama et al., 1993). Moreover, it was known 
that SREBP is oriented in the ER membrane with its N- and C-terminal regions both 
facing the cytosol and that in order to release its transcriptionally active N-terminus it had 
to be cleaved by proteolysis (Duncan et al., 1997; Hua et al., 1995, 1996; Sakai et al., 
1996). However, it was not known what activated SREBP and released its 
transcriptionally active N-terminus from the membrane. In evidence of SREBP activation, 
it was shown that SREBP was released from the membrane specifically by sequential 
proteolytic cleavage (Sakai et al., 1996). Shortly afterwards, another study created 
mutations within SREBP constructs to map the region of site-1 cleavage, dubbing the 
yet-unidentified protease that generates the intermediate SREBP as S1P (Duncan et al., 
1997). This site was predicted to be cut by a protease at the luminal loop connecting the 
cytosol-facing N- and C-termini of SREBP. However, this SREBP intermediate with the 
single proteolytic cut in the loop connecting the N- and C-termini was not 
transcriptionally active. Thus it was recognized that the identity of the protease that 
actually released the transcriptionally active N-terminus of SREBP from the membrane 
was unknown. 
 Working in the mutated CHO line, M19, efforts from the labs of Michael Brown and 
Joseph Goldstein led to the successful isolation of S2P by complementation cloning 
(Rawson et al., 1997). Drawing on the prior report that had identified several DNA clones 
that could rescue defective cholesterol metabolism in M19 (Hasan et al., 1994), Rawson 
and colleagues used a DNA fingerprinting technique (inter-Alu PCR) followed by 
expressed sequence tag (EST) DNA screening to identify the gene Mbtps2 (or S2P), 
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which encodes S2P (Rawson et al., 1997).  If S2P cleavage is prevented, SREBP 
remains bound to the membrane even in the absence of cholesterol and is unable to 
activate its transcriptional programs. This is why SREBP targets like HMG-CoA synthase 
and HMG-CoA reductase could not be induced in the metabolically deficient M19 line as 
reported in earlier work (Hasan et al., 1994). Following the identification of S2P, the 
protease encoding S1P was also confirmed by the Brown and Goldstein labs 
(Espenshade et al., 1999; Sakai et al., 1998). 
 Two important research efforts followed the discovery that S2P cleaves SREBP: 
the identification of other S2P substrates and establishing what is considered the 
canonical mechanism of regulated intramembrane proteolysis (RIP). ATF6 was the first 
protein besides those belonging to the SREBP family that S2P was found to cleave and 
activate (Ye et al., 2000). The authors of this study state they identified ATF6 as a 
candidate for S1P/S2P cleavage by identifying several conserved amino acids in the 
ATF6 transmembrane domain, which resembles the S2P recognition site in SREBPs. In 
addition to this, they noted a glycine-leucine motif in the ATF6 luminal domain, which 
resembles the S1P recognition site in SREBPs (Ye et al., 2000). Like SREBP, this study 
demonstrated that ATF6 must be activated sequentially by S1P and S2P in order for 
transcriptionally active ATF6 to upregulate ER stress pathways. Notably, the cleavage of 
ATF6 was induced by the ER stressor tunicamycin and not by deprivation of sterols (Ye 
et al., 2000). An important conceptual advance of this report was to illustrate that S2P 
activity was not only confined to lipid metabolism, but that it also regulated a major 
pathway of ER stress. 
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2.4.1 Unconventional S2P activity 
 After ATF6 was identified, a conserved picture of S2P activity emerged: an inert 
protein sits in the ER membrane until a designated intracellular signaling event (e.g. low 
cholesterol; ER stress) requires an active transcription factor. First, an initial cleavage is 
carried out by S1P, which eliminates the bulky luminal domain of the protein (Shen and 
Prywes, 2004). This proteolytic event is then followed by S2P cleavage in the 
transmembrane domain, which releases the active N-terminal portion of the transcription 
factor. This sequential process is the canonical RIP mechanism (Brown et al., 2000) and 
it has since governed how every lab has thought about S2P activity. 
 In fact, unlike SREBP and ATF6, S2P does not need prerequisite S1P cleavage in 
order to activate all OASIS family members. In fact, although the significance was never 
expounded upon, several studies have already shown that S2P cleaves OASIS 
(Murakami et al., 2006), CREBH (Zhang et al., 2006), and CREB3L2 (Kondo et al., 
2007), independently of S1P, either by mutating the S1P cleavage site or by inhibiting 
S1P activity. To a lesser extent, Luman can be cleaved independently of S1P, although 
in this case it is not clear if S2P is the protease carrying out the cleavage (Raggo et al., 
2002). So while S1P can and clearly does cleave members of the OASIS family under 
certain contexts, S1P cleavage is not necessary for S2P cleavage to take place. 
 The reason that S1P can be dispensable for OASIS family transcription factors is 
because of the size of their luminal domain, which is far less bulky for all of the OASIS 
members compared to ATF6 (Figure 2.2). In the case of the SREBP family, S1P first 
cleaves SREBPs in the luminal loop between two cytosolic-facing regions to allow S2P 
access to its cleavage site in the transmembrane region of the N-terminus. Although the 
actual luminal portion of SREBP that sticks out of the membrane is quite small, the effect 
of S1P cleavage is to remove essentially half the protein before S2P cleavage can occur 
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(Duncan et al., 1997; Shen and Prywes, 2004). Hence, the primary function of S1P is to 
remove the sterically bulky portion of a protein before S2P cleavage can occur (Shen 
and Prywes, 2004). For the OASIS family, whose members have relatively small luminal 
domains, the prerequisite cleavage by S1P may not be strictly necessary for cleavage by 
S2P to take place. Given that S2P can cleave members of the ER stress-activated 
OASIS family in an S1P-independent manner, it helps explain why the activity of S1P, 
but not S2P, is known to be tightly regulated by sterol levels (DeBose-Boyd et al., 1999; 
Sakai et al., 1996; Zelenski et al., 1999). 
 As a consequence, although S2P can cleave members of the OASIS family 
independently of S1P, the majority of studies have elected to use S1P as the readout for 
proteolysis, which has resulted in a dearth of studies investigating the regulation of 
transcription factors by S2P. The reason why people have focused predominantly on 
S1P is unclear, although most likely the reason for selecting S1P is because according 
to RIP canon, S1P cleavage happens first. Since S2P is by definition supposed to follow 
(Brown et al., 2000), focusing on S1P is similar to tipping over the first domino in a 
sequence and electing to choose the first domino as a readout that the rest of the 
reaction occurred. Indeed, one review on S2P reports a number of proteins that the 
author says are cleaved by S2P simply on the basis that they are also cleaved by S1P 
(Rawson, 2013).  
 However, this focus is problematic when considering the fact that expression of 
S2P and S1P varies both across species and tissues. For example, according to the 
Human Protein Atlas, S2P is expressed in nearly all developed tissues, including the 
brain, but S1P is reportedly not expressed in a number of non-neuronal tissues; neither 
is it expressed in the hippocampus or cerebellum (Uhlén et al., 2015).  
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 As discussed earlier, S2P is essential for the survival of mammalian cells and is 
the major protease required for activating transcriptional responses downstream of ER 
stress and cholesterol metabolism. What are the consequences of S2P mutations in 
vivo? Because it is essential in mammals there is little evidence known about its function 
in vivo using knockout or knockdown approaches. Drosophila lacking S2P are smaller 
than their controls but are viable (Matthews et al., 2009, 2010; Rawson, 2013). This can 
be attributed to the fact that the regulation of cholesterol metabolism in Drosophila can 
be carried out by caspase activity (Amarneh et al., 2009). In contrast, S2P mutations in 
vertebrates result in severe phenotypes.  
 
2.4.2 The role of S2P in vertebrates 
 One of the rare disorders caused by mutations in Mbtps2, the gene coding for 
S2P, is ichthyosis follicularis with atrichia and photophobia (IFAP) syndrome (Oeffner et 
al., 2009). IFAP syndrome results from S2P mutations on the X-chromosome, where the 
protease is encoded, which result in its functional deficiency and as a consequence 
impairs cholesterol metabolism and ER stress pathways (Oeffner et al., 2011; Rawson et 
al., 1997). In this disorder, missense mutations in Mbtps2 result in defective proteolytic 
activity of the translated protein (Mégarbané and Mégarbané, 2011; Oeffner et al., 
2009). This disorder causes a number of severe clinical features including microcephaly, 
an underdeveloped corpus callosum, short stature, vertebral malformations, and loss of 
sebaceous glands, which contribute to dry or scaly skin (Mégarbané and Mégarbané, 
2011).  
 It has also been reported that a missense mutation in the active site of S2P causes 
a form of osteogenesis imperfecta (OI; or brittle-bone disease), due to the reduced 
secretion of type I collagen (Lindert et al., 2016). This report also showed that fibroblast 
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and osteoblast lysates of cells modeling this mutation show impaired activation of 
OASIS, ATF6 and SREBP, which would interfere with collagen secretion and cholesterol 
synthesis. Elements of the secretory pathway, including skeletal development (Melville 
et al., 2011) and chondrogenesis (Saito et al., 2009), are transcriptionally controlled by 
the S2P substrate CREB3L2, and knocking down S2P (or S1P) in zebrafish has been 
shown to impair cartilage development (Schlombs et al., 2003). Unfortunately, to date 
there is no study on S2P that has focused exclusively on its function in the brain. 
However, as discussed earlier, ER stress, the secretory pathway, and transcription 
factors activated by S2P, all play important roles in shaping the developing nervous 
system. Given the importance of S2P in other mammalian cell types, it is worthwhile 
exploring what is known about S2P activity in neurons. 
 There are only a handful of reports where neuronal S2P activity has been 
implicated, although S2P itself was never directly studied. As discussed earlier, ER 
stress pathways are active and essential in the brain and it is known that branches of the 
UPR, including IRE1 and PERK, can be activated locally in axons (Ohtake et al., 2018). 
Notably, it has been shown that members of the OASIS family, which are activated in an 
S2P-dependent manner, are cleaved in the axon in response to nerve injury. For 
example, it has been shown that the mRNA of Luman localizes to axons of sensory 
neurons and is locally translated in response to nerve crush (Ying et al., 2014). This 
study elegantly demonstrates that Luman is cleaved in axons and the N-terminus travels 
retrogradely to the cell body to activate ER stress pathways that promote regeneration of 
the injured axon while the C-terminus remains behind in the axon.  
 While (Ying et al., 2014) did not speculate on or show the protease responsible for 
Luman cleavage, S2P is the one protease that is known to release the N-terminal, 
transcriptional portion of Luman, which suggests that S2P is active in DRG axons. 
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Supporting the fact that S2P should be required for activating Luman, a separate study 
from the same group shows that axon-derived Luman upregulates the cholesterol 
pathway as well as transcription of S2P in response to nerve crush (Ying et al., 2015). 
The strength of these reports is that they show the activation of Luman in a real-time 
response, as opposed to other experimental paradigms that take place over a longer 
period of time. For example, CREB3L2 translation is induced in mouse models of focal 
brain ischemia and knocking down CREB3L2 impairs the ER stress response in neurons 
(Kondo et al., 2007), which implies that CREB3L2 is activated by S2P in neurons. 
However, the moment of activation is not shown and it could also be argued that other 
compensatory mechanisms are in effect. 
 
2.4.3 S2P in developing neurons  
 Developing neurons are an interesting case for studying S2P, not only because ER 
stress machinery is active in developing axons (Cagnetta et al., 2019), but as discussed 
neurons are highly secretory cells and axons themselves can mediate an active 
secretory pathway (Merianda et al., 2009; Wu et al., 2017). This is particularly relevant 
for members of the OASIS family, whose C-termini can be secreted. Transmembrane 
transcription factors such as Luman can be locally translated and activated in axons, 
indicating that there is a local and functional system for proteolysis. However, given the 
vast structural and morphological distinction between neurons and their specialized 
processes compared with the cell lines first used to describe S2P activity, it should not 
be assumed that S2P has the same role in neuronal cells as other mammalian cell 
types. Given the lack of knowledge about S2P in a neuronal context, I set out to examine 
S2P in developing neurons. As will be discussed in the results presented in the 
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manuscript in Chapter 4, I discovered that S2P is expressed and proteolytically active in 
developing DRG axons. 
 My observation that S2P is expressed in developing axons, which has not been 
described previously, suggested that S2P might play a role in axon growth. For my 
thesis, I focused on axons of DRGs given their robust growth and heavy demand on 
biosynthetic pathways to allow for that growth. Given the classic role of S2P in activating 
ER transcription factors, my initial observations that local axon growth was impaired 
when S2P was knocked down or inhibited in axons suggested that an axonal 
transcription factor was unable to be activated (Chapter 4, Figures 2E, 2F; Figure 3B). In 
screening for transcription factors, CREB3L2 was already known to be cleaved by S2P 
(Kondo et al., 2007; Rawson, 2013). Using the same methods that I used to identify that 
S2P promoted axon growth and fasciculation, I screened CREB3L2 and found that it 
was cleaved independently by S2P (Chapter 4, Figures 4A, 4B) and recapitulated the 
effects seen by S2P inhibition or knockdown (Chapter 4, Figures 4E, 4H). In the 
following section, I will discuss CREB3L2, which acts downstream of S2P in developing 
DRGs to promote axon growth. 
 
2.5 CREB3L2 
 CREB3L2/BBF2H7 is a transcription factor belonging to the OASIS family. Its 
translation is highly induced by ER stress (Kondo et al., 2007). Upon its 
cleavage/activation by S2P, the transcriptionally active N-terminus of CREB3L2 
translocates to the nucleus, where it activates UPR and secretory pathways (Ishikawa et 
al., 2017; Kondo et al., 2007; Melville et al., 2011). The structure of CREB3L2 is similar 
to other OASIS family members (Figure 2.2): it is a single-pass transmembrane protein 
containing a transcriptionally active N-terminus with a bZIP domain that binds DNA and 
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permits dimerization, a transmembrane region that contains the S2P cleavage site, and 
a C-terminus that projects into the lumen. The C-terminus of CREB3L2 can be secreted 
and has been found to enhance Hh signaling (Iwamoto et al., 2015; Saito et al., 2014).  
 CREB3L2 was first identified in a rare case of low-grade fibromyxoid sarcoma, 
where it was found to comprise a portion of a chimeric fusion protein with the RNA-
binding protein FUS (Storlazzi et al., 2003). In this study, the authors discovered that the 
first full five exons of FUS and a region of CREB3L2 containing the bZIP domain gave 
rise to a hybrid protein, wherein the RNA-binding portion of FUS was substituted for the 
DNA-binding bZIP region of CREB3L2. While the gene Creb3l2 was noted in the study 
CREB3L2
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ATGAGAGCGG GT CT T CTGCC T T CAT T T TGG ATGCACAT CC CGCT T T AG
ATGAGAGCGG GT CT T CTGCC T T CGT T T TGG ATGCACAT CC CGCT T T AG
ATGAGAGCGG AT CT CCTGCC T T CAT T T TGG ATGCACAT CC CGCT T T AG
ATGAAAGCTG CCT T CT TGCC T T CCT T T TGG ATGCACAGCC CGAT T T AA
ATGCGAGCCG GT T T CT T ACC T T CCT T T CGG ATGCCCAGCC GGGT T T AA
Figure 2.3: Regulation of CREB3L2 by ER stress. (A) The 5’ uORF of CREB3L2 is 
conserved across various higher order vertebrates. CREB3L2 is thought to be lowly 
translated under basal conditions. The presence of the uORF could explain why ER stress 
induces the translation of CREB3L2, similar to ATF4. (B) Regulation of CREB3L2 
downstream of PERK. Cortical neurons were cultured for 10 DIV and treated with 
thapsigargin (1 µM) and/or GSK2606414 (5 µM) for the times indicated. Scramble or 
targeting siRNA were applied for 36 hours before treatments. (C) Quantification of (B). n = 
2 technical, 1 biological replicate. 
A 
B C 
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to be a homolog of the Drosophila gene Bbf-2 (Storlazzi et al., 2003), the function and 
homology of CREB3L2 is best conserved among mammals. 
 The mammalian Creb3l2 mRNA transcript contains an upstream open reading 
frame (uORF) in its 5’ UTR, raising the possibility that CREB3L2 is regulated by 
translation reinitiation in a manner similar to ATF4 (Harding et al., 2000; Vattem and 
Wek, 2004) (Figure 2.3). To date, the ER stress branch that regulates the translational 
induction of CREB3L2 by physiological stress has not been identified. That CREB3L2 
could be translationally controlled downstream of a major ER stress pathway was 
speculated on previously (Kondo et al., 2007), specifically that CREB3L2 acted 
downstream of the PERK-activated branch of ER stress. However, while CREB3L2 and 
ATF4 were both found to be translationally induced by thapsigargin in mouse embryonic 
fibroblasts (MEFs), only CREB3L2 was translated in a PERK-deficient MEF line (Kondo 
et al., 2007).  
 In contrast to this observation, preliminary data I obtained in cortical neurons 
indicated that the thapsigargin-induced translation of CREB3L2 could be prevented with 
the acute application of GSK2606414, an inhibitor of PERK (Figure 2.3). This would 
suggest that the same stress pathway that controls the translation of ATF4 also controls 
the induction of CREB3L2 translation in neurons, i.e. PERK. The observation that 
CREB3L2 might act downstream of PERK in neurons can be reconciled with the 
previous study by acknowledging that CREB3L2 may be regulated through an 
alternative PERK-dependent stress pathway in neural cell types than in a fibroblast cell 
line. Given that ER stress pathways do converge and engage in crosstalk (Hetz, 2012), 
PERK might not be the sole pathway by which CREB3L2 is induced. The fibroblast 
model used previously was knockout for PERK (Kondo et al., 2007), which means that 
other compensatory mechanisms may lead to the induction of CREB3L2 translation. For 
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example, it is possible that the induction of CREB3L2 translation may proceed 
downstream of eIF2α phosphorylation by multiple kinases, including PERK. 
 
2.5.1 Transcriptional activity of CREB3L2  
 The transcriptional activity of CREB3L2 is carried out by its cytosolic, N-terminal 
domain, which is generated by S2P cleavage, contains a bZIP region, and is conserved 
across mammals. The N-terminus of CREB3L2 activates transcriptional pathways that 
promote ER stress and prevent apoptosis (Izumi et al., 2012; Kondo et al., 2007; Saito et 
al., 2009; Sheng et al., 2010). As discussed earlier, ER stress plays important 
physiological roles during development. For CREB3L2, the most notable example of this 
is its activation by physiological stress during chondrogenesis. Mice that are knockout for 
CREB3L2 have severe chondrodysplasia and suffocate immediately after they are born 
(Saito et al., 2009).  
 During development, CREB3L2 upregulates Sec23a, which promotes COPII 
vesicle trafficking and the secretion of extracellular matrix proteins such as type II 
collagen (Ishikawa et al., 2017; Saito et al., 2009). Similarly, the feelgood mutation in 
zebrafish, which is caused by a point mutation in the bZIP region of CREB3L2, impairs 
the expression of Sec23a and Sec23b, and as a consequence disrupts secretory 
trafficking (Melville et al., 2011). The regulation of COPII vesicle formation places 
CREB3L2 squarely in the secretory pathway: upregulation of secretory pathway genes 
by CREB3L2 has been shown to promote notochord formation in Xenopus together with 
Xbp1 (Tanegashima et al., 2009) and activate hepatic stellate cells in rats, enabling their 
proliferation (Tomoishi et al., 2017). 
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2.5.2 The CREB3L2 luminal domain 
 Functionally, perhaps the most unique (and least understood) portion of CREB3L2 
is the luminal domain, which is the C-terminal portion of CREB3L2 that extends into the 
lumen of the ER. Unlike the bZIP domain, the human CREB3L2 C-terminus shares little 
conservation between OASIS family members and it produces no hits on pBLAST other 
than itself. In fact, the homolog of CREB3L2 in Drosophila terminates before the luminal 
region, suggesting that its function is unique to higher vertebrates, such as mammals. 
Based on its sequence, the C-terminus is predicted to undergo non-canonical or 
leaderless secretion (Figure 2.4), meaning there is no signal peptide that targets the 
secreted protein to the extracellular space. Not only is the C-terminus of CREB3L2 
predicted to be secreted based on its sequence, several reports have shown the 
secretion of the CREB3L2 C-terminus and identified a functional role for it (Bendtsen et 
al., 2004; Iwamoto et al., 2015; Saito et al., 2014). Based on its sequence analysis, 
human C-terminal CREB3L2 is glycosylated on amino acids N480, N504, and N517, 
which might play a role in its stability or target it to the secretory pathway (Chan et al., 
2010; Manavalan et al., 2017). After its secretion, C-terminal CREB3L2 is known to 
participate in a non-canonical mechanism where it binds Ihh and promotes the activation 
of the Hh pathway (Saito et al., 2014).  
 As a secreted factor, C-terminal CREB3L2 binds low levels of secreted Ihh, 
preventing its diffusion and facilitating the binding of Ihh to Ptch1 (Iwamoto et al., 2015; 
Saito et al., 2014). CREB3L2 is synthesized as a full-length precursor; in order for the C-
terminus to be secreted it must be liberated by proteolytic cleavage. Through my 
research, I discovered that the secreted C-terminus of CREB3L2 is liberated in DRGs by 
S2P. The next section will discuss the proteolytic activation of CREB3L2 by canonical 
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RIP, as it is understood in the literature, and the evidence for its activation in neurons 
solely by S2P through the work conducted in my thesis. 
 
2.5.3 Proteolytic activation of CREB3L2 
 Given its diverse roles in controlling ER stress, secretion, and activation of Hh 
signaling in at least three cell types (chondrocytes, cancer cells, and neurons), 
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Figure 2.4: Conservation and secretion of C-terminal CREB3L2. (A) Alignment of the first 60 
characters of C-terminal CREB3L2. The C-terminus is more strongly conserved in higher 
order vertebrates (first 4 entries) than lower order vertebrates (last 2 entries). (B) Human C-
terminal CREB3L2 is predicted to undergo leaderless (does not contain a signal peptide) 
secretion. Secretion scores for CREB3L2 were calculated with Secretome 2.0 (Bendtsen et 
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discovery, there have been relatively few reports on CREB3L2. For this reason, there is 
also a lack of consensus on some important aspects of CREB3L2; for example, its 
cleavage and activation. As discussed in the previous section, the understanding of S2P  
activity was strongly influenced by early studies performed in the context of SREBPs and 
ATF6. However, for the OASIS family, S2P has been shown to cleave several members 
independently of S1P cleavage. This is certainly the case for CREB3L2 (Kondo et al., 
2007), which has been confirmed by work presented in this thesis. Not only is the 
expression of S2P alone sufficient to cleave CREB3L2 and generate the C-terminus 
(Chapter 4, Figures 4A and 4B), mutating the S1P cleavage site in CREB3L2 does not 
prevent S2P cleavage from occurring (Appendix, Figure 5.2). Together, these data 
confirm a particularly important point, which is that S2P is the principal protease that 
cleaves CREB3L2 in neurons. CREB3L2 is essential in mammalian cells so the fact that 
S2P activity alone can cleave it would help explain the fact that S1P might not even be 
expressed in certain neuronal cell types (Uhlén et al., 2015). In conclusion, while S1P 
might cleave CREB3L2 in certain contexts, the work conducted in this thesis focuses on 
S2P since it is the essential protease that cleaves CREB3L2 in neurons and generates 
the secreted C-terminus. 
Another point that remains unclear is the organelle in which S2P cleaves 
CREB3L2. Most reports assume S1P and S2P are active in the Golgi. This is based on 
early evidence from SREBP and ATF6, which showed the transport of SREBPs to the 
Golgi by SCAP in the absence of cholesterol (DeBose-Boyd et al., 1999; Nohturfft et al., 
1999) and the accumulation of overexpressed ATF6 in the Golgi following ER stress 
when mutations were made to the S1P cleavage site (Chen et al., 2002b). In both cases, 
given that this is canonical RIP, it was also assumed that S2P cleavage is immediately 
sequential to the cleavage by S1P (i.e. should occur in the Golgi). However, it has also 
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been shown that N-linked carbohydrate chains on S2P are not processed by either α-
mannosidase II or sialyltransferase, which are found in the cis- and trans-Golgi 
compartment, respectively (Zelenski et al., 1999). S2P is also proteolytically active in the 
ER, as shown by several reports that use brefeldin A to merge the trans-Golgi network 
into the ER (Chen et al., 2002b; Kondo et al., 2007; Lippincott-Schwartz et al., 1989; 
Murakami et al., 2006; Shen and Prywes, 2004).  
The difficulty with extrapolating previous studies about S2P and CREB3L2 to 
neurons has to do with the fact that most of the previous experiments were performed in 
cell lines. This thesis presents the finding that active S2P is distributed throughout the 
DRG, including the axon. Although Golgi elements are present in the axon, they could 
not support a protein like S2P, which has several transmembrane domains (Merianda 
and Twiss, 2013; Merianda et al., 2009). The fact that S2P is active in axons suggests 
that it is likely localized to a different organelle other than the Golgi. Most likely this 
organelle is the ER, given that it is the only other organelle where S2P is known to be 
active and where it would be conveniently located in the same compartments as its 
substrates (OASIS family members, for example) (DeBose-Boyd et al., 1999; Murakami 
et al., 2006; Shen and Prywes, 2004). The compartmentalization of S2P in neurons 
therefore presents an interesting starting point for a future project that wishes to examine 
the localization of this protease in specialized structures such as the axon. It would also 
be interesting to see whether a co-localization mechanism between substrate and 
protease promotes constitutive cleavage of proteins such as those belonging to the 
OASIS family.  
In this thesis, I show that S2P is active in axons and cleaves CREB3L2, generating 
its secreted C-terminus. Notably, the C-terminus of CREB3L2 is known to bind Hh 
isoforms and promote their association with the Ptch1 receptor (Saito et al., 2014). As 
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will be covered in Chapter 4, I identified that the C-terminus of CREB3L2 promotes the 
formation of complexes between Shh and Ptch1 along DRG axons. In the following 
section, the role of Hh will be discussed from its identification as a morphogen up until its 
discovery as a chemoattractive molecule.  
 
2.6 Hedgehog 
 Hh was identified by genetic screens in Drosophila, where it was found that fly 
larvae containing a mutation for hh had an abnormal ventricular cuticular pattern, which 
resembled the spines of a hedgehog (Nüsslein-Volhard and Wieschaus, 1980). Since 
the discovery that Hh is required for proper segmentation in the fly, the functions 
discovered for Hh signaling have been numerous. Members of the Hh family have been 
shown to have a polarizing effect on developing (Echelard et al., 1993) and post-
developmental tissues (Reimer et al., 2009), in addition to activating signaling pathways 
in various organs including the brain (Ahn and Joyner, 2005), skin (Brownell et al., 
2011), and bladder (Shin et al., 2011), which are required for cell fate and polarization. 
During embryogenesis, Hh also directs the neuronal differentiation of cell types such as 
motor neurons (Wichterle et al., 2002).  
 The principal vertebrate isoforms of the Hh protein are Sonic Hh (Shh), Indian Hh 
(Ihh), and Desert Hh (Dhh). The Shh, Ihh, and Dhh loci each code for a secreted 
signaling protein with distinct expression domains (Bitgood and McMahon, 1995), and 
the three isoforms can have unique functional roles (Pathi et al., 2001) as well as 
differential expression in tissues (Varjosalo and Taipale, 2008). Conversely, Shh, Ihh, 
and Dhh can cooperate in their signaling, and the Hh isoforms can have some degree of 
functional redundancy. For example, studies examining yolk sac vasculogenesis 
(Astorga and Carlsson, 2007) and left/right asymmetry in mice (Zhang et al., 2001) have 
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revealed redundant signaling roles for Ihh and Shh. Similarly, follicles in the ovary 
require cooperative Ihh and Dhh signaling derived from granulosa cells (Wijgerde et al., 
2005). 
 Hh is synthesized as a full-length precursor and is activated by autoproteolysis in 
the ER by its own C-terminus, producing the active N-terminal signaling peptide (Porter 
et al., 1995), which participates in both long- and short-range signaling pathways. The C-
terminus is essential for Hh autocatalysis and attachment of cholesterol to the N-
terminus, which is essential for the signaling done by the N-terminus (Burke et al., 1999; 
Porter et al., 1996; Roessler et al., 1997), as well as its localization (Chu et al., 2006). 
The N-terminal signaling domains of Shh, Ihh, and Dhh are all conserved, and they have 
similar binding affinities for the Ptch1 receptor (Pathi et al., 2001). The Hh–Ptch ligand–
receptor pathway that was speculated to occur in Drosophila (Hooper and Scott, 1989; 
Nakano et al., 1989) was later confirmed in vertebrates (Marigo et al., 1996; Stone et al., 
1996). In addition to signaling through Ptch, transduction of Hh signaling, e.g. during cell 
fate specification, can also occur downstream of other signaling receptors such as Boc 
and Cdo (Okada et al., 2006; Tenzen et al., 2006; Yao et al., 2006b). 
 The binding of Hh to Ptch activates a conserved signaling pathway in vertebrates: 
when Hh is unbound, Ptch represses the activation of Smoothened (Smo), a 
transmembrane signaling protein that is a member of the G-protein-coupled receptor 
family (Ayers and Thérond, 2010; Luchetti et al., 2016). However, once Hh binds to Ptch, 
it relieves the inhibition on Smo by Ptch, activating downstream pathways. Inhibition of 
Smo is the basis of the drug cyclopamine, which binds directly to Smo (Chen et al., 
2002a), and is frequently used to inhibit Hh signaling. The relief of Smo inhibition by the 
Hh morphogen activates the Gli family of transcription factors (Bai et al., 2004; 
Motoyama et al., 1998). Together, the Gli effectors (Gli1, Gli2, and Gli3) orchestrate 
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developmental decisions such as cell fate, morphogenesis, and spinal cord patterning, 
by acting as activators or repressors of target genes (Bai et al., 2004). It is the 
transcriptionally-dependent activity of the Gli family activated by Hh morphogenic 
signaling that is considered to be the “canonical” signaling pathway (Briscoe and 
Thérond, 2013; Dessaud et al., 2008). 
 In the developing nervous system, one of the best-studied regions of Hh signaling 
is the developing spinal cord. Early studies of this region demonstrated that ablation of 
the notochord, which produces Hh, reduced the number of spinal cord neurons (van 
Straaten and Hekking, 1991), a consequence of disrupting the differentiation and 
position of neural cell types (Bovolenta and Dodd, 1991; Yamada et al., 1991). Similarly, 
it was found that functionally blocking Shh signaling with targeting antibodies eliminated 
the induction of motor neurons (Ericson et al., 1996) and targeted recombination of Shh 
prevented the differentiation of motor neurons and floorplate cells (Chiang et al., 1996). 
The finding that motor neurons and floor plate cells are induced with different thresholds 
of secreted Shh led to the discovery that there is a Hh gradient along the neural tube 
(Ericson et al., 1997; Roelink et al., 1995).  
 In the neural tube, graded Shh as well as retinoids and family members of Wnt and 
BMP collectively control the fate and patterning of neural progenitors by determining the 
transcriptional profiles of neuronal subtypes (Dessaud et al., 2008; Dréau and Martí, 
2012). The concentration and length of exposure to Hh controls the induction of Gli 
transcription factors and their subsequent gene expression profiles (Dessaud et al., 
2007). Sustained (or diminished) levels of Gli activity will cause differential levels of 
expression, repression, or consolidation of these factors, as in the case of Nkx2.2 and 
the transcriptional repressor, Olig2 (Dessaud et al., 2008; Lei et al., 2006; Novitch et al., 
2001). Indeed, changing the level of Gli activity in the developing spinal cord is sufficient 
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to recreate the ventral neuronal patterning of graded Shh signaling (Lei, 2004). The 
resulting picture is that graded Shh signaling, acting in a tightly controlled regulatory 
network with other dorsal-ventral signaling factors, acts as a morphogen to control 
patterning and cell fate in the developing spinal cord. 
 
2.6.1 Hedgehog as a guidance factor 
 In the context of neuronal specification and patterning, a very exciting 
breakthrough for Hh signaling occurred when it was discovered that Shh could act not 
only as a morphogen but also as a chemoattractive guidance cue for commissural axons 
approaching the floorplate (Charron et al., 2003). Vertebrate Hh had been found to 
signal over long-range distances (Gritli-Linde et al., 2001), and the fact that a subset of 
commissural neurons, which are homozygous mutant for netrin, could still reach the 
floorplate offered a clue at the time that other guidance factors worked in concert with 
netrin signaling to attract commissural axons (Serafini et al., 1996).  
 In a surprising development, the attraction of these pre-crossing commissural 
neurons by Hh was found to be mediated not by transcription, but through the activation 
of Src family kinase (SFK) (Yam et al., 2009). It was later found that Hh can act as a 
switch to induce repulsion by Semaphorin 3A through the cAMP/protein kinase A 
pathways at the midline (Parra and Zou, 2010). This non-canonical signaling mechanism 
illuminated a new facet of Hh signaling, where active Hh encountered in the axonal 
periphery could elicit an immediate, local response in the axon. Another recent example 
of this phenomenon is the secretion of Shh by contralateral retinal ganglion axons to 
repel ipsilateral ganglion axons at the optic chiasm through Boc and Smo (Peng et al., 
2018).  
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 As discussed earlier, axons are faced with the challenge of forming immensely 
complicated connections during development. It has been proposed that crosstalk 
mechanisms provide a way for developing axons of numerous neuronal types and 
subclasses to reach their targets with a modest number of guidance cues and receptors 
(Stoeckli, 2018). Hh signaling, as a morphogen or guidance factor, can be modulated by 
a number of different factors, including the co-receptors Boc and Cdo (Kavran et al., 
2010; Tenzen et al., 2006; Yao et al., 2006b), cell surface proteoglycans (Whalen et al., 
2013; Yan and Lin, 2009), and Hh-interacting protein (Bourikas et al., 2005; Chuang and 
McMahon, 1999). Pathways such as these allow for cells to activate and control a 
diverse array of intracellular signaling choices with a conserved ligand-receptor 
interaction.  
 
2.6.2 The CREB3L2-Hedgehog complex 
 Another novel Hh signaling complex was recently described in chondrocytes, 
where a ternary complex between Ihh, Ptch1, and the secreted C-terminus of CREB3L2 
was identified (Saito et al., 2014). This study found that the C-terminus of CREB3L2 is 
secreted and binds Ihh extracellularly, which promotes its association with the Ptch1 
receptor and induces chondrocyte proliferation. In this thesis, I identified a similar 
mechanism that occurs in DRGs where the C-terminus of CREB3L2 binds Shh and 
enhances the formation of complexes between Shh and Ptch1, which promotes axon 
growth. The Shh of this complex is also produced and activated in DRGs, making this a 
cell-intrinsic mechanism for regulating the growth of sensory axons during development. 
 DRG neurons do not respond to exogenously supplied Shh (Trousse et al., 2001), 
nor have DRGs been a classic model used to study Shh signaling. However, DRGs do 
produce Shh as well as Smo and Ptch1, and Shh knockdown prevents both neurite 
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outgrowth and axon regeneration after injury (Martinez et al., 2015). One reason DRGs 
do not respond to exogenous Shh could be due to the fact that they produce functionally 
saturating levels of activated Shh on their own. Hence, Shh derived from other sources 
does not attract developing DRG axons (Trousse et al., 2001) while knocking down 
endogenous Shh impedes their growth (Martinez et al., 2015). 
 
2.7 Final points 
 The project outlined in this thesis identifies a neuron-intrinsic way that axons can 
influence their own growth. The CREB3L2-Shh signaling complex has not been 
identified previously in neurons. By modulating their own Shh signaling pathway, I 
propose that DRG axons are able to control their own growth. The results presented in 
this thesis also demonstrate how ER stress-associated proteins are required for axon 
growth. As my experimental approach, I used DRG explants and live-imaging assays in 
microfluidic devices that allowed me to study the rate of DRG axon outgrowth.  
Surprisingly, I found that rather than relying on the activation of canonical transcriptional 
pathways downstream of S2P, the C-terminus of CREB3L2 is secreted from axons into 
the extracellular environment.  Once secreted, the C-terminus of CREB3L2 binds Shh 
and activates Hh signaling by promoting the association of Shh with its receptor, Ptch1.  
 This project expands our understanding of the unconventional role of ER stress in 
the nervous system. Beneficial ER stress factors are important for neuronal health and 
given that neurons are highly secretory cells, it follows that ER stress-associated 
pathways would promote the secretion of factors that are required for axon growth. In 
this thesis, I identify a novel role for two ER stress factors that were previously 
unassociated with axon development: S2P and CREB3L2. Given that S2P is known to 
be essential for mammalian cells but has not been directly studied in neurons, identifying 
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the localization of S2P to axons and describing its connection with Shh is an entirely new 
finding. The work presented in this thesis ties together the topics that have been 
discussed in this introduction: the cell-intrinsic control of axon growth, the role of 
axonally derived transcription factors during neural development, ER stress and the 
secretory pathway, S2P and CREB3L2, and the activation of Shh signaling.  
 In Chapter 3 I expand on the materials and methods used for the manuscript 
presented in Chapter 4. While this work is yet published, the manuscript is currently 
under peer review.  
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Chapter 3. Materials and Methods 
3.1 Animal Use 
3.1.1 Rat handling 
Pregnant Sprague Dawley rats (Rattus norvegicus) were obtained from Envigo 
and housed in a high-level barrier facility at the Columbia University Institute of 
Comparative Medicine (ICM).  All animal procedures were approved by the Columbia 
University Institutional Animal Care and Use Committee (IACUC). 
 
3.1.2 Euthanasia 
Rodents were euthanized by gas displacement with 5% min-1 CO2 for 
approximately 7 min, until there were no signs of breathing.  Bilateral thoracotomy was 
used as a secondary measure of euthanasia to ensure death. 
 
3.2 Tissue Culture 
3.2.1 Dorsal root ganglion cultures 
Stage E14 rat embryos were removed from the uterus of the pregnant dam 
immediately following euthanasia and placed in a dish containing cold Leibovitz L-15 
medium. The remainder of the dissection was performed in a positive pressure hood.  
Primary DRG neurons were harvested from the embryos and trypsinized with TrypLE for 
20 min at 37°C. Trypsinized DRGs were washed in HBSS and dissociated by trituration 
in DRG growth medium (Neurobasal, 1x B27, 1x L-glutamine, 1x Pen/Strep, 20 µM 5-
FdU, 50 ng mL-1 NGF) with a fine pipette tip. Cells were passed through a 0.45 micron 
mesh filter to achieve single-cell density and seeded at approximately 40,000 cells per 
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microfluidic device or 400,000 cells per well in 6-well dissociated culture. For explant 
cultures, individual DRG explants were removed from the E14 embryo and seeded 
individually in a 6-well plate in DRG medium on PLL- and laminin-coated coverslips in a 
6-well plate. DRG cultures were maintained until DIV2, when the medium was fully 
replaced with fresh growth medium containing 5 ng mL-1 NGF for all cultures and 20 µM 
5-FdU for microfluidic and dissociated cultures only. 
 
3.2.2 Hippocampal cultures 
Stage E16 rat embryos were removed from the pregnant dam immediately 
following euthanasia and placed in a dish containing cold HBSS. Hippocampi were 
harvested from the embryos according to a well-known protocol (Banker and Goslin, 
1998) and trypsinized with TrypLE for 20 min at 37°C. Trypsinized hippocampi were 
washed in HBSS and dissociated by trituration using a flame-polished pipette. The cells 
were then passed through a 0.45 micron mesh filter and centrifuged for 5 min at 1000 
rpm at 4 °C. Cells were then resuspended in hippocampal plating medium (Neurobasal, 
10% FBS, 1X B27, 1x L-glutamine, 1x Pen/Strep) and seeded in microfluidic devices at 
approximately 55,000 cells per chamber. On DIV1, plating medium was exchanged for 
serum-free growth medium (Neurobasal, 1X B27, 1x L-glutamine, 25 µM 5-FdU), and 
maintained until DIV 5, when half the medium was replaced with fresh serum-free growth 
medium. Half the media was exchanged in this manner every 2-3 days thereafter until 
the completion of each experiment. 
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3.2.3 Microfluidic devices 
Tripartite microfluidic devices were produced from molds designed in-house and 
manufactured at the Advanced Science Research Center NanoFabrication Facility of the 
Graduate Center at the City University of New York, based on previous reports (Park et 
al., 2006; Taylor et al., 2005). Briefly, photomasks were designed using AutoCAD 
software and ordered according to specification (Front Range Photomask). To 
manufacture the microfluidic silicon masters, 100 mm silicon wafers (University Wafer, 
Inc.) were dehydrated at 200ºC for 5 minutes on a hot plate and cleaned with 
pressurized nitrogen. The grooves of the microfluidics were produced by spinning a layer 
of SU-8 at 2500 rpm for 60 seconds, aligning the wafer to the photomask containing the 
grooves, and exposing the SU-8 layer to 100 mJ/cm2 UV using a Nanoscribe Photonic 
Professional 3D Lithography mask aligner. The wafer was then hard-baked at 95ºC, 
cooled to room temperature, and submerged in propylene glycol methyl ether acetate 
(SU-8 developer) with gentle agitation. Next, the wells of the microfluidics were produced 
by spinning a layer of SU-8 2050 over the groove layer at 1500 rpm for 60 seconds. The 
photomask for the wells was then aligned over the existing layer of microgrooves on the 
wafer using the mask aligner and exposed to 230 mJ/cm2 UV. Afterwards, the wafer was 
hard-baked at 95ºC, cooled to room temperature, and submerged in SU-8 developer, 
followed by a wash with isopropanol and a hard-bake at 150ºC. 
After the masters were manufactured, the tripartite microfluidic devices were 
produced from a 9:1 elastomer base to curing agent mixture of Sylgard 184 (Ellsworth 
Adhesives). The bubbles produced from the PDMS mixture were allowed to dissipate for 
approximately 20 minutes and were then baked overnight at 65°C, or approximately 12 
hours. The following day, the molds were removed from the incubator and allowed to 
cool to room temperature for 2 hours. Individual microfluidic chambers were cut out and 
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the reservoirs were opened with a sterile biopsy punch. The chambers were then 
cleaned with vinyl tape to remove any existing debris that could interfere with adhesion 
to coverslips or optical dishes. Afterwards, the chambers were washed briefly in 70% 
ethanol in a cell culture hood and allowed to air-dry before use. 
 
3.3 Experimental Interventions 
3.3.1 Targeted RNA interference with siRNA 
The silencing of Mbtps2 and Creb3l2 mRNA transcripts in DRGs was achieved 
using targeting siRNA (Invitrogen). The following duplex siRNA sequences were used to 
target Mbtps2 (NM_001035007.1) and Creb3l2 (NM_001012188.1): 
Mbtps2 siRNA 1 – 5’-GCAUACAUGUCUACCUGCCCGGAAA-3’  
Mbtps2 siRNA 2 – 5’-UUUCCGGGCAGGUAGACAUGUAUGC-3’  
Creb3l2 siRNA 1 – 5’-CGAGGGCUAUCCCAUUCCAACCAAA-3’   
Creb3l2 siRNA 2 – 5’-UUUGGUUGGAAUGGGAUAGCCCUCG-3’  
Negative control siRNA was purchased from ThermoFisher Scientific (Stealth RNAi 
siRNA Negative Control Med GC Duplex #3) and used in parallel with targeting siRNAs 
in all experiments. The efficacy of each siRNA and confirmation of knockdown was 
validated by RT-PCR. Whenever microfluidic devices were used, siRNAs were delivered 
using the NeuroPORTER transfection reagent (Genlantis). Whenever dissociated 
cultures were used, siRNAs were delivered using Lipofectamine 3000. Transfections 
with siRNA were performed according to the guidelines of the respective company. 
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3.3.2 Electroporation 
The delivery of siRNA into DRG explants was achieved using electroporation. 
Following the dissection of whole-strip DRG explants from E14 rat embryos, the explants 
were fixed in place at the bottom of a 0.4 cm Gene Pulser cuvette (Bio-Rad). 
Electroporations were performed in 500 microliters cold 1X MMR buffer (100 mM NaCl, 
2 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 5 mM HEPES, 1 mM EDTA) using the ECM830 
Square Wave Porator Harvard Apparatus (BTX). The following program was used to 
deliver siRNA to DRG explants: 100 V, 50 ms pulse length, 4 pulses, 1 s interval. 
Approximately 30 micrograms of siRNA was adjusted in the MMR buffer for each 
electroporation. Immediately following the electroporation, the DRG explants were 
returned to cold Leibovitz (L-15) medium for recovery. Electroporations of siCntrl, siS2P, 
and siCreb3l2 used for Sholl analyses were all performed in parallel. The 
electroporations for siCntrl and siS2P with the exogenous CREB3L2 C-terminus rescue, 
or the BSA control rescue, or for DMSO and robotnikinin, were also performed in 
parallel.  
 
3.4 Experimental Methods 
3.4.1 Quantitative immunofluorescence 
Cultured neurons were fixed using 4% PFA in cytoskeletal buffer (10 mM 2-(N-
morpholino)ethanesulfonic acid [MES], 3 mM MgCl2, 138 mM KCl, 2 mM EGTA, 0.32 M 
sucrose [pH 6.1]) for 20 minutes in the dark. The cytoskeletal fixative was washed out 
with one wash in 1X TBS followed by two washes in 1X TBST to permeabilize the cells. 
Following permeabilization, neurons were blocked for 30 minutes with BGT (3 mg mL-1 
BSA, 100 mM glycine, and 0.25% Triton X-100) at room temperature. The following 
antibodies were applied overnight at 4°C: rabbit S2P (1:200, Abcam, 196797), mouse 
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S2P (1:100, Santa Cruz, 293341), rabbit N-terminal CREB3L2 (1:100, Sigma-Aldrich, 
HPA015068), rabbit C-terminal CREB3L2 (1:100, abcam, 102989).  
The following day, the samples were washed with TBST and incubated with 
fluorophore-conjugated Alexa secondary antibodies (1:500) and anti-βIII-tubulin 
conjugated to Alexa Fluor 488 (1:500, BioLegend, 801203) in the dark for 1 hour at room 
temperature. The samples were mounted using ProLong Diamond Antifade (Invitrogen). 
Images of the samples were acquired using an Axio Observer.Z1 inverted microscope 
equipped with an AxioCam MRm Rev 3. Camera (Zeiss) or a Zeiss LSM 800 confocal 
microscope. The acquisition settings were kept the same for each set of samples in any 
given experiment. For the detection of secreted C-terminal CREB3L2 on the surface of 
DRGs, the cells were not permeabilized before labeling with the C-terminal antibody. 
Following incubation with C-terminal CREB3L2 primary antibody overnight at 4 degrees 
in a BSA/TBS buffer, DRGs were washed three times with TBS to remove any excess 
antibody. Afterwards, the samples were permeabilized with TBST and labeled with 
fluorophore-conjugated Alexa secondaries and conjugated tubulin. 
 
3.4.2 Proximity Ligation Assay 
Protein-protein complexes were labeled using PLA. First, DRGs were fixed and 
prepared with primary antibodies as described in the section on quantitative 
immunofluorescence. The following antibodies were used: mouse N-terminal CREB3L2 
(1:100, Santa Cruz, 515816), rabbit C-terminal CREB3L2 (1:100, abcam, 102989), 
mouse Hh (1:100, Santa Cruz, 365112), rabbit Ptch1 (1:100, ProteinTech, 17520-1-AP). 
The following day, any unbound antibody was washed off with a 2X TBST wash and the 
samples were labeled with plus or minus conjugated PLA probes, and incubated for 1 
hour at 37°C. Following a 2X TBST wash, the probes were ligated for 30 minutes at 
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37°C. Following another 2X TBST wash, the ligation reaction was followed by the 
amplification reaction (Duolink in situ detection reagents red, Sigma Aldrich) for 100 
minutes at 37°C. The samples were then washed 2X in TBS and labeled with anti-βIII-
tubulin conjugated to Alexa Fluor 488 (1:500, BioLegend, 801203) in the dark for 1 hour 
at room temperature. Afterwards the samples were washed 1X in TBS followed by 1X 
with ddH2O and were mounted using Duolink Mounting Media with DAPI. All PLA 
reactions were prepared on glass bottom cultures dishes (MatTek) and imaged 
immediately. 
 
3.4.3 Live-imaging and outgrowth assays 
DRGs were seeded in microfluidic devices prepared on glass bottom dishes and 
grown for 4 DIV. Tripartite microfluidics were used to provide maximum separation 
between the distal axon and cell body (≥1500 µm from soma to growth cone) and all 
imaging was performed in the most distal axonal compartment. To measure the average 
growth rate, microfluidics were briefly removed from the incubator and images were 
acquired along the microgrooves in the distal axonal compartment. After acquiring these 
images, fresh growth media containing 5 ng mL-1 NGF was applied to the axonal 
compartment and the microfluidic devices were returned to the incubator to allow the 
axons to grow for 1 hour. If a pharmacological agent was used, for example 15 µM 
nelfinavir or 30 µM ciliobrevin A, it was supplemented into the fresh growth media 
containing 5 ng mL-1 NGF with the proportional volume of DMSO as a vehicle for the 
control conditions used in parallel.  
After 1 hour, the devices were brought back to the microscope and images were 
acquired from the same fields imaged at the initial hour and the average rate of growth 
was calculated for every axon as the distance spanned between t = 0 hour and t = 1 
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hour using the FIJI plugin Simple Neurite Tracer (Longair et al., 2011). All images were 
acquired using an Axio Observer.Z1 inverted microscope equipped with an AxioCam 
MRm Rev 3 and, during all imaging, neurons were kept in a CO2-, and humidity-
controlled incubation chamber maintained at 37°C. Only axons that grew individually 
(that is did not make contact with another axon during the assay) were counted. Any 
minor retractions in growth were scored as zero. 
 
3.4.4 Quantitative Real-Time PCR 
Total RNA was collected from neurons with RNA lysis buffer and purified using 
the Direct-zol RNA purification kit (Zymo Research). RNA was purified according to 
manufacturer instructions and included a DNase1 digestion step. Purified RNA was 
measured by qPCR using the One-Step RT-qPCR kit (Bio-Rad) and gene-specific 
Taqman probes. Transcripts were measured in a StepOnePlus Real-Time PCR system. 
Experimental transcripts in each condition were normalized to the control transcript 
Tubb3. Relative fold gene expression is reported as 2–∆∆Ct. 
 
3.4.5 Immunoblot 
 DRG neurons were seeded at a density of 400,000 cells per well in 6-well plates 
and cultured for a total of 5 DIV. If siRNAs were to be used in the experimental design, 
they were transfected on DIV3 using Lipofectamine 3000 according to the instructions of 
the manufacturer for 48 hours. For protein isolation, each well was washed once in 2 
milliliters of cold HBSS and collected on ice in 100 µL cold RIPA buffer supplemented 
with protease and phosphatase inhibitors (Pierce). To prepare the samples for Western, 
10 µL of RIPA from each sample was mixed 1:1 with 10 µL 2X Laemmli sample buffer 
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(4% SDS, 20% glycerol, 120 mM Tris-HCl [pH 6.8]) containing 10% β-Me. The samples 
were heated at 100°C for 5 minutes, cooled to room temperature and spun down briefly 
with a tabletop centrifuge, then loaded into a precast NuPAGE Bis-Tris gel (Thermo 
Fisher Scientific). Gels were run at 65 V for 20 minutes followed by 165 V until 
completion. For transfer, 0.45 micron PVDF membrane was activated in methanol and 
sandwiched with the gel. Transfers were run for 2.5 hours on ice at 30 V. Following the 
transfer step, the PVDF membrane was incubated with an antibody of interest at 4°C 
overnight in TBS-T. For detection, blots were washed in TBS-T and incubated with their 
respective secondary antibodies (1:5000 anti-Ms-HRP or anti-Rb-HRP) for 1 hour at 
room temperature and developed with 1-Shot Digital-ECL (KindleBio, R1003). Images 
were acquired using the KwikQuant Imager (KindleBio, D1001).  
For the IP of secreted C-terminal CREB3L2 from DRG medium, the medium 
covering the wells of dissociated rat DRGs was collected and centrifuged at 10,000 x g 
for 20 minutes at 4°C to remove any debris. The media was then adjusted with protease 
and phosphatase inhibitors to prevent any degradation of protein and supplemented with 
a primary antibody against C-terminal CREB3L2, Shh, or the appropriate IgG control 
antibody adjusted to the same concentration as the targeting primary. The medium with 
primary was rotated overnight at 4°C. The next day anti-rabbit IgG Dynabeads were 
blocked 30 minutes in BGT at 4°C and 30 microliters were added to the IgG control and 
C-terminal CREB3L2 condition using a cut P200 pipette. The samples were rotated for 6 
hours at 4°C and washed 4X in cold wash buffer (10 mM Tris-HCl [pH 7.4], 150 mM 
NaCl, 0.1% Tween-20). Following the washes, the samples were suspended in 30 
microliters 1X Laemmli sample buffer with 5% βMe and prepared for Western as 
described above. To recognize specific IP signal over contamination from IgG, Veriblot 
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(1:200, Abcam) was used. Images were acquired using the KwikQuant Imager 
(KindleBio, D1001).  
 
3.4.6 Purification of C-terminal CREB3L2  
 HEK293 cells were cultured to approximately 50% confluency and transfected for 
24 hours with a plasmid encoding C-terminal CREB3L2 followed by a hexa-histidine tag. 
After washing the cells once with cold HBSS, the cells were lysed in 5 milliliters of cold 
RIPA buffer supplemented with protease and phosphatase inhibitors (Pierce). The lysate 
was collected on ice and passed through a 21G1 followed by a 25G5/8 needle three to 
five times to shear DNA. The lysates were centrifuged at 4°C Celsius for 20 minutes at 
12,000 rpm and the supernatant containing C-terminal CREB3L2 was collected, leaving 
behind the pellet. The C-terminus was purified using HisPur Ni-NTA resin (Thermo) 
according to the manufacturer instructions for purification of His-tagged proteins by 
batch method. Briefly, one milliliter of resin was loaded with the HEK293 lysate and 
rotated head-over-end at 4°C for 30 minutes. Afterwards the resin was washed 3-4 times 
with 5 milliliters each of cold TBS supplemented with 25 mM imidazole. After the wash 
steps, the final elution was performed with 1 milliliter of cold TBS supplemented with 250 
mM imidazole. The final elution was then desalted using an Amicon Ultracel-3K 
centrifugal filter unit (Millipore) and the purified product was measured by BCA analysis 
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3.4.7 Immunohistochemistry 
 To prepare the in vivo spinal cord and DRG section, a small (4 mm) midline portion 
of an E16 rat embryo was isolated in a 10 cm dish of cold HBSS. The blood was cleared 
with two brief washes in 50 ml cold HBSS. The section was then fixed with 20 ml of 4% 
PFA in cytoskeletal buffer (10 mM 2-(N-morpholino)ethanesulfonic acid [MES], 3 mM 
MgCl2, 138 mM KCl, 2 mM EGTA, 0.32 M sucrose [pH 6.1]) for 3 hours (penetrance is 
approximately 2 to 3 mm per hour). The PFA was removed with 2 washes in TBS and 
was followed by sucrose infiltration at 10%, 20%, and 30% in TBS until the sample 
reached the bottom of the vial in each solution. The sample was then embedded in 
O.C.T compound (Fisher Scientific) on dry ice. 20 µm sections were taken from the 
O.C.T. block with a Microm HM505e cryostat, and inverted onto Superfrost Plus 
coverglass (Fisher Scientific). The sections were permeabilized in TBS containing 0.1% 
Tween-20 and blocked for 30 min with 3 mg ml-1 BSA, 100 mM glycine, and 0.25% 
Triton X-100 for 30 minutes. Afterwards, the sections were incubated overnight at 4°C 
with rabbit S2P (1:100, Abcam, 196797) and chicken Neurofilament (1:500, Abcam, 
4680) primary antibodies in BGT. The following day the sections were washed with TBS 
and incubated with fluorophore-conjugated Alexa secondary antibodies (1:500) in the 
dark for 1 h at room temperature. Samples were mounted with ProLong Diamond 
Antifade (Invitrogen, Carlsbad, CA) and images were acquired using a Zeiss LSM 800 
confocal microscope using a 10x objective and 40x oil objective and Zen Blue 2.1 
software. 
 
3.4.8 DNA constructs 
 The GFP-CREB3L2-mCherry (GCM) construct was produced by modifying a full-
length CREB3L2 plasmid that was originally obtained from Genecopoeia (EX-H2495-
  59 
M01-GS; NM_194071). First, the open reading frame (ORF) of CREB3L2 was subcloned 
into a vector containing GFP (Takara, pEGFP-C1) using the In Fusion HD Cloning Plus 
kit (Takara, 638913). Afterwards, the ORF for mCherry (Takara, pmCherry-C1, 632524) 
was amplified and inserted into the GFP-CREB3L2 construct using the In Fusion kit. To 
produce the C-terminal fragment of CREB3L2 used for purification, the full-length 
CREB3L2 plasmid was modified by site-directed mutagenesis using the In Fusion kit to 
produce an ORF encoding a start codon followed by the truncated human protein that 
results from the cleavage site of S2P, which contains amino acids 386 through 520, 
followed by a hexa-histidine tag. The CREB3L2 constructs were cloned using Stellar 
competent cells (Takara, 636766) and purified with the ZymoPure Plasmid Midiprep kit 
(Zymo Research). The S2P construct pCGN-S2P-WT was a gift from Ron Prywes 
(Addgene, 32957). The sequences of all DNA products described above were validated 
by Sanger sequencing. 
 
3.5 Experimental Analysis 
3.5.1 Sholl analysis 
To provide an objective measure of assaying axon growth, the axons of DRG explants 
were measured using the Sholl analysis FIJI plugin according to the recommended 
guidelines (Ferreira et al., 2014). Explant images were imported into FIJI (Schindelin et 
al., 2012) and thresholded to comparable levels across conditions. Using the straight line 
tool, a line was drawn from the center of the explant (the ganglia containing the cell 
bodies) to the most distal axonal region. This line defines the starting and ending radius. 
The step size in the setting was defined as 10 µm. The output of the Sholl analysis gives 
the number of (axonal) intersections, which are the number of axons encountered within 
a given shell. Hence, as you project outwards from the center of the explant, there is a 
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diminishing number of intersections. The plot of this analysis gives the number of 
intersections along 2D distance in micrometers. However, since the cell bodies are also 
falsely scored in this analysis, the number of concentric shells were divided and only the 
second distal half were analyzed in order to restrict the analysis to axons. To plot the 
Sholl analysis as indicated in the figures, the average number of axonal intersections 
within each shell were plotted along every 10 µm step size per condition. To determine 
changes in axon growth for statistical analysis, the area under curve (AUC) was 
calculated for each explant per condition.  
 
3.5.2 Statistical analysis 
All experiments were performed with a minimum of three biological replicates and 
contained several technical replicates per biological condition. Two means were 
compared using the Mann-Whitney unpaired t-test, whereas multiple means were 
compared by the Kruskal-Wallis test with Dunn’s multiple comparison test. Statistics 
were performed using GraphPad Prism 6 software (GraphPad Software). 
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Axon growth is regulated externally by attractive and repulsive cues generated in the 
environment. In addition, intrinsic pathways govern axon development, although the 
extent to which axons themselves can influence their own growth is unknown. We found 
that dorsal root ganglion (DRG) axons secrete a factor supporting axon growth and 
identified it as the C-terminus of the ER stress-induced transcription factor CREB3L2, 
which is generated by site-2 protease (S2P) cleavage in sensory neurons. S2P and 
CREB3L2 knockdown, or inhibition of axonal S2P, interfered with the growth of axons, 
and C-terminal CREB3L2 was sufficient to rescue these effects. C-terminal CREB3L2 
formed a complex with Shh and stabilized its association with the Patched-1 receptor on 
developing axons. Our results reveal a neuron-intrinsic pathway downstream of S2P that 
promotes axon growth. 
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Introduction 
During neural development, numerous extracellular guidance and neurotropic cues steer 
and modulate axon growth (Stoeckli, 2018). In addition to these extrinsic signals, there 
are also neuron-intrinsic pathways that regulate axon growth. These pathways are 
essential because they allow axons to carry out diverse behaviors in response to a 
limited number of extracellular signaling factors. For example, differential expression of 
transcription factors determines responsiveness to guidance cues, and these factors can 
act as retrograde signals to relay the information from extrinsic signals from axons to the 
cell bodies (Butler and Tear, 2007; Polleux et al., 2007). 
Transcription factors can be activated in axons by local synthesis (Baleriola et al., 2014; 
Ben-Yaakov et al., 2012; Cox et al., 2008; Ji and Jaffrey, 2012; Ying et al., 2014) or 
through intramembrane proteolysis of precursor proteins catalyzed by specific 
membrane-bound proteases (Hoppe et al., 2001). For example, site-2 protease (S2P) 
cleaves endoplasmic reticulum (ER) membrane-bound proteins, leading to the 
generation of soluble, cytoplasmic transcription factors (Rawson, 2013). As an organelle, 
the ER is essential for maintaining cellular homeostasis. In response to various cellular 
stressors, adaptive response pathways of the unfolded protein response (UPR) are 
activated in the ER, which trigger intracellular changes aimed at preventing cellular 
damage. Additionally, there is a growing body of evidence that ER stress and the UPR 
have beneficial or protective neuronal roles aside from reacting to acute stressors. 
Examples for this so-called physiological ER stress in the nervous system include the 
regulation of memory formation (Martinez et al., 2016), dendrite morphogenesis (Wei et 
al., 2015), and regenerative axon growth (Ohtake et al., 2018; Oñate et al., 2016; Ying et 
al., 2014). The best-known UPR pathways are those mediated by PERK, IRE1, and 
ATF6. More recently, another group of transmembrane ER stress transducers has been 
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identified, collectively called the OASIS family (Asada et al., 2011). The N-terminal, 
cytoplasmic domains of OASIS family members comprise bZIP transcription factors, and 
cleavage by site-1 and/or site-2 proteases (S1P and S2P, respectively) releases the 
transcriptionally active end. OASIS proteins are activated in response to very mild, 
physiological ER stress, meaning that they are necessary for the regulation of their 
target genes under physiological conditions (Kondo et al., 2011; Kondo et al., 2007). 
Here, we asked whether the S2P-dependent activation of transcription factors within 
axons is required for the generation of retrograde signals from axons to cell bodies 
during axonal development. We found that axonal S2P activity is required for axon 
growth, surprisingly not via regulation of transcription, but instead by liberating a 
secreted peptide derived from the C-terminus of the transcription factor CREB3L2. The 
secreted C-terminal part of CREB3L2 is part of a neuron-intrinsic pathway that supports 
axon growth by enabling sonic Hedgehog (Shh) signaling in developing axons. 
 
Results 
S2P is required for the normal growth of developing axons 
The presence and activation of transcription factors from the OASIS family in axons 
(Ying et al., 2014) raised the questions of whether S2P is present or active in axons. To 
address the first of these questions, we stained sections of dorsal root ganglia (DRG) 
with adjacent spinal cords of rat embryos for S2P and neurofilament (Figure 1A). We 
also prepared dissociated embryonic DRG neurons, which were grown for 3 days in vitro 
(DIV) and labeled with S2P and Tuj1 (Figure 1B). In both immunolabelings, a signal for 
S2P was readily apparent throughout the neuron, including the axon. The prominent 
expression of S2P in developing axons suggested that it might have a physiological 
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function for axon growth. To test whether S2P is required for axon growth, we 
suppressed its expression in DRG explants by delivering siRNA with electroporation 
(Figure 1C). Because DRG explants are comprised of many sensory neurons, they 
provide a robust approach to assess changes in growth across numerous axons. 
Following electroporation, the DRG explants were grown in culture for 3 DIV with 
minimal experimental intervention (Figure 1D). Quantitative RT-PCR revealed that 
electroporation of siRNA targeting S2P efficiently knocked down S2P transcripts in 
explants as compared to a control, non-targeting siRNA (Figure 1E). Knockdown of S2P 
levels in axons was confirmed by quantitative immunofluorescence (Figures 1F, S1A). 
Explants that received control siRNA exhibited a typical morphology of a fairly round and 
even halo of axons emanating from the explants. In contrast, siS2P-transfected explants 
displayed overall shorter axon growth and a more uneven appearance (Figure 1G). To 
quantitatively assess changes in axon growth, we performed a Sholl analysis of these 
explants (Ferreira et al., 2014), which revealed a significant reduction in the growth of 
the axons emanating from siS2P-transfected explants (Figure 1G). Given its prominent 
localization to axons, we next asked whether S2P activity specifically within axons was 
required for their development. 
 
Axonal S2P activity is required for axon outgrowth 
To investigate a potential, local role of S2P on outgrowth, we cultured DRGs in 
microfluidic devices, which allow for fluidic isolation of axons and cell bodies (Figure 2A) 
(Hengst et al., 2009; Taylor et al., 2005). In these chambers, three compartments are 
separated by 500-µm-long microgrooves through which only axons can extend. We 
seeded dissociated DRG neurons in an upper compartment and transfected them with 
control siRNA or siRNA targeting S2P for 48 h (Figure 2B), leading to a significant 
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reduction of S2P expression in axons as assessed by IF (Figure 2C). Suppression of 
S2P expression did not interfere with cell viability as assessed by the TUNEL assay 
(Figure 2D). To assess axon outgrowth, we imaged fields in the most distal 
compartment, before applying fresh medium locally and returning the devices to the 
incubator. 1 h later we identified the same fields and measured how much individual 
axons had grown. The rate of axon outgrowth was significantly reduced upon delivery of 
S2P siRNA as compared to control axons (Figure 2E). Next, to test the role of axonally 
localized S2P we applied the S2P inhibitor nelfinavir (NF) specifically to axons during the 
growth assay (Guan et al., 2011, 2012, 2015). We observed that the rate of axon 
outgrowth was diminished when NF was acutely applied in the distal axonal 
compartment of microfluidics for 1 h (Figure 2F). Together, these results demonstrated 
that suppression of S2P activity within axons impairs axon growth rates. To identify what 
acts downstream of S2P activity, we next considered the possibility that S2P activates a 
retrograde-acting transcriptional signal, such as a transcription factor, in the axon. 
 
Intra-axonal S2P promotes growth locally 
S2P is a known regulator of the SREBP family of transcription factors that control the 
expression of genes required for fatty acid metabolism. Therefore, we considered that 
S2P inhibition or knockdown could interfere with lipid synthesis required for the 
expansion of the plasma membrane of developing axons (Pfenninger, 2009). To test this 
idea, we electroporated DRG explants with control or S2P siRNA for 72 h and 
determined the mRNA levels by qRT-PCR for two major transcriptional targets of 
SREBPs, fatty acid synthase (FAS) and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-
CoA) reductase (Brown and Goldstein, 1997; Horton et al., 2003) (Figure 3A). Contrary 
to expectation, knockdown of S2P did not have an effect on mRNA levels of either 
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transcript as measured by qRT-PCR (Figure 3B). This observation led us to reconsider 
the hypothesis that axonal S2P was required for the generation of a retrograde signal 
such as a transcription factor. In our live growth assays performed in microfluidic 
devices, the distance from growth cones to their soma is at minimum 1,500 µm given the 
separation of the compartments by the microgrooves. Assuming the maximum speed of 
cytoplasmic dynein and kinesin-3, the fastest anterograde member of the kinesin family, 
the 1 h assay would not allow for a signal to reach the soma and the response to return 
to growth cones with enough time to significantly affect axon growth (Twelvetrees et al., 
2016). Our findings instead suggested that S2P would be exerting an effect on 
outgrowth by acting through a local, intra-axonal mechanism. To directly test the 
requirement for a signal to reach the cell body from the distal axon, we inhibited dynein-
dependent retrograde transport in axons by co-treating axons with NF and ciliobrevin A 
(Firestone et al., 2012) (Figure 3C). Since all motor-based retrograde transport in axons 
is mediated by dynein, we reasoned that if S2P acts in the same pathway as dynein by 
generating a retrograde transcription factor, then the corresponding decrease in 
outgrowth resulting from S2P inhibition would be prevented in the presence of ciliobrevin 
A. The effective concentration of ciliobrevin A that we used in microfluidics (30 µM) was 
established previously (Baleriola et al., 2014). We found that even in the presence of 
ciliobrevin A, axon outgrowth was diminished by NF, suggesting that S2P inhibition 
prevented a local, growth-promoting response from occurring rather than acting through 
a retrograde signal (Figure 3D).  
Previous studies have reported that DRG axons may secrete proteins (Gonzalez et al., 
2016; Merianda and Twiss, 2013; Merianda et al., 2009). Hence one explanation for 
diminished outgrowth under S2P knockdown or inhibition is that S2P generates a locally 
secreted factor that promotes axon growth in an auto- or paracrine manner. To test 
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whether S2P was required for the generation of a growth-promoting, secreted factor, we 
exchanged the axonal medium of control and S2P knockdown DRGs (Figure 3E) and 
measured axon growth over 1 h as before. The impaired outgrowth of DRG axons with 
S2P KD was rescued by the application of medium from control axons (Figure 3F). 
Notably, the rescue in outgrowth was due to an increase in axon growth for siS2P 
neurons that received the control medium. This result suggests that control axons locally 
produce a secreted factor in the medium that the S2P-deficient axons can no longer 
generate. Together, these results revealed that S2P acts locally by generating a 
secreted factor that regulates axon outgrowth. 
 
Loss of CREB3L2 phenocopies S2P inhibition and knockdown 
Previous work in chondrocytes had revealed that cleavage by S2P in some cases 
(OASIS, CREB3L2, CREB4) generates not only one but two bioactive proteins: the 
transcription factor in the cytoplasm and the carboxy-terminal part in the ER lumen 
(Saito et al., 2014). These luminal domains are secreted and at least one of them, the 
luminal portion of CREB3L2, acts in an auto- or paracrine manner as a growth-promoting 
factor on chondrocytes (Saito et al., 2014). Several publications have proposed that 
CREB3L2 is cleaved not only by S2P but also by S1P (Kondo et al., 2007; Saito et al., 
2014). This assumption is primarily based on analogies with ATF6 and SREBP (Shen 
and Prywes, 2004), but importantly, cleavage of CREB3L2 by S2P occurs in the 
presence of brefeldin A, i.e. without being transported to the Golgi, and with the S1P 
cleavage site mutated (Kondo et al., 2007). First, to directly test whether S2P activity is 
sufficient to drive CREB3L2 cleavage, we expressed S2P together with CREB3L2 fused 
to GFP on its N-terminal, transcriptionally active portion and fused to mCherry on its C-
terminus in HEK293 cells. In the absence of S2P, the majority of the GFP and mCherry 
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signals overlap in a perinuclear, ER-like pattern (Figure 4A). Upon co-expression of S2P, 
the majority of the GFP signal, i.e. the transcription factor part of CREB3L2, translocated 
to the nucleus while the mCherry signal remained perinuclear. In parallel, we found by 
immunoblot that S2P expression drove the production of the CREB3L2 C-terminus 
(Figure 4B). Together, these results demonstrated that S2P alone is sufficient to cleave 
CREB3L2 and generate its C-terminus, as indicated previously (Kondo et al., 2007). 
Given that the C-terminus of CREB3L2 can act as a growth factor, we next asked 
whether depleting available C-terminal CREB3L2 by knocking down CREB3L2 would 
phenocopy the axonal growth defects seen in S2P-deficient neurons. Electroporation of 
DRG explants for 72 h significantly reduced the levels of CREB3L2 mRNA (Figures 4C, 
4D) and the levels CREB3L2 protein in axons (Figure S1B), causing an axon growth 
phenotype reminiscent to what we had observed for S2P knockdown (Figure 4E). Next, 
we examined whether outgrowth of DRG axons was affected by knocking down 
CREB3L2 in microfluidic chambers (Figures 4F, 4G). We found that axons of neurons 
deficient in CREB3L2 had impaired rates of outgrowth compared to control axons 
(Figure 4H). Together these results indicate that CREB3L2 can be cleaved in an S2P-
dependent manner and that knocking down CREB3L2 phenocopies knockdown or 
inhibition of S2P, suggesting that the luminal domain of CREB3L2 might be an S2P-
dependent, secreted growth-promoting factor in neurons. 
 
S2P generates C-terminal CREB3L2 in DRG neurons 
To investigate whether S2P generates the C-terminus of CREB3L2 in axons, we used a 
proximity ligation assay (PLA) with an antibody pair recognizing the N- and the C-
terminal parts of the protein, respectively (Figure 5A). DRGs were cultured in microfluidic 
chambers for 4 DIV, and we applied DMSO or NF to the axonal compartment for 24 h 
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(Figure 5B, 5C). Sparse PLA signals for full-length CREB3L2 were detectable in axons 
with a significant increase upon inhibition of S2P with NF (Figure 5D), establishing that 
CREB3L2 is localized to and processed by S2P within axons. We reasoned that the C-
terminus of CREB3L2 could be depleted either by preventing the generation of the full-
length protein or by knocking down CREB3L2 directly using siRNA targeting S2P or 
CREB3L2, respectively. We confirmed that delivery of S2P or CREB3L2 siRNA 
significantly reduced the endogenous levels of the C-terminal part of CREB3L2 in DRGs 
(Figure 5E). Next, we used an antibody raised against the C-terminal part of CREB3L2 
to immunoprecipitate the luminal fragment from the medium of DIV4 DRGs, 
demonstrating that it is indeed secreted by DRG neurons (Figure 5F). If the C-terminal 
part of CREB3L2 is the secreted growth-promoting factor, one might expect to be able to 
detect it bound to the surface of axons. When we immunostained axons under non-
permeabilizing conditions with the antibody raised against the C-terminal part of 
CREB3L2, we obtained a signal on growth cones and axons that was significantly 
reduced on axons of neurons deficient in S2P (Figure 5G). Together, these results 
demonstrate that S2P cleavage of CREB3L2 in DRG axons generates the free C-
terminus, which is secreted and promotes axon growth and fasciculation in a paracrine 
manner. 
 
Hedgehog signaling is active in DRGs 
In mammalian chondrocytes, the secreted luminal domain of CREB3L2 acts by 
enhancing Indian Hh (Ihh) signaling by forming a ternary complex with the Hh receptor 
Patched-1 and Ihh (Saito et al., 2014). In higher vertebrates, Sonic hedgehog (Shh) is 
the principal Hedgehog isoform in neurons, although its signaling mechanism is 
conserved with Ihh (Pathi et al., 2001). Originally identified as a morphogen, Shh is also 
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an axon guidance cue. Shh attracts pre-crossing spinal cord commissural axons via 
binding to its receptor Boc and the activation of non-canonical, Src family kinase 
dependent activation of local translation (Charron et al., 2003; Lepelletier et al., 2017; 
Okada et al., 2006; Yam et al., 2009). While DRGs do not respond to exogenously 
applied Hh, they do express Shh, its receptors, and relevant signaling machinery, 
including Patched-1 and Smoothened (Martinez et al., 2015; Trousse et al., 2001). 
Moreover, knocking down Shh in sensory neurons has been shown to impair neuritic 
growth (Martinez et al., 2015). This suggests that sensory neurons require their own 
endogenously produced Shh in order to grow, which is likely functionally saturating and 
would explain why they do not respond to exogenous Shh. 
The facilitation of Hedgehog signaling by C-terminal CREB3L2 in developing neurons 
had not been reported previously, prompting us to ask whether this mechanism existed 
in DRGs. To test the hypothesis that Shh signaling was required for axon growth, we 
acutely treated DRG explants with vehicle or robotnikinin, which neutralizes Shh 
signaling by competitively binding to Shh (Stanton et al., 2009). Under these conditions, 
we observed that robotnikinin led to a modest reduction in axon growth by Sholl analysis 
(Figure 6A), suggesting that Shh signaling was required for DRG axonal growth. To see 
whether depleting the C-terminus of CREB3L2 in developing neurons affected the 
endogenous levels of active Shh, we transfected dissociated DRGs with control, S2P, or 
CREB3L2 siRNA, and tested whole cell lysates for endogenous Shh 72 hours later by 
immunoblotting. Since the Shh antibody used for immunoblotting specifically recognizes 
the N-terminus, we measured the N-terminal active signaling portion at approximately 19 
kDa, which is produced by autocatalysis. Knockdown of S2P or CREB3L2 significantly 
reduced the amount of active Shh in whole cell lysates, which includes Shh bound to the 
cell surface (Figure 6B). An explanation for the decrease in Shh in these conditions is 
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that without secreted C-terminal CREB3L2 less Shh binds its receptor Patched-1 (Saito 
et al., 2014). To determine whether the secreted C-terminus of CREB3L2 binds to 
extracellular Shh, we performed a co-IP on conditioned medium from developing DRGs 
and detected a complex between the CREB3L2 C-terminus and Shh using antibodies 
against either protein (Figure 6C). To directly investigate whether the C-terminus of 
CREB3L2 actually binds Shh along axons, we electroporated DRG explants with non-
targeting control, S2P-targeting, or CREB3L2-targeting siRNA and used PLA to detect 
complexes between C-terminal CREB3L2 and Shh after 3 DIV (Figure 6D). Axons 
deficient in S2P or CREB3L2 had significantly fewer PLA puncta, indicating a reduction 
in C-terminal CREB3L2-Hh complexes (Figure 6E). Likewise, when we performed PLA 
for Patched-1 and Shh on equally treated cultures, we observed that fewer ligand-
receptor complexes had formed (Figure 6F). The PLA signal was specific, as a 
significant reduction in PLA puncta was observed when one member of each pair was 
omitted (Figure S2). Together, these results demonstrate that depleting the C-terminus 
of CREB3L2, either by knocking down S2P or CREB3L2 itself, diminishes the ability of 
neuronally derived Shh to bind Patched-1 along DRG axons. 
 
Exogenous C-terminal CREB3L2 rescues axon development and Shh binding to 
axons 
Finally, we asked if exogenously applied, purified C-terminal CREB3L2 was sufficient to 
rescue the growth of axons lacking S2P. We cultured explants that were electroporated 
with control siRNA or siRNA targeting S2P as described above and supplemented the 
medium with approximately 100 ng ml-1 purified C-terminal CREB3L2 (Figure 7A, 7B). 
Axon growth between control and S2P-deficient axons was indistinguishable as 
measured by Sholl analysis (Figures 7C). Importantly, this rescue was not recapitulated 
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by exogenously supplied BSA, which confirmed the specificity of the purified C-terminus 
of CREB3L2 for rescuing axon growth (Figure S3). To determine whether the rescue by 
C-terminal CREB3L2 was paralleled by a restoration of Hh–Patched-1 interactions on 
axons, we prepared DRG explants electroporated with control or S2P- or CREB3L2-
targeting siRNA as before and supplemented the medium with purified C-terminal 
CREB3L2 (Figure 7D). While there was a trend towards an increased number of 
complexes in the siS2P condition compared with siCntrl, no significant differences in the 
number of PLA puncta were detected between the different conditions, establishing that 
exogenous C-terminal CREB3L2 is sufficient to restore axon growth (Figure 7C) and 
rescue the formation of Shh and Patched-1 complexes on DRG axons (Figure 7D).  
Overall our data show that the physiological stress sensor S2P promotes axon growth by 
cleaving a transcription factor locally, leading to the secretion of its luminal domain, 
which in turn promotes the assembly of active Hedgehog signaling machinery on 
developing sensory axons (Figure 7E). These findings describe a novel mechanism by 




Axons respond to a repertoire of signaling molecules that control their projection toward 
target regions. However, the extent to which axons can regulate their own growth is 
incompletely understood. We discovered that S2P cleaves CREB3L2 in developing DRG 
axons and that the secreted C-terminus promotes axon growth. A question that arises 
from this finding is why neurons would possess a mechanism to modulate growth of their 
axon through a secreted factor. Current models suggest that adhesive or repellant 
molecules in the axonal environment or on other neurons create a permissive corridor 
  74 
for axon growth. Mechanisms involving diffusible, growth-promoting factors derived from 
the axon have been suggested, but their necessity remains unresolved. Our results 
presented here describe a mechanism in which the secreted portion of a transcription 
factor creates a local, growth-promoting gradient around individual axons that activates 
Hedgehog signaling. The in vivo relevance of this newly discovered activity remains 
unknown, but intriguingly, mutations in the gene encoding S2P cause Ichthyosis 
Follicularis, Alopecia, and Photophobia (IFAP) syndrome, which includes hypoplasia of 
the corpus callosum (Mégarbané and Mégarbané, 2011), i.e. an axon growth phenotype. 
We found that the physiological ER stress effectors S2P and CREB3L2 support growth 
adding to the emerging realization that low level ER stress is required for several 
aspects of neuronal development and function (Cagnetta et al., 2019; Martinez et al., 
2016; Wei et al., 2015; Ying et al., 2015). What happens to this signaling pathway in 
mature neurons? Post-developmental DRGs continue to produce Hedgehog (Brownell et 
al., 2011) indicating that the regulation of S2P downstream of ER stress might be a 
switch to lower C-terminal CREB3L2 levels to control intra-axonal Hedgehog signaling. 
In fact, axonal ER stress is positively correlated with axon growth and regeneration 
(Hayashi et al., 2007; Ohtake et al., 2018; Oñate et al., 2016; Ying et al., 2014). 
While the primary DRG cultures were the source for Shh in our study, it is known that 
during development and as adult neurons, DRGs encounter additional sources of 
Hedgehog: for example, Schwann cells, which myelinate DRGs, produce Desert 
Hedgehog (Parmantier et al., 1999) and Hedgehog signaling in Schwann cells regulates 
the myelination of DRG axons (Yoshimura and Takeda, 2012) raising the possibility that 
axon-derived C-terminal CREB3L2 facilitates myelination in a paracrine manner. 
Similarly, adult DRGs supply Hedgehog to bulge cells in the hair follicle to maintain an 
active stem cell population (Brownell et al., 2011). One possibility is that axon-derived C-
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terminal CREB3L2 helps modulate the crosstalk between competing sources of 
Hedgehog protein in these contexts. 
An interesting aspect of our findings is that S2P cleavage of CREB3L2 simultaneously 
generates a transcription factor and a secreted protein that supports axon growth. 
Whether and how these two signaling modalities are integrated in the control of axon 
development remains unknown. The fact that we did not detect a requirement for the 
transcriptional activity of CREB3L2 in our assays is potentially a reflection of the short 
experimental periods of S2P or CREB3L2 knockdown, which do not allow for 
transcriptional deficits to significantly affect axon growth. Among the transcriptional 
targets of CREB3L2 are genes necessary for COPII vesicle formation, including Sec23a 
and Sec23b (Melville et al., 2011; Saito et al., 2009). ER exit sites (ERES), of which 
Sec23 is a component, are selectively targeted to rapidly growing axons to meet their 
biosynthetic demands (Aridor and Fish, 2009), indicating that S2P-dependent cleavage 
of CREB3L2 supports axonal development through secreted C-terminal CREB3L2, 
which has immediate, local effects, and through the liberation of the transcription factor, 
which induces slower transcriptional changes.  
In conclusion, our results reveal a novel, neuron-intrinsic mechanism for how developing 
axons regulate their own growth. We show that S2P-dependent generation of the 
secreted C-terminus of CREB3L2 is required for axon growth and we identify the S2P-
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Figure 1. Axonal S2P is required for axon growth 
(A) Immunohistochemistry for S2P on DRG and spinal cord of an E16 rat embryo. The 
10X panel is labeled with neurofilament and the arrow points to axons of spinal cord 
neurons. The DRG is outlined with a dotted line. The 40X panel shows the staining for 
neurofilament and S2P, which is expressed in the nerve bundle exiting the DRG. Scale 
bars, 25 µm. 
(B) Rat embryonic DRG neurons were seeded at a low density, cultured for 3 DIV, and 
stained for S2P and tubulin. Lower panels focus on the respective areas outlined with a 
rectangle. Scale bar, 20 µm. 
(C) Electroporation: DRG explants were dissected from E14 rat embryos and transferred 
to a cuvette containing electroporation buffer and control or targeting siRNA. Following 
electroporation, individual explants were plated in culture dishes. 
(D) Experimental design for (E-G): Explants were plated on DIV0 and cultured for 48 h. 
On DIV2, the medium was completely exchanged with fresh DRG growth medium 
containing 5 ng ml-1 NGF, and either total RNA was collected, or explants were fixed on 
DIV3. 
(E) DRG explants were electroporated with non-targeting control siRNA or siRNA 
targeting S2P and cultured for 3 DIV. S2P mRNA levels were quantified by RT-PCR in 
lysates obtained from the explants 72 h after electroporation. Means ± SEM (n = 5 
biological replicates). Wilcoxon signed-rank test, ***P ≤ 0.001. 
(F) DRG explants were electroporated with non-targeting control siRNA or siRNA 
targeting S2P and cultured for 3 DIV. Axonal S2P levels were measured by 
immunofluorescence. Percent knockdown relative to control is shown. Means ± SEM 10-
15 optical fields per condition (n = 3 biological replicates). Mann-Whitney t-test, ***P ≤ 
0.001. Scale bar, 20 µm. 
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(G) DRG explants were electroporated and cultured as described in (C, D). Explants 
were fixed, visualized by IF staining against Tuj1, and axon growth was assessed using 
the Sholl analysis. The area under the curve (AUC) was measured between conditions. 
Means ± SEM of 2–7 explants per condition (n = 5 biological replicates). Mann-Whitney 
t-test, **P ≤ 0.01. Scale bar, 250 µm. 
See also Figure S1. 
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Figure 2. Axonal S2P activity promotes axon growth 
(A) Depiction of a microfluidic device used to isolate axons. DRG neurons were seeded 
in the top (somatic) compartment and cultured as described in (B). Live cell microscopy 
was performed in the bottom (most distal) axonal compartment. 
(B) Experimental design for (C-F): DRG neurons were seeded in microfluidics and 
cultured for 2 DIV, at which point the medium was completely exchanged for DRG 
growth medium containing 5 ng mL-1 NGF, and non-targeting control siRNA or siRNA 
targeting S2P was transfected into all compartments when applicable. 48 h later, DRGs 
were prepared for IF (C), TUNEL (D), or used for live cell microscopy.  
(C) DRG neurons were cultured and treated as in (A) and (B). Axonal S2P levels were 
measured by immunofluorescence. Percent knockdown relative to control is shown. 
Means ± SEM of 10-15 optical fields per condition (n = 4 biological replicates). Mann-
Whitney t-test, ***P ≤ 0.001. Scale bar, 10 µm. 
(D) Neurons were cultured and treated with siRNA as in (A) and (B). Cell death was 
assessed by TUNEL assay. Means ± SEM of 10-20 optical fields per condition (n = 3 
biological replicates). Mann-Whitney t-test; ns, not significant. Scale bar, 15 µm. 
(E) Axon growth between siCntrl and siS2P was measured by comparing images taken 
before and after axonal application of fresh medium for 1 h. Means ± SEM of 10-20 
fields per condition, 126 siCntrl axons and 121 siS2P axons total (n = 4 biological 
replicates). Mann-Whitney t-test, ***P ≤ 0.001. Scale bar, 20 µm. 
(F) Axon growth between DMSO and NF was measured by comparing images taken 
before and after axonal application of fresh medium in the distal most axonal 
compartment containing either DMSO or NF (15 µM) for 1 h. Means ± SEM of 10-20 
fields per condition, 110 DMSO-treated and 92 NF-treated axons total (n = 4 biological 
replicates). Mann-Whitney t-test, **P ≤ 0.01. Scale bar, 20 µm. 
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Figure 3. Axonal S2P acts through a secreted factor  
(A) Experimental design for (B): DRG explants were electroporated with non-targeting 
control siRNA or siRNA targeting S2P and cultured for 3 DIV. RNA was collected at 72 h 
and RT-PCR was performed to assess efficiency of knockdown. 
(B) Fatty acid synthase (FAS) and HMG-CoA reductase (HMG) mRNA levels were 
quantified by qRT-PCR in lysates obtained from the explants 72 h after electroporation. 
Means ± SEM (n = 3–4 biological replicates). Mann-Whitney t-tests, no significant 
differences. 
(C) Experimental design for (D): DRG neurons were seeded in microfluidics and cultured 
for 96 h. Axons in the distal compartment were treated with DMSO and NF concomitant 
with 30 µM ciliobrevin A for 1 h and live imaged in the same compartment. 
(D) Axon outgrowth assay of DRG neurons treated with DMSO or NF (15 µM) with 
ciliobrevin A (30 µM). Means ± SEM of 10-20 fields per condition, 93 DMSO-treated and 
122 NF-treated axons total (n = 3 biological replicates). Mann-Whitney t-test, *P ≤ 0.05. 
Scale bar, 20 µm. 
(E) Representation of axonal medium exchange experiment. DRG neurons were 
cultured and transfected with siRNA as described earlier. On DIV4 axonal medium was 
replaced with fresh medium for 6 h. Images of initial fields of each condition were then 
collected and axonal medium from control and S2P-targeting siRNA were exchanged 
and images were acquired 1 hour later to measure outgrowth. 
(F) Axon growth measurement of DRG neurons cultured as described in (E). The siCntrl 
and siS2P data are from Figure 2D and shown here for comparison. Means ± SEM of 
10-20 fields per condition, 95 siCntrl and 89 siS2P axons total (n = 4 biological 
replicates). Kruskal-Wallis test with Dunn’s multiple comparisons test, **P ≤ 0.01, ns, not 
significant. Scale bar, 20 µm. 
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Figure 4. CREB3L2 is required for axon growth  
(A) HEK293T cells were grown and transfected with constructs expressing S2P ± CREB3L2 
fused to GFP on the N-terminus and mCherry or FLAG on the C-terminus. Representative 
images are shown from 3 independent replicates. Scale bar, 20 µm. 
(B) Western blot of HEK293T cells overexpressing a CREB3L2 fusion protein ± S2P. 
Immunoblotting was performed for full-length and C-terminal CREB3L2 fragments and a 
loading control (top). The production of the CREB3L2 C-terminus by S2P was quantified in 
FIJI (bottom). A representative blot is shown from 3 independent replicates. Paired t-test, *P 
≤ 0.05. 
(C) Experimental design for (D): DRG explants were electroporated with non-targeting 
control siRNA or siRNA targeting CREB3L2 and cultured for 3 DIV. RNA was collected at 72 
h and RT-PCR was performed to assess efficiency of knockdown. 
(D) CREB3L2 mRNA levels were quantified by qRT-PCR in lysates obtained from the 
explants 72 h after electroporation with the siRNA. Means ± SEM (n = 4 biological 
replicates). Mann-Whitney t-test, ***P ≤ 0.001. 
(E) DRG explants were electroporated and cultured as in (C). Explants were fixed, visualized 
by IF staining against Tuj1, and axon growth was assessed using the Sholl analysis. AUC 
was measured between conditions. Means ± SEM of 2–7 explants per condition (n = 5 
biological replicates). Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 250 µm. Because the 
electroporations for siCntrl, siS2P, and siCreb3l2 were performed in parallel, the same 
representative siCntrl explant image (Figure 1F) is shown for reference. 
(F) Experimental design for (G-H): DRG neurons were cultured in microfluidics for 2 DIV, and 
non-targeting control siRNA or siRNA targeting CREB3L2 were transfected into all 
compartments for 48 h. On DIV4 the DRGs were fixed and prepared for IF (G) or live 
imaging (H).  
(G) CREB3L2 levels were measured by quantitative immunofluorescence to confirm axonal 
KD. Percent knockdown relative to control is shown. Means ± SEM of 10-15 optical fields per 
condition (n = 3 biological replicates). Mann-Whitney t-test, ***P ≤ 0.001. Scale bar, 10 µm. 
(H) Axon outgrowth assay of DRG neurons cultured and treated as in (F). Axon growth was 
measured by comparing images taken before and after axonal application of fresh medium 
for 1 h. Means ± SEM of 10-20 fields per condition, 128 siCntrl and 114 siCreb3l2 axons total 
(n = 4 biological replicates). Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 20 µm. 
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Figure 5. C-terminal CREB3L2 is secreted from axons in an S2P-dependent 
manner 
(A) Principle of proximity ligation assay: the N- and C-terminus of CREB3L2 are labeled 
with antibodies raised in different species, which are recognized by positive and negative 
probes.  The CREB3L2 precursor (full-length protein) will not be labeled by the PLA 
reaction if it has been cleaved by S2P.  
(B) Representation of microfluidic device used in (D) and local treatments of DMSO or 
NF (15 µM). 
(C) DRG neurons were cultured in microfluidics for 3 DIV. Axonal medium was 
supplemented with DMSO or NF (15 µM) for 24 h. On DIV4, DRGs were processed for 
PLA using two antibodies targeting the N- or C-terminus of CREB3L2. 
(D) PLA for full-length CREB3L2 in DRG axons. Means ± SEM of 20-30 optical fields per 
condition (n = 4 biological replicates). Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 20 µm. 
(E) Dissociated DRGs were cultured for 2 DIV and transfected with non-targeting control 
siRNA or siRNA targeting S2P or CREB3L2 for 72 h. On DIV5, whole cell lysates were 
obtained and analyzed by Western blot for endogenous C-terminal CREB3L2 (n = 4 
biological replicates). A blot with 2 repeats is shown. Kruskal-Wallis test with Dunn’s 
multiple comparisons test, ***P ≤ 0.001. 
(F) Immunoprecipitation was performed on conditioned medium of dissociated DRGs 
using a C-terminal CREB3L2 or IgG control antibody 48 h after a medium change on 
DIV 2. A representative IP is shown from 3 independent experiments. 
(G) DRG explants were electroporated with non-targeting control siRNA or siRNA 
targeting S2P and cultured for 3 DIV as described earlier. Explants were fixed and 
prepared for IF for C-terminal CREB3L2 under non-permeabilizing conditions, followed 
by permeabilization and staining for Tuj1. Means ± SEM of 10-15 optical fields per 
condition (n = 3 biological replicates). Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 10 µm. 
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Figure 6. C-terminal CREB3L2 promotes the formation of Hh-Patched-1 complexes 
in sensory axons 
(A) DRG explants were cultured for 2 days. On DIV2, the medium was completely 
exchanged for DRG growth medium containing 5 ng ml-1 NGF and supplemented with 
either robotnikinin (25 µM) or an equal volume of DMSO for 24 h. On DIV3 the explants 
were fixed and visualized for IF by staining against Tuj1 and axon growth was assessed 
using Sholl analysis. The area under the curve (AUC) was measured between 
conditions. Means ± SEM of 2–3 explants per condition (n = 3 biological replicates). 
Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 250 µm. 
(B) Dissociated DRGs were cultured for 2 DIV and transfected with non-targeting control 
siRNA or siRNA targeting S2P or CREB3L2 for 72 h. On DIV5, whole cell lysates were 
collected and analyzed by Western blot for endogenous Shh (n = 4 biological replicates). 
A blot with 2 repeats is shown. Kruskal-Wallis test with Dunn’s multiple comparisons 
test, *P ≤ 0.05, **P ≤ 0.01. 
(C) Dissociated DRGs were cultured for 2 DIV and their medium was completely 
exchanged for DRG growth medium containing 5 ng ml-1 NGF for 48 h. The medium was 
collected on DIV4 and co-IPs were performed for C-terminal CREB3L2 and Shh. 
(D) Experimental design for (E) and (F): DRG explants were electroporated with non-
targeting control siRNA or siRNA targeting S2P or CREB3L2. On DIV2, the medium was 
completely exchanged for DRG growth medium containing 5 ng ml-1 NGF for 24 h. On 
DIV3 the explants were fixed and prepared for PLA. 
(E, F) DRG explants were fixed and prepared for PLA using antibodies against C-
terminal CREB3L2 and Shh (C) or Patched-1 and Shh (D) (n = 3 biological replicates). 
Kruskal-Wallis tests with Dunn’s multiple comparisons tests, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 
0.001. Scale bars, 20 µm. 
See also Figure S2. 
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Figure 7
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Figure 7. C-terminal CREB3L2 rescues DRG growth through a Hedgehog-
dependent mechanism 
(A) His-tagged C-terminal CREB3L2 was expressed in HEK293 cells and batch purified 
using Ni-NTA resin. Samples of the cell lysates, wash fractions, and the eluate were 
analyzed by immunoblotting. Images of the Ponceau S-stained membrane and the 
immunoblot with C-terminal CREB3L2 antibody are shown. 
(B) Experimental design for (C): DRG explants were electroporated with non-targeting 
control siRNA or siRNA targeting S2P and cultured for 2 DIV in medium containing 100 
ng ml-1 purified C-terminal CREB3L2. On DIV2 explant medium was exchanged for fresh 
medium supplemented with 100 ng ml-1 purified C-terminal CREB3L2. 
(C) DRG explants were fixed on DIV3 and axon growth was assessed by Sholl analysis. 
AUC was measured between conditions. Means ± SEM of 2–5 explants per condition (n 
= 4 biological replicates). Mann-Whitney t-test, ns, not significant. Scale bar, 250 µm. 
(D) DRG explants were electroporated with non-targeting control siRNA or siRNA 
targeting S2P or CREB3L2 and treated with exogenous C-terminal CREB3L2 as 
described in (B). The explants were then fixed and prepared for PLA using antibodies 
against Hedgehog and Patched-1 (n = 4 biological replicates). Kruskal-Wallis tests with 
Dunn’s multiple comparisons tests, ns, not significant. Scale bar, 20 µm. 
(E) Model of the proposed mechanism for the regulation of axon growth by C-terminal 
CREB3L2. CREB3L2 is cleaved in developing DRG axons by S2P and the C-terminus is 
secreted. C-terminal CREB3L2 binds Hedgehog and promotes its association with the 
Patched-1 receptor. Activation of intracellular Hedgehog signaling promotes axon growth 
in a neuron-intrinsic manner. 







































































































































Figure S1. Knockdown of axonal S2P and CREB3L2 by electroporation 
(A) DRG explants were electroporated with non-targeting control siRNA or siRNA 
targeting S2P and cultured for 3 DIV. Axonal S2P levels were labeled with a primary 
antibody recognizing S2P and a secondary antibody, and were measured by quantitative 
immunofluorescence. Percent knockdown relative to control is shown. Means ± SEM (n 
= 3 biological replicates). Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 20 µm. 
(B) DRG explants were electroporated with non-targeting control siRNA or siRNA 
targeting CREB3L2 and cultured for 3 DIV. Axonal CREB3L2 levels were labeled with a 
primary antibody recognizing C-terminal CREB3L2 and a secondary antibody, and were 
measured by quantitative immunofluorescence. Percent knockdown relative to control is 
shown. Means ± SEM (n = 3 biological replicates). Mann-Whitney t-test, ***P ≤ 0.001. 
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Figure S2. Specificity of PLA labeling 
DRG explants were fixed and prepared for PLA using antibodies against C-terminal 
CREB3L2 and Shh, C-terminal CREB3L2 alone, Shh and Patched-1, and Shh alone. As 
the positive PLA pairs were a rabbit-mouse combination, the negative controls were 
used to provide a readout of signal specificity for either pair on its own. The number of 
positive PLA puncta from the control condition of Figure 6E and 6F are reported 
alongside the number of positive PLA puncta of either antibody alone. Values were 
normalized to the axonal area measured (n = 3 biological replicates). Kruskal-Wallis 










































































































Figure S3. Axon growth is not rescued by a control protein 
DRG explants were electroporated with non-targeting control siRNA or siRNA targeting 
S2P and cultured for 2 DIV in medium containing 100 ng ml-1 bovine serum albumin 
(BSA). On DIV2 explant medium was exchanged for fresh medium supplemented with 
100 ng ml-1 BSA and cultured until DIV3, when explants were fixed and axon growth was 
assessed by Sholl analysis. The area under the curve (AUC) was measured between 
conditions. Means ± SEM of 3–6 explants per condition (n = 3 biological replicates). 
Mann-Whitney t-test, *P ≤ 0.05. Scale bar, 250 µm. 
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Chapter 5. Discussion and Future Directions 
 Together these results describe a mechanism that enables axons to control their 
own growth during neural development through a cell-intrinsic pathway. During my 
graduate studies, I discovered that S2P, an indispensable protease in mammals that is 
best known for regulating stress and cholesterol metabolism, cleaves and drives the 
secretion of the CREB3L2 C-terminus from developing DRGs. The secreted C-terminus 
of CREB3L2 binds Shh, which is endogenously derived from DRGs, and promotes the 
formation of active Shh and Ptch1 complexes along axons. Feasibly, by creating a 
growth-promoting corridor around axons made up of secreted C-terminal CREB3L2, a 
consequence of this in vivo may be to favor axon fasciculation since more axons 
growing together should create a stronger diffused gradient and discourage individual 
axons from leaving the growth-promoting corridor around an axon fascicle.  
Why should axons require additional mechanisms to manage growth and 
fasciculation when others already exist? As discussed in this thesis, there are numerous 
trophic and physical cues that direct and promote growth of the developing axon. The 
mechanism identified here does not dispense with any of the pathways that we already 
know govern axon growth. Rather, this mechanism demonstrates an additional way for 
locally regulating axon outgrowth and underscores the agency of the axon in its own 
development. If CREB3L2 acts in a paracrine manner, that is after its secretion it 
promotes the growth of neighboring axons, one physiological implication of the 
mechanism identified here is that the C-terminus promotes bundled axon growth. In the 
developing nervous system, axonal tracts are formed along pioneer axons, which is 
known to be facilitated by contact-mediated fasciculation (Dodd and Jessell, 1988; 
Raper et al., 1983; Singer et al., 1979). Chemical signaling by guidance cues has been 
proposed to promote fasciculation, however, this is thought to be mediated by an 
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interaction between the DCC receptors of adjacent axons (Liu et al., 2018). In other 
words, this is still a mechanism mediated by adhesion. If the secreted C-terminus of 
CREB3L2 promotes the bundled growth of axons, it would be through creating a local 
environment that is conducive for growth. This would be novel because it would provide 
a way for axons to self-organize through an autonomous mechanism. Alternatively, if 
tropic factors encountered by a pioneer axon enhanced the secretion of the C-terminus 
of CREB3L2, another possibility is that the C-terminus provides spatial information about 
growth to the subsequent axons that follow the pioneer axon.  
From the work presented in this thesis, we do not conclusively know whether the 
C-terminus of CREB3L2 promotes growth in other neuronal cells or just DRGs. While I 
was working on this project, I found that S2P is expressed in the axons of other 
embryonic neurons (cortical; hippocampal), suggesting that it is at least possible that 
there is some conserved mechanism involving S2P and CREB3L2 in other neuronal cell 
types. However, this will have to be assessed by future experiments. The easiest 
approach for identifying whether S2P and CREB3L2 have a conserved role in promoting 
axon growth in other neurons is to evaluate whether knocking down S2P or CREB3L2 
impairs their rate of axon outgrowth. Similarly, it would be relatively straightforward to 
probe for the presence of C-terminal CREB3L2 and Shh complexes in developing axons 
using the PLA assay. Another point that remains unclear is whether the mechanism 
identified here has any significant physiological (in vivo) consequence, which could not 
be assessed in the work presented in this thesis. For example, in the developing 
organism there are competing signals of Hh that are derived from other cell types that 
interact with DRGs, such as Schwann cells, which myelinate DRG axons.  
Future work will illuminate some of these outstanding points. However, at present 
there are three main conceptual advances made by this thesis: the identification of a 
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novel developmental role for S2P and CREB3L2 in neurons, expanding what is known 
about ER stress components that underlie axon growth, and describing the presence of 
an active, self-regulated Hh signaling pathway in developing DRGs.  
 
5.1 Conceptual significance 
There is a growing appreciation for the fact that neurons use the machinery that 
is classically associated with ER stress to carry out beneficial physiological functions. 
The ER stress transcription factor XBP1 has been shown to contribute to long-term 
memory formation by driving the expression of BDNF in the hippocampus (Martínez et 
al., 2016). Recently, it was demonstrated that the PERK pathway controls levels of 
translation during axon guidance (Cagnetta et al., 2019). In response to axonal injury, 
the translation and activation of OASIS family member CREB3 in sensory axons is 
required for axon regeneration (Ying et al., 2014, 2015). In summary, ER stress factors 
are active and essential for neuronal function outside of the canonical ER stress 
response. However, identifying the contributions of these factors is still underway.  
As I have shown in this thesis, DRG axons are equipped with the ER stress 
factors S2P and CREB3L2, which help to promote axon outgrowth. Does this really 
mean that axons are perpetually agitated by ER stress? On one hand, because neurons 
are highly secretory cells it is not surprising that they would be prone to stress given the 
demand for sustained protein translation. However, as more studies come out tying 
together ER stress components and neural metabolism, it will have to be decided 
whether this represents true ER stress as it is classically viewed, or whether this is 
merely cells making use of a finite number of proteins to accomplish multiple functions, 
which happens to fall under the physiological umbrella of a stress response. Given that 
other members of the OASIS family are required for axon regeneration, future work may 
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also find that CREB3L2 is activated by S2P during axon injury. The preparation of 
primary DRG cultures in vitro from embryonic rats necessitates the severing of sensory 
axons in the developing organism. Hence, the very culturing of DRG neurons induces 
injury. Although I found that S2P is expressed in developing axons in vivo (Chapter 4, 
Figure 1A), this does not rule out the potential relevance of the mechanism outlined in 
this thesis for regeneration.        
The axon itself presents an interesting model for studying ER stress: axons span 
a large distance from the cell body, and ER stress-related transcription factors act as 
sensors to inform the cell body about local changes in the axonal environment. 
Moreover, the axon contains smooth ER but no classical Golgi structures, which given 
conflicting reports about its localization and activity, makes the identification of an axonal 
role for S2P especially interesting. Identifying a role for S2P in axons demonstrates how 
supposedly canonical processes such as RIP can function in a unique way in different 
cell types. In the case of neurons, which possess specialized structures like the axon, 
these cells may carry out the proteolytic activation of transcription factors in a way that is 
entirely different than say, in a fibroblast.  
The relationship between ER stress and the secretory pathway is underscored by 
the fact that mutations to S2P or CREB3L2 cause defective secretory trafficking by 
preventing the transcriptional activity of the CREB3L2 N-terminus. While the short 
timeframe for knockdown that I used in my experiments did not allow for examining the 
effect of a sustained transcriptional deficit in secretory trafficking pathways, the work 
conducted in this thesis provides a starting point for studying other pathways that are 
regulated by S2P in neurons. Moreover, there is the possibility that the functions of 
pathways downstream of S2P are not necessarily shared between cells, such as the 
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secretion of the C-terminus in promoting axon growth in neurons versus the proliferation 
of chondrocytes. 
 The secretion of C-terminal CREB3L2 from axons in the absence of Golgi would 
make a case for Type IV (or ER-to-cell-surface) secretion in developing neurons 
(Rabouille, 2017). In this pathway, proteins containing a signal peptide can bypass the 
Golgi and are targeted directly to the plasma membrane. Unconventionally secreted 
proteins can also be leaderless, which means that instead of containing a signal 
sequence the protein contains other sequence characteristics that target it towards 
Golgi-independent secretion (Bendtsen et al., 2004). Alternatively, perhaps the Golgi 
components that are present can mediate some elemental aspects of axon secretion 
(Merianda et al., 2009). However, this would not explain the supposed expression of 
proteases in the Golgi apparatus that have multiple transmembrane domains, such as 
S2P. The work conducted in this thesis does not resolve how the secretory pathway 
functions in axons, but it does contribute to our knowledge that axons contain a 
functional secretory system (González et al., 2016; Merianda and Twiss, 2013; Merianda 
et al., 2009), namely by defining a local secretory pathway that is required for normal 
axon development. 
My results show that Shh is synthesized and processed in DRGs, and forms an 
active complex with Ptch1. Because DRGs do not respond to exogenous Shh (Trousse 
et al., 2001), its role in developing axons has been overlooked. In this thesis I show that 
developing DRGs produce Shh and that the CREB3L2 C-terminus and Shh form active 
complexes along DRG axons. One point to note in parallel to this observation is that 
DRGs produce Shh from development until death. How does endogenous Shh signaling 
work in DRGs in vivo? In the developing organism, DRGs encounter Dhh that is 
secreted from myelinating Schwann cells (Parmantier et al., 1999). In the adult 
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organism, DRGs provide Hh signaling to other cell types, such as bulge cells in the hair 
follicle in order to maintain an active stem cell population (Brownell et al., 2011). Yet 
DRG axons do not respond to exogenous Hh in culture (Trousse et al., 2001). It remains 
unclear why DRGs are unresponsive to exogenous Hh, yet rely on Hh derived from their 
own endogenous production for neuritic growth, for example after injury (Martinez et al., 
2015). However, one explanation is that DRGs produce their own Hedgehog to 
functionally saturating levels. 
Shh signaling is modulated by the formation of complexes. Hence, the C-terminal 
CREB3L2 and Shh complexes formed along DRG axons may change the type of 
intracellular signaling pathways that could occur downstream of Ptch1 should Shh have 
been bound alone. If the CREB3L2-Shh complexes are saturating, this may also explain 
why DRG axons do not respond to exogenous Shh. Does C-terminal CREB3L2 bind 
activated Shh exclusively outside the cell (i.e. after it has been secreted) or can this 
complex form within the axon and subsequently be co-secreted to the cell surface? 
Because DRGs are also known to supply Shh to other cell types, two possibilities are 
that highly secreted C-terminal CREB3L2 helps soak up and deliver the diffuse amounts 
of secreted Shh to other cell types in the developing organism. Alternatively, these 
complexes might be delivered by cell-cell contact. 
The primary neuronal cultures that I used throughout my experimental 
approaches were highly enriched for DRGs and consequently the axons of these 
cultures were not myelinated. However, DRG axons in vivo are myelinated by Schwann 
cells. While I reported that Shh signaling promotes axon growth, it may also prove that 
sustained Shh signaling by DRGs in the developing organism is important for 
myelination. Axon myelination is not a static process and it is known that neurons 
undergo myelin remodeling (Auer et al., 2018; Hughes et al., 2018). After axons have 
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reached their targets and functional neural connections have been established, one 
function of the CREB3L2 C-terminus may be to regulate myelin remodeling by Schwann 
cells. 
 
5.2 Future directions 
5.2.1 Turning off the mechanism 
Whether the mechanism outlined in this thesis provides a way for helping 
developing axons reach their target regions at a particular developmental point or 
whether it promotes axon growth in a more general sense, one expects it must turned off 
once axons reach and subsequently innervate their target regions. Adult DRGs continue 
to produce Shh throughout their lifespan (Brownell et al., 2011; Martinez et al., 2015). 
Given that Shh is continuously supplied by DRGs throughout development, turning off 
the S2P-CREB3L2-Shh pathway that promotes axon growth most likely occurs via a 
different mechanism. ER stress is upstream of both S2P and CREB3L2 activity. 
Although the pathway that activates CREB3L2 during ER stress is unknown, 
physiological stress does induce its translation (Kondo et al., 2007). Hence, one way to 
exert translational control of CREB3L2 would be if this ER stress pathway, e.g. PERK, is 
modulated across development. For example, axonal activation of PERK helps guide 
developing axons (Cagnetta et al., 2019). However, in mature neurons, PERK is only 
basally translated until a signal such as nerve injury causes its levels to spike, driving the 
activation of downstream PERK-dependent pathways (Ohtake et al., 2018). A future 
direction of this project could be to explore whether PERK or another regulatory kinase 
controlling eIF2α phosphorylation provides the translational control of CREB3L2 
throughout development. 
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Besides the translational control of full-length CREB3L2, the work conducted in 
this thesis suggests that another way to control CREB3L2 activity is by altering the 
production of the secreted C-terminus through S2P activity. In this thesis I show that 
S2P is expressed in developing axons. However, it is not known whether the expression 
of S2P changes throughout development. Given that it is essential for mammalian cells, 
it is most likely that S2P continues to be expressed in DRGs. However, the localization 
of S2P to axons may change after they reach their targets and synapses are formed. 
Given that axonal S2P is likely active within the smooth ER of neurons along with 
CREB3L2 for reasons discussed in the introduction, perhaps the localization of S2P to 
axons is an adaptation that ensures the constitutive cleavage and secretion of 
CREB3L2. In mature neurons, the localization of S2P might be restricted to the ER/Golgi 
network surrounding the cell body, or S2P might even be localized solely to the Golgi 
apparatus. If this were the case, S2P could only cleave CREB3L2 when CREB3L2 was 
transported to the Golgi from the ER in response to stress. Alternatively, another way to 
control S2P besides altering its intracellular distribution would be to downregulate either 
S2P or CREB3L2 expression in mature cells, ensuring baseline functionality but 
ultimately lowering the levels of the secreted CREB3L2 C-terminus. 
S2P is an apex protease that is indispensable for mammalian cells. Additionally, 
the N-terminus of CREB3L2 is at the very least required for the secretory pathway. Data 
from our lab and previous reports suggest that both of these proteins are active in the 
developing and post-developmental nervous system. The question then arises, after this 
pathway is shut off (or downregulated once axons reach their targets) is it ever turned 
back on? An important implication of this project is that when CREB3L2 is cleaved in 
neurons it simultaneously generates a transcription factor and a secreted protein, which 
functions as an extracellular signaling molecule. Because S2P has not been directly 
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studied in neurons, the roles of the N- and C-terminus of CREB3L2 in the adult brain are 
not understood. An important future direction of this project is to investigate what the N- 
and C-terminal parts of CREB3L2 are doing in the developing and adult brain. 
 
5.2.2 Additional neuronal functions of CREB3L2 
Separate from the project that makes up this thesis, extensive work in our lab 
has found a neurodegenerative function for the N-terminus of CREB3L2 during 
Alzheimer’s disease (AD) (manuscript in preparation at the time of writing this thesis). A 
previous report from our group found that a small population of locally translated ATF4 
derived from axons activates neurodegenerative programs in hippocampal neurons in 
response to Aβ1-42 (Baleriola et al., 2014). However, at the time there remained an 
outstanding question of how a small population of locally translated protein in the axon 
could activate a unique transcriptional response, especially since ATF4 is already 
abundant in the cell body. Following up on this report, work from our group has found 
that ATF4 forms a unique heterodimeric transcriptional complex with the N-terminus of 
CREB3L2 in hippocampal axons. After this complex forms in axons, it travels 
retrogradely to the cell body to activate inflammatory programs that cause cell death.  
The unique signature of this complex provided a simple explanation as to why a 
small pool of locally translated ATF4 activated a specific degenerative insult: it was 
never acting alone. Rather, it is the ATF4 and CREB3L2 complex that activates distinct 
neurodegenerative pathways. Work on this project from one of the senior members of 
our group, Cláudio Gouveia Roque, confirmed the formation of this complex and found 
that ATF4-CREB3L2 is significantly enriched in brains of patients with moderate AD. 
Ideally, interfering with the formation or accumulation of this complex in cell bodies could 
be a potential candidate for pharmacological intervention. 
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While working on this project, I found that like ATF4, CREB3L2 is locally 
translated in axons of mature hippocampal neurons in response to Aβ1-42 (Appendix, 
Figure 5.1). Given the presence of the Creb3l2 uORF (Figure 2.3), one explanation for 
the co-translational control of ATF4 and CREB3L2 is that exogenous Aβ1-42 oligomers 
activate a kinase that phosphorylates eIF2α, which leads to the selective translation of 
ATF4 and CREB3L2 concomitantly in axons (Harding et al., 2000; Vattem and Wek, 
2004). My preliminary data had indicated that this kinase might be PERK, however, 
reports in the literature dispute that PERK signaling exerts translational control over 
CREB3L2 (Kondo et al., 2007). Since the translational control of CREB3L2 in neurons 
was unclear, I chose to focus on the regulatory control of CREB3L2 by proteolysis. As 
described in the introduction, CREB3L2 is synthesized as a full-length protein and is 
inactive until it is cleaved, which liberates the transcriptionally active N-terminus. As 
CREB3L2 is locally translated in axons, it should be co-translationally inserted into the 
ER (Merianda and Twiss, 2013; Merianda et al., 2013); thus proteolytic cleavage should 
be required to activate CREB3L2. The question I wanted to address was whether S2P 
generates transcriptionally active CREB3L2 in axons of mature hippocampal neurons in 
response to Aβ1-42. 
While working on my thesis, I discovered that S2P activates CREB3L2 in a rate-
limiting manner. Subsequent work by Cláudio Gouveia Roque also confirmed that S2P is 
the major protease that regulates CREB3L2 cleavage (Appendix, Figure 5.2). His work 
had also shown that the CREB3L2-ATF4 complex forms in axons and is subsequently 
transported to the cell body, which eventually leads to cell death for hippocampal 
neurons. The previous report from our lab had shown that the induction of CHOP and 
cell death in microfluidics in response to axonally-applied Aβ1-42 were due to locally 
translated ATF4 (Baleriola et al., 2014). Since it forms an active complex with ATF4 in 
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the axon, an active ATF4-CREB3L2 complex also implied that CREB3L2 must be 
cleaved in axons after it is translated. To study whether CHOP induction and cell death 
could be controlled by the proteolytic activation of CREB3L2 by S2P in axons, I 
maintained the same protocols described previously (Baleriola et al., 2014), but also 
treated axons locally with nelfinavir (NF), a compound that inhibits S2P proteolytic 
activity (Guan et al., 2011, 2015) to prevent the cleavage of CREB3L2. Indeed, I 
observed that axonal treatment with nelfinavir prevented the induction of CHOP in cell 
bodies (Appendix, Figure 5.3). Using the TUNEL assay, I also found that cell death was 
prevented with axonal NF treatment (Baleriola et al., 2014) (Appendix, Figure 5.3). 
While I did not assess CHOP under these conditions, I found that cell death was not 
prevented with the application of 3,4-dichloroisocoumarin, a protease inhibitor of S1P 
activity. 
I wanted to investigate whether preventing the induction of CHOP and cell death 
was due to the formation and transport of the CREB3L2-ATF4 complex from the axon to 
cell bodies. Theoretically, inactive full-length CREB3L2 should remain bound to the 
axonal ER. As a consequence, if S2P activity was inhibited, ATF4/CREB3L2 complexes 
would either be restricted to the axon or perhaps not form at all. Using PLA, I assessed 
the formation and localization of ATF4-CREB3L2 complexes following axonal treatments 
with Aβ1-42 or Aβ1-42 and NF (Appendix, Figure 5.4). I did not detect a significant change 
in complexes between control and Aβ1-42 conditions, although there was a trend towards 
an increase in PLA-positive puncta in cell bodies following axonal Aβ1-42 treatment, 
simultaneous with a decrease in axons. However, the difference measured between Aβ1-
42 and Aβ1-42 + NF was significant, implying that ATF4-CREB3L2 complexes can form in 
response to Aβ1-42 when CREB3L2 is not cleaved (i.e. bound to the membrane), but they 
cannot leave the axon until the N-terminus of CREB3L2 is liberated by S2P. As a 
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consequence, fewer ATF4-CREB3L2 complexes accumulate in the cell body 
(Appendix, Figure 5.4). 
 The sparse labeling of the complexes was peculiar since experiments performed in 
dissociated cells had shown higher labeling of ATF4-CREB3L2 puncta (data not shown 
here). However, not every hippocampal neuron in the microfluidic device will extend its 
axon into the axonal compartments and therefore will not encounter Aβ1-42 oligomers, 
partially explaining the low number of PLA-positive complexes in cell bodies (the ATF4-
CREB3L2 complex rarely forms unless cells are treated with Aβ1-42). While the data 
presented here are part of a much larger project and thus cannot convey the full picture, 
from these experiments I was able to identify a pathway where CREB3L2 is cleaved by 
S2P in response to Aβ1-42 in hippocampal axons. I also identified that the proteolysis of 
CREB3L2 is necessary for the transport of the ATF4-CREB3L2 complex to cell bodies to 
induce CHOP and cause cell death. 
In this separate project from the work presented in this thesis, I found that Aβ1-42 
induces the local translation of CREB3L2 in axons, which is likely controlled by its 5’ 
uORF. I also found that S2P cleaves CREB3L2 in response to Aβ1-42 and that this 
activation is required for the induction of CHOP and cell death. An orthogonal approach 
that could strengthen these results would be through the use of a genetic-specific 
knockdown of S2P using siRNA or shRNA. However, since the questions I asked had a 
restrictive spatial component for studying the formation of ATF4-CREB3L2 in axons, the 
benefit of using nelfinavir as a method of S2P inhibition is that I was able to restrict S2P 
inhibition to the axonal compartment. Hence, another way to strengthen these results 
would be to use a different pharmacological inhibitor of S2P, namely 1,10-
phenanthroline. However, as a potential caveat, this compound is known to be less 
potent than NF (Guan et al., 2015). 
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Everything known about S2P and CREB3L2 at this point suggests that both of 
these proteins have essential functions across the lifespan of a neuron, at least in the 
vertebrate homologs conserved in mammals. On one hand, the transcriptionally active 
N-terminus of CREB3L2 binds ATF4 and upregulates inflammatory signaling in 
Alzheimer’s disease; on the other, the secreted C-terminus of CREB3L2 binds Shh and 
promotes axon growth during neural development (Appendix, Figure 5.5). A future 
direction coming out of the work presented in this thesis will be to identify what happens 
to the C-terminus of CREB3L2 in mature neurons and the N-terminus of CREB3L2 in 
developing ones. CREB3L2, like other OASIS family members, is modified by post-
translational modifications (PTMs), which most likely contribute to its stability (Chan et 
al., 2010) and entrance into the secretory pathway (Moremen et al., 2012). Regulating 
PTMs on CREB3L2 may enable neurons to control which part of CREB3L2 is active or 
which part is degraded, for example via the proteasome. In this scenario, the regulation 
of PTMs on CREB3L2 could control the lifespan and activity of N- and C-terminal 
CREB3L2 once they are liberated by S2P. As a result, a situation may exist in which the 
part of CREB3L2 that is not needed is degraded at a rate below that of its production by 
cleavage. However, over time it might accumulate in the cell. Alternatively the 
mechanism controlling PTMs that shunt it towards protein degradation could be 
modified.  
The N-terminus of CREB3L2 activates secretory and stress pathways whereas 
the C-terminus activates Shh signaling. However, the N- and C-terminus may have 
additional neuronal roles that have not been identified. In Chapter 4, I posited that the 
reason I did not observe overt transcriptional changes of S2P knockdown in DRGs was 
because I performed knockdowns over a short timeframe. One approach to identifying 
whether there is any transcriptional role mediated downstream of S2P or CREB3L2 
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during development can be accomplished by extending the length of knockdown, ideally 
in vivo, using null CREB3L2 N- and C-terminus mice.  
The inflammatory transcriptional programs that are activated in response to Aβ1-
42 deposition are intended to restore the cell towards a healthy state, however, a 
prolonged stress response without abatement eventually leads to cell death (Oakes and 
Papa, 2015). While the degenerative aspect of N-terminal CREB3L2 is emerging 
through recent work in our group, a neuroprotective function has not been identified. Yet 
the transient formation of ATF-CREB3L2 in early stages of AD may prove to be 
protective whereas it is the long-term upregulation that is deleterious. Consider the C-
terminus in degeneration: since the C-terminus of CREB3L2 should be generated and 
secreted at the same time the N-terminus is being generated and transported, perhaps 
the C-terminus has a protective role for axonal or synaptic maintenance by remodeling 
the cytoskeleton as a result of non-canonical Shh signaling mediated by Src family 
kinases (Yam et al., 2009). While initially protective, constitutive remodeling of the 
cytoskeleton could lead to the disruption of axonal stability. Indeed axonal atrophy and 
retraction is a hallmark of several neurodegenerative diseases, including AD (Luo and 
O’Leary, 2005).  
While the only known role of the CREB3L2 C-terminus is to promote Shh 
signaling, it is not known whether mature or degenerating hippocampal neurons produce 
active Shh. Another future direction will be to assess whether application of Aβ1-42 
oligomers a) promote the secretion of C-terminal CREB3L2 or b) induce changes in the 
activation and secretion of Shh. The work in this thesis demonstrated that Shh derived 
from sensory axons comprises a signaling pathway that promotes growth. An interesting 
direction will be to investigate whether C-terminal CREB3L2 promotes signaling with Shh 
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in mature or degenerating neurons through a local, non-canonical mechanism and 















  113 
References 
Ahn, S., and Joyner, A.L. (2005). In vivo analysis of quiescent adult neural stem cells 
responding to Sonic hedgehog. Nature 437, 894. 
Amarneh, B., Matthews, K.A., and Rawson, R.B. (2009). Activation of Sterol Regulatory 
Element-binding Protein by the Caspase Drice in Drosophila Larvae. J. Biol. Chem. 284, 
9674–9682. 
Aridor, M., and Fish, K.N. (2009). Selective targeting of ER exit sites supports axon 
development. Traffic 10, 1669–1684. 
Asada, R., Kanemoto, S., Kondo, S., Saito, A., and Imaizumi, K. (2011). The signalling 
from endoplasmic reticulum-resident bZIP transcription factors involved in diverse 
cellular physiology. J Biochem 149, 507–518. 
Astorga, J., and Carlsson, P. (2007). Hedgehog induction of murine vasculogenesis is 
mediated by Foxf1 and Bmp4. Development 134, 3753–3761. 
Auer, F., Vagionitis, S., and Czopka, T. (2018). Evidence for Myelin Sheath Remodeling 
in the CNS Revealed by In Vivo Imaging. Curr. Biol. 28, 549-559.e3. 
Ayers, K.L., and Thérond, P.P. (2010). Evaluating Smoothened as a G-protein-coupled 
receptor for Hedgehog signalling. Trends in Cell Biology 20, 287–298. 
Azevedo, F.A.C., Carvalho, L.R.B., Grinberg, L.T., Farfel, J.M., Ferretti, R.E.L., Leite, 
R.E.P., Jacob Filho, W., Lent, R., and Herculano-Houzel, S. (2009). Equal numbers of 
neuronal and nonneuronal cells make the human brain an isometrically scaled-up 
primate brain. J. Comp. Neurol. 513, 532–541. 
Bagnard, D., Lohrum, M., Uziel, D., Püschel, A.W., and Bolz, J. (1998). Semaphorins act 
as attractive and repulsive guidance signals during the development of cortical 
projections. Development 125, 5043–5053. 
Bai, C.B., Stephen, D., and Joyner, A.L. (2004). All Mouse Ventral Spinal Cord 
Patterning by Hedgehog Is Gli Dependent and Involves an Activator Function of Gli3. 
Developmental Cell 6, 103–115. 
Baleriola, J., Walker, C.A., Jean, Y.Y., Crary, J.F., Troy, C.M., Nagy, P.L., and Hengst, 
U. (2014). Axonally synthesized ATF4 transmits a neurodegenerative signal across brain 
regions. Cell 158, 1159–1172. 
Banker, G., and Goslin, K. (1998). Culturing Nerve Cells (MIT Press). 
Batista, A.F.R., Martínez, J.C., and Hengst, U. (2017). Intra-axonal Synthesis of 
SNAP25 Is Required for the Formation of Presynaptic Terminals. Cell Reports 20, 3085–
3098. 
Baum, P.D., and Garriga, G. (1997). Neuronal Migrations and Axon Fasciculation Are 
Disrupted in ina-1 Integrin Mutants. Neuron 19, 51–62. 
  114 
Bendtsen, J.D., Jensen, L.J., Blom, N., von Heijne, G., and Brunak, S. (2004). Feature-
based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 
17, 349–356. 
Bennett, M.K., Lopez, J.M., Sanchez, H.B., and Osborne, T.F. (1995). Sterol Regulation 
of Fatty Acid Synthase Promoter COORDINATE FEEDBACK REGULATION OF TWO 
MAJOR LIPID PATHWAYS. J. Biol. Chem. 270, 25578–25583. 
Ben‐Yaakov, K., Dagan, S.Y., Segal‐Ruder, Y., Shalem, O., Vuppalanchi, D., Willis, 
D.E., Yudin, D., Rishal, I., Rother, F., Bader, M., et al. (2012). Axonal transcription 
factors signal retrogradely in lesioned peripheral nerve. The EMBO Journal 31, 1350–
1363. 
Ben-Zvi, A., Manor, O., Schachner, M., Yaron, A., Tessier-Lavigne, M., and Behar, O. 
(2008). The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal 
root ganglia development. J. Neurosci. 28, 12427–12432. 
Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P., and Ron, D. (2000). Dynamic 
interaction of BiP and ER stress transducers in the unfolded-protein response. Nature 
Cell Biology 2, 326–332. 
Bitgood, M.J., and McMahon, A.P. (1995). HedgehogandBmpGenes Are Coexpressed 
at Many Diverse Sites of Cell–Cell Interaction in the Mouse Embryo. Developmental 
Biology 172, 126–138. 
Bodian, D. (1965). A SUGGESTIVE RELATIONSHIP OF NERVE CELL RNA WITH 
SPECIFIC SYNAPTIC SITES. Proc. Natl. Acad. Sci. U.S.A. 53, 418–425. 
Bonni, A., and Greenberg, M.E. (1997). Neurotrophin regulation of gene expression. Can 
J Neurol Sci 24, 272–283. 
Borrell, V., Cárdenas, A., Ciceri, G., Galcerán, J., Flames, N., Pla, R., Nóbrega-Pereira, 
S., García-Frigola, C., Peregrín, S., Zhao, Z., et al. (2012). Slit/Robo Signaling 
Modulates the Proliferation of Central Nervous System Progenitors. Neuron 76, 338–
352. 
Bourikas, D., Pekarik, V., Baeriswyl, T., Grunditz, Å., Sadhu, R., Nardó, M., and Stoeckli, 
E.T. (2005). Sonic hedgehog guides commissural axons along the longitudinal axis of 
the spinal cord. Nature Neuroscience 8, 297. 
Bovolenta, P., and Dodd, J. (1991). Perturbation of neuronal differentiation and axon 
guidance in the spinal cord of mouse embryos lacking a floor plate: analysis of 
Danforth’s short-tail mutation. Development 113, 625–639. 
Briggs, M.R., Yokoyama, C., Wang, X., Brown, M.S., and Goldstein, J.L. (1993). Nuclear 
protein that binds sterol regulatory element of low density lipoprotein receptor promoter. 
I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. 
Chem. 268, 14490–14496. 
Briscoe, J., and Thérond, P.P. (2013). The mechanisms of Hedgehog signalling and its 
roles in development and disease. Nature Reviews Molecular Cell Biology 14, 416–429. 
  115 
Brittis, P.A., Lu, Q., and Flanagan, J.G. (2002). Axonal Protein Synthesis Provides a 
Mechanism for Localized Regulation at an Intermediate Target. Cell 110, 223–235. 
Brown, M.S., and Goldstein, J.L. (1997). The SREBP Pathway: Regulation of 
Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor. Cell 
89, 331–340. 
Brown, M.S., Ye, J., Rawson, R.B., and Goldstein, J.L. (2000). Regulated 
Intramembrane Proteolysis: A Control Mechanism Conserved from Bacteria to Humans. 
Cell 100, 391–398. 
Brownell, I., Guevara, E., Bai, C.B., Loomis, C.A., and Joyner, A.L. (2011). Nerve-
Derived Sonic Hedgehog Defines a Niche for Hair Follicle Stem Cells Capable of 
Becoming Epidermal Stem Cells. Cell Stem Cell 8, 552–565. 
Brunet, I., Weinl, C., Piper, M., Trembleau, A., Volovitch, M., Harris, W., Prochiantz, A., 
and Holt, C. (2005). The transcription factor Engrailed-2 guides retinal axons. Nature 
438, 94–98. 
Burke, R., Nellen, D., Bellotto, M., Hafen, E., Senti, K.A., Dickson, B.J., and Basler, K. 
(1999). Dispatched, a novel sterol-sensing domain protein dedicated to the release of 
cholesterol-modified hedgehog from signaling cells. Cell 99, 803–815. 
Butler, S.J., and Tear, G. (2007). Getting axons onto the right path: the role of 
transcription factors in axon guidance. Development 134, 439–448. 
Cagnetta, R., Wong, H.H.-W., Frese, C.K., Mallucci, G.R., Krijgsveld, J., and Holt, C.E. 
(2019). Noncanonical Modulation of the eIF2 Pathway Controls an Increase in Local 
Translation during Neural Wiring. Molecular Cell 73, 474-489.e5. 
Campbell, D.S., and Holt, C.E. (2001). Chemotropic Responses of Retinal Growth 
Cones Mediated by Rapid Local Protein Synthesis and Degradation. Neuron 32, 1013–
1026. 
Campenot, R.B. (1977). Local control of neurite development by nerve growth factor. 
Proc. Natl. Acad. Sci. U.S.A. 74, 4516–4519. 
de Castro, F., Hu, L., Drabkin, H., Sotelo, C., and Chédotal, A. (1999). Chemoattraction 
and chemorepulsion of olfactory bulb axons by different secreted semaphorins. J. 
Neurosci. 19, 4428–4436. 
Chan, C.-P., Mak, T.-Y., Chin, K.-T., Ng, I.O.-L., and Jin, D.-Y. (2010). N-linked 
glycosylation is required for optimal proteolytic activation of membrane-bound 
transcription factor CREB-H. J Cell Sci 123, 1438–1448. 
Charron, F., Stein, E., Jeong, J., McMahon, A.P., and Tessier-Lavigne, M. (2003). The 
Morphogen Sonic Hedgehog Is an Axonal Chemoattractant that Collaborates with 
Netrin-1 in Midline Axon Guidance. Cell 113, 11–23. 
Chauvet, S., Cohen, S., Yoshida, Y., Fekrane, L., Livet, J., Gayet, O., Segu, L., Buhot, 
M.-C., Jessell, T.M., Henderson, C.E., et al. (2007). Gating of Sema3E/PlexinD1 
  116 
signaling by neuropilin-1 switches axonal repulsion to attraction during brain 
development. Neuron 56, 807–822. 
Chen, J.K., Taipale, J., Cooper, M.K., and Beachy, P.A. (2002a). Inhibition of Hedgehog 
signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743–2748. 
Chen, T.-J., Gehler, S., Shaw, A.E., Bamburg, J.R., and Letourneau, P.C. (2006). Cdc42 
participates in the regulation of ADF/cofilin and retinal growth cone filopodia by brain 
derived neurotrophic factor. J. Neurobiol. 66, 103–114. 
Chen, X., Shen, J., and Prywes, R. (2002b). The Luminal Domain of ATF6 Senses 
Endoplasmic Reticulum (ER) Stress and Causes Translocation of ATF6 from the ER to 
the Golgi. J. Biol. Chem. 277, 13045–13052. 
Chiang, C., Litingtung, Y., Lee, E., Young, K.E., Corden, J.L., Westphal, H., and Beachy, 
P.A. (1996). Cyclopia and defective axial patterning in mice lacking Sonic hedgehog 
gene function. Nature 383, 407. 
Chilton, J.K. (2006). Molecular mechanisms of axon guidance. Developmental Biology 
292, 13–24. 
Chu, T., Chiu, M., Zhang, E., and Kunes, S. (2006). A C-Terminal Motif Targets 
Hedgehog to Axons, Coordinating Assembly of the Drosophila Eye and Brain. 
Developmental Cell 10, 635–646. 
Chuang, P.T., and McMahon, A.P. (1999). Vertebrate Hedgehog signalling modulated by 
induction of a Hedgehog-binding protein. Nature 397, 617–621. 
Cowan, C.A., and Henkemeyer, M. (2002). Ephrins in reverse, park and drive. Trends in 
Cell Biology 12, 339–346. 
Cox, J.S., Shamu, C.E., and Walter, P. (1993). Transcriptional induction of genes 
encoding endoplasmic reticulum resident proteins requires a transmembrane protein 
kinase. Cell 73, 1197–1206. 
Cox, L.J., Hengst, U., Gurskaya, N.G., Lukyanov, K.A., and Jaffrey, S.R. (2008). Intra-
axonal translation and retrograde trafficking of CREB promotes neuronal survival. Nature 
Cell Biology; London 10, 149–159. 
Credle, J.J., Finer-Moore, J.S., Papa, F.R., Stroud, R.M., and Walter, P. (2005). On the 
mechanism of sensing unfolded protein in the endoplasmic reticulum. PNAS 102, 
18773–18784. 
Crowley, C., Spencer, S.D., Nishimura, M.C., Chen, K.S., Pitts-Meek, S., Armanini, M.P., 
Ling, L.H., McMahon, S.B., Shelton, D.L., and Levinson, A.D. (1994). Mice lacking nerve 
growth factor display perinatal loss of sensory and sympathetic neurons yet develop 
basal forebrain cholinergic neurons. Cell 76, 1001–1011. 
DeBose-Boyd, R.A., Brown, M.S., Li, W.-P., Nohturfft, A., Goldstein, J.L., and 
Espenshade, P.J. (1999). Transport-Dependent Proteolysis of SREBP: Relocation of 
  117 
Site-1 Protease from Golgi to ER Obviates the Need for SREBP Transport to Golgi. Cell 
99, 703–712. 
Dent, E.W., Gupton, S.L., and Gertler, F.B. (2011). The Growth Cone Cytoskeleton in 
Axon Outgrowth and Guidance. Cold Spring Harb Perspect Biol 3. 
Dessaud, E., Yang, L.L., Hill, K., Cox, B., Ulloa, F., Ribeiro, A., Mynett, A., Novitch, B.G., 
and Briscoe, J. (2007). Interpretation of the sonic hedgehog morphogen gradient by a 
temporal adaptation mechanism. Nature 450, 717–720. 
Dessaud, E., McMahon, A.P., and Briscoe, J. (2008). Pattern formation in the vertebrate 
neural tube: a sonic hedgehog morphogen-regulated transcriptional network. 
Development 135, 2489–2503. 
Dickson, B.J. (2002). Molecular Mechanisms of Axon Guidance. Science 298, 1959–
1964. 
Dodd, J., and Jessell, T.M. (1988). Axon guidance and the patterning of neuronal 
projections in vertebrates. Science 242, 692–699. 
Dominici, C., Moreno-Bravo, J.A., Puiggros, S.R., Rappeneau, Q., Rama, N., Vieugue, 
P., Bernet, A., Mehlen, P., and Chédotal, A. (2017). Floor-plate-derived netrin-1 is 
dispensable for commissural axon guidance. Nature 545, 350–354. 
Dréau, G.L., and Martí, E. (2012). Dorsal–ventral patterning of the neural tube: A tale of 
three signals. Developmental Neurobiology 72, 1471–1481. 
Dulabon, L., Olson, E.C., Taglienti, M.G., Eisenhuth, S., McGrath, B., Walsh, C.A., 
Kreidberg, J.A., and Anton, E.S. (2000). Reelin binds alpha3beta1 integrin and inhibits 
neuronal migration. Neuron 27, 33–44. 
Duncan, E.A., Brown, M.S., Goldstein, J.L., and Sakai, J. (1997). Cleavage Site for 
Sterol-regulated Protease Localized to a Leu-Ser Bond in the Lumenal Loop of Sterol 
Regulatory Element-binding Protein-2. J. Biol. Chem. 272, 12778–12785. 
Echelard, Y., Epstein, D.J., St-Jacques, B., Shen, L., Mohler, J., McMahon, J.A., and 
McMahon, A.P. (1993). Sonic hedgehog, a member of a family of putative signaling 
molecules, is implicated in the regulation of CNS polarity. Cell 75, 1417–1430. 
Ericson, J., Morton, S., Kawakami, A., Roelink, H., and Jessell, T.M. (1996). Two Critical 
Periods of Sonic Hedgehog Signaling Required for the Specification of Motor Neuron 
Identity. Cell 87, 661–673. 
Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van 
Heyningen, V., Jessell, T.M., and Briscoe, J. (1997). Pax6 Controls Progenitor Cell 
Identity and Neuronal Fate in Response to Graded Shh Signaling. Cell 90, 169–180. 
Espenshade, P.J., Cheng, D., Goldstein, J.L., and Brown, M.S. (1999). Autocatalytic 
Processing of Site-1 Protease Removes Propeptide and Permits Cleavage of Sterol 
Regulatory Element-binding Proteins. J. Biol. Chem. 274, 22795–22804. 
  118 
Ferreira, T.A., Blackman, A.V., Oyrer, J., Jayabal, S., Chung, A.J., Watt, A.J., Sjöström, 
P.J., and van Meyel, D.J. (2014). Neuronal morphometry directly from bitmap images. 
Nature Methods 11, 982–984. 
Franze, K. (2013). The mechanical control of nervous system development. 
Development 140, 3069–3077. 
Gehler, S., Shaw, A.E., Sarmiere, P.D., Bamburg, J.R., and Letourneau, P.C. (2004). 
Brain-derived neurotrophic factor regulation of retinal growth cone filopodial dynamics is 
mediated through actin depolymerizing factor/cofilin. J. Neurosci. 24, 10741–10749. 
Ginty, D.D., and Segal, R.A. (2002). Retrograde neurotrophin signaling: Trk-ing along 
the axon. Current Opinion in Neurobiology 12, 268–274. 
Giuliani, F., Grieve, A., and Rabouille, C. (2011). Unconventional secretion: a stress on 
GRASP. Curr. Opin. Cell Biol. 23, 498–504. 
Goldberg, J.L., Espinosa, J.S., Xu, Y., Davidson, N., Kovacs, G.T.A., and Barres, B.A. 
(2002). Retinal Ganglion Cells Do Not Extend Axons by Default: Promotion by 
Neurotrophic Signaling and Electrical Activity. Neuron 33, 689–702. 
Goldstein, J.L., and Brown, M.S. (1984). Progress in understanding the LDL receptor 
and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. 
J. Lipid Res. 25, 1450–1461. 
González, C., Cánovas, J., Fresno, J., Couve, E., Court, F.A., and Couve, A. (2016). 
Axons provide the secretory machinery for trafficking of voltage-gated sodium channels 
in peripheral nerve. PNAS 113, 1823–1828. 
González, C., Cornejo, V.H., and Couve, A. (2018). Golgi bypass for local delivery of 
axonal proteins, fact or fiction? Curr. Opin. Cell Biol. 53, 9–14. 
Gracias, N.G., Shirkey-Son, N.J., and Hengst, U. (2014). Local translation of TC10 is 
required for membrane expansion during axon outgrowth. Nature Communications 5, 
3506. 
Greene, L.A., and Kaplan, D.R. (1995). Early events in neurotrophin signalling via Trk 
and p75 receptors. Current Opinion in Neurobiology 5, 579–587. 
Grimes, M.L., Zhou, J., Beattie, E.C., Yuen, E.C., Hall, D.E., Valletta, J.S., Topp, K.S., 
LaVail, J.H., Bunnett, N.W., and Mobley, W.C. (1996). Endocytosis of Activated TrkA: 
Evidence that Nerve Growth Factor Induces Formation of Signaling Endosomes. J. 
Neurosci. 16, 7950–7964. 
Gritli-Linde, A., Lewis, P., McMahon, A.P., and Linde, A. (2001). The Whereabouts of a 
Morphogen: Direct Evidence for Short- and Graded Long-Range Activity of Hedgehog 
Signaling Peptides. Developmental Biology 236, 364–386. 
Guan, M., Fousek, K., Jiang, C., Guo, S., Synold, T., Xi, B., Shih, C.-C., and Chow, W.A. 
(2011). Nelfinavir Induces Liposarcoma Apoptosis through Inhibition of Regulated 
Intramembrane Proteolysis of SREBP-1 and ATF6. Clin Cancer Res 17, 1796–1806. 
  119 
Guan, M., Fousek, K., and Chow, W.A. (2012). Nelfinavir inhibits regulated 
intramembrane proteolysis of sterol regulatory element binding protein-1 and activating 
transcription factor 6 in castration-resistant prostate cancer. FEBS J. 279, 2399–2411. 
Guan, M., Su, L., Yuan, Y.-C., Li, H., and Chow, W.A. (2015). Nelfinavir and Nelfinavir 
Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer. 
Scientific Reports 5, 9698. 
Gumy, L.F., Yeo, G.S.H., Tung, Y.-C.L., Zivraj, K.H., Willis, D., Coppola, G., Lam, 
B.Y.H., Twiss, J.L., Holt, C.E., and Fawcett, J.W. (2011). Transcriptome analysis of 
embryonic and adult sensory axons reveals changes in mRNA repertoire localization. 
RNA 17, 85–98. 
Gundersen, R.W., and Barrett, J.N. (1979). Neuronal chemotaxis: chick dorsal-root 
axons turn toward high concentrations of nerve growth factor. Science 206, 1079–1080. 
Guo, Y., Sirkis, D.W., and Schekman, R. (2014). Protein Sorting at the trans-Golgi 
Network. Annual Review of Cell and Developmental Biology 30, 169–206. 
Harding, H.P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., and Ron, D. 
(2000). Regulated Translation Initiation Controls Stress-Induced Gene Expression in 
Mammalian Cells. Molecular Cell 6, 1099–1108. 
Harding, H.P., Zhang, Y., Zeng, H., Novoa, I., Lu, P.D., Calfon, M., Sadri, N., Yun, C., 
Popko, B., Paules, R., et al. (2003). An Integrated Stress Response Regulates Amino 
Acid Metabolism and Resistance to Oxidative Stress. Molecular Cell 11, 619–633. 
Hasan, M.T., Chang, C.C.Y., and Chang, T.Y. (1994). Somatic cell genetic and 
biochemical characterization of cell lines resulting from human genomic DNA 
transfections of Chinese hamster ovary cell mutants defective in sterol-dependent 
activation of sterol synthesis and LDL receptor expression. Somat Cell Mol Genet 20, 
183–194. 
Hayashi, A., Kasahara, T., Iwamoto, K., Ishiwata, M., Kametani, M., Kakiuchi, C., 
Furuichi, T., and Kato, T. (2007). The role of brain-derived neurotrophic factor (BDNF)-
induced XBP1 splicing during brain development. J. Biol. Chem. 282, 34525–34534. 
Hengst, U., Deglincerti, A., Kim, H.J., Jeon, N.L., and Jaffrey, S.R. (2009). Axonal 
elongation triggered by stimulus-induced local translation of a polarity complex protein. 
Nature Cell Biology 11, 1024–1030. 
Herrera, E., Brown, L., Aruga, J., Rachel, R.A., Dolen, G., Mikoshiba, K., Brown, S., and 
Mason, C.A. (2003). Zic2 patterns binocular vision by specifying the uncrossed retinal 
projection. Cell 114, 545–557. 
Hetz, C. (2012). The unfolded protein response: controlling cell fate decisions under ER 
stress and beyond. Nature Reviews Molecular Cell Biology 13, 89–102. 
Hetz, C., and Saxena, S. (2017). ER stress and the unfolded protein response in 
neurodegeneration. Nature Reviews Neurology 13, 477–491. 
  120 
Hirokawa, N., Niwa, S., and Tanaka, Y. (2010). Molecular Motors in Neurons: Transport 
Mechanisms and Roles in Brain Function, Development, and Disease. Neuron 68, 610–
638. 
Hoang, B.V., and Chiba, A. (1998). Genetic analysis on the role of integrin during axon 
guidance in Drosophila. The Journal of Neuroscience : The Official Journal of the Society 
for Neuroscience 18, 7847–7855. 
Holland, S.J., Gale, N.W., Mbamalu, G., Yancopoulos, G.D., Henkemeyer, M., and 
Pawson, T. (1996). Bidirectional signalling through the EPH-family receptor Nuk and its 
transmembrane ligands. Nature 383, 722–725. 
Hooper, J.E., and Scott, M.P. (1989). The Drosophila patched gene encodes a putative 
membrane protein required for segmental patterning. Cell 59, 751–765. 
Hoppe, T., Rape, M., and Jentsch, S. (2001). Membrane-bound transcription factors: 
regulated release by RIP or RUP. Curr. Opin. Cell Biol. 13, 344–348. 
Horton, A.C., Rácz, B., Monson, E.E., Lin, A.L., Weinberg, R.J., and Ehlers, M.D. (2005). 
Polarized Secretory Trafficking Directs Cargo for Asymmetric Dendrite Growth and 
Morphogenesis. Neuron 48, 757–771. 
Horton, J.D., Shah, N.A., Warrington, J.A., Anderson, N.N., Park, S.W., Brown, M.S., 
and Goldstein, J.L. (2003). Combined analysis of oligonucleotide microarray data from 
transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci 
U S A 100, 12027–12032. 
Hu, Y., Park, K.K., Yang, L., Wei, X., Yang, Q., Cho, K.-S., Thielen, P., Lee, A.-H., 
Cartoni, R., Glimcher, L.H., et al. (2012). Differential Effects of Unfolded Protein 
Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells. Neuron 
73, 445–452. 
Hua, X., Yokoyama, C., Wu, J., Briggs, M.R., Brown, M.S., Goldstein, J.L., and Wang, X. 
(1993). SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates 
transcription by binding to a sterol regulatory element. PNAS 90, 11603–11607. 
Hua, X., Sakai, J., K, H.Y., Goldstein, J.L., and Brown, M.S. (1995). Hairpin Orientation 
of Sterol Regulatory Element-binding Protein-2 in Cell Membranes as Determined by 
Protease Protection. J. Biol. Chem. 270, 29422–29427. 
Hua, X., Sakai, J., Brown, M.S., and Goldstein, J.L. (1996). Regulated Cleavage of 
Sterol Regulatory Element Binding Proteins Requires Sequences on Both Sides of the 
Endoplasmic Reticulum Membrane. J. Biol. Chem. 271, 10379–10384. 
Huang, Z., Shimazu, K., Woo, N.H., Zang, K., Müller, U., Lu, B., and Reichardt, L.F. 
(2006). Distinct Roles of the β1-Class Integrins at the Developing and the Mature 
Hippocampal Excitatory Synapse. J Neurosci 26, 11208–11219. 
Huber, A.B., Kania, A., Tran, T.S., Gu, C., Garcia, N.D.M., Lieberam, I., Johnson, D., 
Jessell, T.M., Ginty, D.D., and Kolodkin, A.L. (2005). Distinct Roles for Secreted 
Semaphorin Signaling in Spinal Motor Axon Guidance. Neuron 48, 949–964. 
  121 
Hughes, E.G., Orthmann-Murphy, J.L., Langseth, A.J., and Bergles, D.E. (2018). Myelin 
remodeling through experience-dependent oligodendrogenesis in the adult 
somatosensory cortex. Nature Neuroscience 21, 696. 
Ince-Dunn, G., Hall, B.J., Hu, S.-C., Ripley, B., Huganir, R.L., Olson, J.M., Tapscott, 
S.J., and Ghosh, A. (2006). Regulation of Thalamocortical Patterning and Synaptic 
Maturation by NeuroD2. Neuron 49, 683–695. 
Ishikawa, T., Toyama, T., Nakamura, Y., Tamada, K., Shimizu, H., Ninagawa, S., 
Okada, T., Kamei, Y., Ishikawa-Fujiwara, T., Todo, T., et al. (2017). UPR transducer 
BBF2H7 allows export of type II collagen in a cargo- and developmental stage–specific 
manner. J Cell Biol 216, 1761–1774. 
Iwamoto, H., Matsuhisa, K., Saito, A., Kanemoto, S., Asada, R., Hino, K., Takai, T., Cui, 
M., Cui, X., Kaneko, M., et al. (2015). Promotion of Cancer Cell Proliferation by Cleaved 
and Secreted Luminal Domains of ER Stress Transducer BBF2H7. PLOS ONE 10, 
e0125982. 
Izumi, S., Saito, A., Kanemoto, S., Kawasaki, N., Asada, R., Iwamoto, H., Oki, M., 
Miyagi, H., Ochi, M., and Imaizumi, K. (2012). The Endoplasmic Reticulum Stress 
Transducer BBF2H7 Suppresses Apoptosis by Activating the ATF5-MCL1 Pathway in 
Growth Plate Cartilage. J Biol Chem 287, 36190–36200. 
Ji, S.-J., and Jaffrey, S.R. (2012). Intra-axonal Translation of SMAD1/5/8 Mediates 
Retrograde Regulation of Trigeminal Ganglia Subtype Specification. Neuron 74, 95–107. 
Ji, S.-J., and Jaffrey, S.R. (2014). Axonal transcription factors: Novel regulators of 
growth cone-to-nucleus signaling. Developmental Neurobiology 74, 245–258. 
Kavran, J.M., Ward, M.D., Oladosu, O.O., Mulepati, S., and Leahy, D.J. (2010). All 
mammalian hedgehog proteins interact with CDO and BOC in a conserved manner. J. 
Biol. Chem. jbc.M110.131680. 
Kennedy, T.E., Serafini, T., de la Torre, J.R., and Tessier-Lavigne, M. (1994). Netrins 
are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. 
Cell 78, 425–435. 
Kent, C.B., Shimada, T., Ferraro, G.B., Ritter, B., Yam, P.T., McPherson, P.S., Charron, 
F., Kennedy, T.E., and Fournier, A.E. (2010). 14-3-3 proteins regulate protein kinase a 
activity to modulate growth cone turning responses. J. Neurosci. 30, 14059–14067. 
Kinseth, M.A., Anjard, C., Fuller, D., Guizzunti, G., Loomis, W.F., and Malhotra, V. 
(2007). The Golgi-associated protein GRASP is required for unconventional protein 
secretion during development. Cell 130, 524–534. 
Kirby, E.D., Muroy, S.E., Sun, W.G., Covarrubias, D., Leong, M.J., Barchas, L.A., and 
Kaufer, D. (2013). Acute stress enhances adult rat hippocampal neurogenesis and 
activation of newborn neurons via secreted astrocytic FGF2. 
Koenig, E., and Martin, R. (1996). Cortical plaque-like structures identify ribosome-
containing domains in the Mauthner cell axon. J. Neurosci. 16, 1400–1411. 
  122 
Koenig, E., Martin, R., Titmus, M., and Sotelo-Silveira, J.R. (2000). Cryptic peripheral 
ribosomal domains distributed intermittently along mammalian myelinated axons. J. 
Neurosci. 20, 8390–8400. 
Kondo, S., Saito, A., Hino, S. -i., Murakami, T., Ogata, M., Kanemoto, S., Nara, S., 
Yamashita, A., Yoshinaga, K., Hara, H., et al. (2007). BBF2H7, a Novel Transmembrane 
bZIP Transcription Factor, Is a New Type of Endoplasmic Reticulum Stress Transducer. 
Molecular and Cellular Biology 27, 1716–1729. 
Korennykh, A.V., Egea, P.F., Korostelev, A.A., Finer-Moore, J., Zhang, C., Shokat, K.M., 
Stroud, R.M., and Walter, P. (2009). The unfolded protein response signals through 
high-order assembly of Ire1. Nature 457, 687–693. 
Kuhn, P.-H., Colombo, A.V., Schusser, B., Dreymueller, D., Wetzel, S., Schepers, U., 
Herber, J., Ludwig, A., Kremmer, E., Montag, D., et al. (2016). Systematic substrate 
identification indicates a central role for the metalloprotease ADAM10 in axon targeting 
and synapse function. ELife 5. 
Lee, K.P.K., Dey, M., Neculai, D., Cao, C., Dever, T.E., and Sicheri, F. (2008a). 
Structure of the Dual Enzyme Ire1 Reveals the Basis for Catalysis and Regulation in 
Nonconventional RNA Splicing. Cell 132, 89–100. 
Lee, R., Petros, T.J., and Mason, C.A. (2008b). Zic2 Regulates Retinal Ganglion Cell 
Axon Avoidance of ephrinB2 through Inducing Expression of the Guidance Receptor 
EphB1. J Neurosci 28, 5910–5919. 
Lei, Q. (2004). Transduction of graded Hedgehog signaling by a combination of Gli2 and 
Gli3 activator functions in the developing spinal cord. Development 131, 3593–3604. 
Lei, Q., Jeong, Y., Misra, K., Li, S., Zelman, A.K., Epstein, D.J., and Matise, M.P. (2006). 
Wnt Signaling Inhibitors Regulate the Transcriptional Response to Morphogenetic Shh-
Gli Signaling in the Neural Tube. Developmental Cell 11, 325–337. 
Lepelletier, L., Langlois, S.D., Kent, C.B., Welshhans, K., Morin, S., Bassell, G.J., Yam, 
P.T., and Charron, F. (2017). Sonic Hedgehog Guides Axons via Zipcode Binding 
Protein 1-Mediated Local Translation. J. Neurosci. 37, 1685–1695. 
Leung, L.C., Urbančič, V., Baudet, M.-L., Dwivedy, A., Bayley, T.G., Lee, A.C., Harris, 
W.A., and Holt, C.E. (2013). Coupling of NF-protocadherin signaling to axon guidance by 
cue-induced translation. Nat. Neurosci. 16, 166–173. 
Li, H., Korennykh, A.V., Behrman, S.L., and Walter, P. (2010). Mammalian endoplasmic 
reticulum stress sensor IRE1 signals by dynamic clustering. PNAS 107, 16113–16118. 
Lindert, U., Cabral, W.A., Ausavarat, S., Tongkobpetch, S., Ludin, K., Barnes, A.M., 
Yeetong, P., Weis, M., Krabichler, B., Srichomthong, C., et al. (2016). MBTPS2 
mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis 
imperfecta. Nat Commun 7, 11920. 
  123 
Lippincott-Schwartz, J., Yuan, L.C., Bonifacino, J.S., and Klausner, R.D. (1989). Rapid 
redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for 
membrane cycling from Golgi to ER. Cell 56, 801–813. 
Liu, Y., Bhowmick, T., Liu, Y., Gao, X., Mertens, H.D.T., Svergun, D.I., Xiao, J., Zhang, 
Y., Wang, J., and Meijers, R. (2018). Structural Basis for Draxin-Modulated Axon 
Guidance and Fasciculation by Netrin-1 through DCC. Neuron 97, 1261-1267.e4. 
Longair, M.H., Baker, D.A., and Armstrong, J.D. (2011). Simple Neurite Tracer: open 
source software for reconstruction, visualization and analysis of neuronal processes. 
Bioinformatics 27, 2453–2454. 
Lopez-Verrilli, M.A., Picou, F., and Court, F.A. (2013). Schwann cell-derived exosomes 
enhance axonal regeneration in the peripheral nervous system. Glia 61, 1795–1806. 
Luchetti, G., Sircar, R., Kong, J.H., Nachtergaele, S., Sagner, A., Byrne, E.F., Covey, 
D.F., Siebold, C., and Rohatgi, R. (2016). Cholesterol activates the G-protein coupled 
receptor Smoothened to promote Hedgehog signaling. 
Luo, L., and O’Leary, D.D.M. (2005). Axon retraction and degeneration in development 
and disease. Annu. Rev. Neurosci. 28, 127–156. 
Luo, Y., Raible, D., and Raper, J.A. (1993). Collapsin: a protein in brain that induces the 
collapse and paralysis of neuronal growth cones. Cell 75, 217–227. 
MacInnis, B.L., and Campenot, R.B. (2002). Retrograde Support of Neuronal Survival 
Without Retrograde Transport of Nerve Growth Factor. Science 295, 1536–1539. 
Maizel, A., Bensaude, O., Prochiantz, A., and Joliot, A. (1999). A short region of its 
homeodomain is necessary for engrailed nuclear export and secretion. Development 
126, 3183–3190. 
Maizel, A., Tassetto, M., Filhol, O., Cochet, C., Prochiantz, A., and Joliot, A. (2002). 
Engrailed homeoprotein secretion is a regulated process. Development 129, 3545–3553. 
Manavalan, M.A., Jayasinghe, V.R., Grewal, R., and Bhat, K.M. (2017). The 
glycosylation pathway is required for the secretion of Slit and for the maintenance of the 
Slit receptor Robo on axons. Sci. Signal. 10, eaam5841. 
Marigo, V., Davey, R.A., Zuo, Y., Cunningham, J.M., and Tabin, C.J. (1996). 
Biochemical evidence that Patched is the Hedgehog receptor. Nature 384, 176. 
Marsick, B.M., Flynn, K.C., Santiago-Medina, M., Bamburg, J.R., and Letourneau, P.C. 
(2010). Activation of ADF/cofilin mediates attractive growth cone turning toward nerve 
growth factor and netrin-1. Dev Neurobiol 70, 565–588. 
Martínez, G., Vidal, R.L., Mardones, P., Serrano, F.G., Ardiles, A.O., Wirth, C., Valdés, 
P., Thielen, P., Schneider, B.L., Kerr, B., et al. (2016). Regulation of Memory Formation 
by the Transcription Factor XBP1. Cell Reports 14, 1382–1394. 
  124 
Martinez, J.A., Kobayashi, M., Krishnan, A., Webber, C., Christie, K., Guo, G., Singh, V., 
and Zochodne, D.W. (2015). Intrinsic facilitation of adult peripheral nerve regeneration 
by the Sonic hedgehog morphogen. Experimental Neurology 271, 493–505. 
Matthews, K.A., Kunte, A.S., Tambe-Ebot, E., and Rawson, R.B. (2009). Alternative 
Processing of Sterol Regulatory Element Binding Protein During Larval Development in 
Drosophila melanogaster. Genetics 181, 119–128. 
Matthews, K.A., Ozdemir, C., and Rawson, R.B. (2010). Activation of Sterol Regulatory 
Element Binding Proteins in the Absence of Scap in Drosophila melanogaster. Genetics 
185, 189–198. 
Mégarbané, H., and Mégarbané, A. (2011). Ichthyosis follicularis, alopecia, and 
photophobia (IFAP) syndrome. Orphanet J Rare Dis 6, 29. 
Melville, D.B., Montero-Balaguer, M., Levic, D.S., Bradley, K., Smith, J.R., Hatzopoulos, 
A.K., and Knapik, E.W. (2011). The feelgood mutation in zebrafish dysregulates COPII-
dependent secretion of select extracellular matrix proteins in skeletal morphogenesis. 
Disease Models & Mechanisms 4, 763–776. 
Merianda, T., and Twiss, J. (2013). Peripheral nerve axons contain machinery for co-
translational secretion of axonally-generated proteins. Neuroscience Bulletin 29, 493–
500. 
Merianda, T.T., Lin, A.C., Lam, J.S.Y., Vuppalanchi, D., Willis, D.E., Karin, N., Holt, C.E., 
and Twiss, J.L. (2009). A functional equivalent of endoplasmic reticulum and Golgi in 
axons for secretion of locally synthesized proteins. Molecular and Cellular Neuroscience 
40, 128–142. 
Merianda, T.T., Vuppalanchi, D., Yoo, S., Blesch, A., and Twiss, J.L. (2013). Axonal 
transport of neural membrane protein 35 mRNA increases axon growth. J Cell Sci 126, 
90–102. 
Mohamed, N.-V., Plouffe, V., Rémillard-Labrosse, G., Planel, E., and Leclerc, N. (2014). 
Starvation and inhibition of lysosomal function increased tau secretion by primary 
cortical neurons. Scientific Reports 4, 5715. 
Mok, S.-A., Lund, K., and Campenot, R.B. (2009). A retrograde apoptotic signal 
originating in NGF-deprived distal axons of rat sympathetic neurons in compartmented 
cultures. Cell Res. 19, 546–560. 
Moore, D.L., and Goldberg, J.L. (2011). Multiple transcription factor families regulate 
axon growth and regeneration. Dev Neurobiol 71, 1186–1211. 
Moremen, K.W., Tiemeyer, M., and Nairn, A.V. (2012). Vertebrate protein glycosylation: 
diversity, synthesis and function. Nature Reviews Molecular Cell Biology 13, 448–462. 
Motoyama, J., Liu, J., Mo, R., Ding, Q., Post, M., and Hui, C. (1998). Essential function 
of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nature Genetics 20, 
54–57. 
  125 
Murakami, T., Kondo, S., Ogata, M., Kanemoto, S., Saito, A., Wanaka, A., and Imaizumi, 
K. (2006). Cleavage of the membrane-bound transcription factor OASIS in response to 
endoplasmic reticulum stress. Journal of Neurochemistry 96, 1090–1100. 
Nakano, Y., Guerrero, I., Hidalgo, A., Taylor, A., Whittle, J.R.S., and Ingham, P.W. 
(1989). A protein with several possible membrane-spanning domains encoded by the 
Drosophila segment polarity gene patched. Nature 341, 508. 
Neuhaus-Follini, A., and Bashaw, G.J. (2015). The Intracellular Domain of the 
Frazzled/DCC Receptor Is a Transcription Factor Required for Commissural Axon 
Guidance. Neuron 87, 751–763. 
Nohturfft, A., DeBose-Boyd, R.A., Scheek, S., Goldstein, J.L., and Brown, M.S. (1999). 
Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between 
endoplasmic reticulum and Golgi. PNAS 96, 11235–11240. 
Novitch, B.G., Chen, A.I., and Jessell, T.M. (2001). Coordinate Regulation of Motor 
Neuron Subtype Identity and Pan-Neuronal Properties by the bHLH Repressor Olig2. 
Neuron 31, 773–789. 
Nüsslein-Volhard, C., and Wieschaus, E. (1980). Mutations affecting segment number 
and polarity in Drosophila. Nature 287, 795–801. 
Oakes, S.A., and Papa, F.R. (2015). The role of endoplasmic reticulum stress in human 
pathology. Annu Rev Pathol 10, 173–194. 
Oeffner, F., Fischer, G., Happle, R., König, A., Betz, R.C., Bornholdt, D., Neidel, U., del 
Carmen Boente, M., Redler, S., Romero-Gomez, J., et al. (2009). IFAP Syndrome Is 
Caused by Deficiency in MBTPS2, an Intramembrane Zinc Metalloprotease Essential for 
Cholesterol Homeostasis and ER Stress Response. Am J Hum Genet 84, 459–467. 
Oeffner, F., Martinez, F., Schaffer, J., Salhi, A., Monfort, S., Oltra, S., Neidel, U., 
Bornholdt, D., Bon, B. van, König, A., et al. (2011). Intronic mutations affecting splicing 
of MBTPS2 cause ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome. 
Experimental Dermatology 20, 447–449. 
Ohtake, Y., Matsuhisa, K., Kaneko, M., Kanemoto, S., Asada, R., Imaizumi, K., and 
Saito, A. (2018). Axonal Activation of the Unfolded Protein Response Promotes Axonal 
Regeneration Following Peripheral Nerve Injury. Neuroscience 375, 34–48. 
Oikawa, D., Kimata, Y., Kohno, K., and Iwawaki, T. (2009). Activation of mammalian 
IRE1α upon ER stress depends on dissociation of BiP rather than on direct interaction 
with unfolded proteins. Experimental Cell Research 315, 2496–2504. 
Okada, A., Charron, F., Morin, S., Shin, D.S., Wong, K., Fabre, P.J., Tessier-Lavigne, 
M., and McConnell, S.K. (2006). Boc is a receptor for sonic hedgehog in the guidance of 
commissural axons. Nature 444, 369–373. 
Oñate, M., Catenaccio, A., Martínez, G., Armentano, D., Parsons, G., Kerr, B., Hetz, C., 
and Court, F.A. (2016). Activation of the unfolded protein response promotes axonal 
regeneration after peripheral nerve injury. Scientific Reports 6, 21709. 
  126 
Park, J.W., Vahidi, B., Taylor, A.M., Rhee, S.W., and Jeon, N.L. (2006). Microfluidic 
culture platform for neuroscience research. Nat Protoc 1, 2128–2136. 
Parmantier, E., Lynn, B., Lawson, D., Turmaine, M., Namini, S.S., Chakrabarti, L., 
McMahon, A.P., Jessen, K.R., and Mirsky, R. (1999). Schwann Cell–Derived Desert 
Hedgehog Controls the Development of Peripheral Nerve Sheaths. Neuron 23, 713–724. 
Parra, L.M., and Zou, Y. (2010). Sonic hedgehog induces response of commissural 
axons to Semaphorin repulsion during midline crossing. Nature Neuroscience 13, 29–35. 
Pasterkamp, R.J., Peschon, J.J., Spriggs, M.K., and Kolodkin, A.L. (2003). Semaphorin 
7A promotes axon outgrowth through integrins and MAPKs. Nature 424, 398–405. 
Patel, T.D., Jackman, A., Rice, F.L., Kucera, J., and Snider, W.D. (2000). Development 
of Sensory Neurons in the Absence of NGF/TrkA Signaling In Vivo. Neuron 25, 345–
357. 
Pathi, S., Pagan-Westphal, S., Baker, D.P., Garber, E.A., Rayhorn, P., Bumcrot, D., 
Tabin, C.J., Blake Pepinsky, R., and Williams, K.P. (2001). Comparative biological 
responses to human Sonic, Indian, and Desert hedgehog. Mechanisms of Development 
106, 107–117. 
Peng, J., Fabre, P.J., Dolique, T., Swikert, S.M., Kermasson, L., Shimogori, T., and 
Charron, F. (2018). Sonic Hedgehog Is a Remotely Produced Cue that Controls Axon 
Guidance Trans-axonally at a Midline Choice Point. Neuron 97, 326-340.e4. 
Pfenninger, K.H. (2009). Plasma membrane expansion: a neuron’s Herculean task. 
Nature Reviews Neuroscience 10, 251–261. 
Piper, M., Salih, S., Weinl, C., Holt, C.E., and Harris, W.A. (2005). Endocytosis-
dependent desensitization and protein synthesis-dependent resensitization in retinal 
growth cone adaptation. Nat. Neurosci. 8, 179–186. 
Polleux, F., Ince-Dunn, G., and Ghosh, A. (2007). Transcriptional regulation of 
vertebrate axon guidance and synapse formation. Nature Reviews Neuroscience 8, 
331–340. 
Porter, J.A., Kessler, D.P. von, Ekker, S.C., Young, K.E., Lee, J.J., Moses, K., and 
Beachy, P.A. (1995). The product of hedgehog autoproteolytic cleavage active in local 
and long-range signalling. Nature 374, 363. 
Porter, J.A., Ekker, S.C., Park, W.J., von Kessler, D.P., Young, K.E., Chen, C.H., Ma, Y., 
Woods, A.S., Cotter, R.J., Koonin, E.V., et al. (1996). Hedgehog patterning activity: role 
of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. 
Cell 86, 21–34. 
Rabouille, C. (2017). Pathways of Unconventional Protein Secretion. Trends in Cell 
Biology 27, 230–240. 
Raggo, C., Rapin, N., Stirling, J., Gobeil, P., Smith-Windsor, E., O’Hare, P., and Misra, 
V. (2002). Luman, the Cellular Counterpart of Herpes Simplex Virus VP16, Is Processed 
  127 
by Regulated Intramembrane Proteolysis. Molecular and Cellular Biology 22, 5639–
5649. 
Ramírez, O.A., and Couve, A. (2011). The endoplasmic reticulum and protein trafficking 
in dendrites and axons. Trends in Cell Biology 21, 219–227. 
Raper, J., and Mason, C. (2010). Cellular Strategies of Axonal Pathfinding. Cold Spring 
Harb Perspect Biol 2, a001933. 
Raper, J.A., Bastiani, M., and Goodman, C.S. (1983). Pathfinding by neuronal growth 
cones in grasshopper embryos. II. Selective fasciculation onto specific axonal pathways. 
J. Neurosci. 3, 31–41. 
Rapoport, T.A. (2007). Protein translocation across the eukaryotic endoplasmic 
reticulum and bacterial plasma membranes. Nature 450, 663–669. 
Rawson, R.B. (2013). The site-2 protease. Biochimica et Biophysica Acta (BBA) - 
Biomembranes 1828, 2801–2807. 
Rawson, R.B., Zelenski, N.G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M.T., Chang, T.Y., 
Brown, M.S., and Goldstein, J.L. (1997). Complementation Cloning of S2P, a Gene 
Encoding a Putative Metalloprotease Required for Intramembrane Cleavage of SREBPs. 
Molecular Cell 1, 47–57. 
Reck-Peterson, S.L., Redwine, W.B., Vale, R.D., and Carter, A.P. (2018). The 
cytoplasmic dynein transport machinery and its many cargoes. Nature Reviews 
Molecular Cell Biology 19, 382. 
Reimer, M.M., Kuscha, V., Wyatt, C., Sörensen, I., Frank, R.E., Knüwer, M., Becker, T., 
and Becker, C.G. (2009). Sonic Hedgehog Is a Polarized Signal for Motor Neuron 
Regeneration in Adult Zebrafish. J. Neurosci. 29, 15073–15082. 
Reinke, A.W., Baek, J., Ashenberg, O., and Keating, A.E. (2013). Networks of bZIP 
Protein-Protein Interactions Diversified Over a Billion Years of Evolution. Science 340, 
730–734. 
Renzi, M.J., Wexler, T.L., and Raper, J.A. (2000). Olfactory sensory axons expressing a 
dominant-negative semaphorin receptor enter the CNS early and overshoot their target. 
Neuron 28, 437–447. 
Riccio, A., Pierchala, B.A., Ciarallo, C.L., and Ginty, D.D. (1997). An NGF-TrkA-
Mediated Retrograde Signal to Transcription Factor CREB in Sympathetic Neurons. 
Science 277, 1097–1100. 
Riccio, A., Ahn, S., Davenport, C.M., Blendy, J.A., and Ginty, D.D. (1999). Mediation by 
a CREB Family Transcription Factor of NGF-Dependent Survival of Sympathetic 
Neurons. Science 286, 2358–2361. 
Rodríguez-Martínez, J.A., Reinke, A.W., Bhimsaria, D., Keating, A.E., and Ansari, A.Z. 
(2017). Combinatorial bZIP dimers display complex DNA-binding specificity landscapes. 
  128 
Roelink, H., Porter, J.A., Chiang, C., Tanabe, Y., Chang, D.T., Beachy, P.A., and 
Jessell, T.M. (1995). Floor plate and motor neuron induction by different concentrations 
of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81, 445–
455. 
Roessler, E., Belloni, E., Gaudenz, K., Vargas, F., Scherer, S.W., Tsui, L.-C., and 
Muenke, M. (1997). Mutations in the C-Terminal Domain of Sonic Hedgehog Cause 
Holoprosencephaly. Hum Mol Genet 6, 1847–1853. 
Saito, A., Hino, S., Murakami, T., Kanemoto, S., Kondo, S., Saitoh, M., Nishimura, R., 
Yoneda, T., Furuichi, T., Ikegawa, S., et al. (2009). Regulation of endoplasmic reticulum 
stress response by a BBF2H7-mediated Sec23a pathway is essential for 
chondrogenesis. Nature Cell Biology 11, 1197–1204. 
Saito, A., Kanemoto, S., Zhang, Y., Asada, R., Hino, K., and Imaizumi, K. (2014). 
Chondrocyte Proliferation Regulated by Secreted Luminal Domain of ER Stress 
Transducer BBF2H7/CREB3L2. Molecular Cell 53, 127–139. 
Sakai, J., Duncan, E.A., Rawson, R.B., Hua, X., Brown, M.S., and Goldstein, J.L. (1996). 
Sterol-Regulated Release of SREBP-2 from Cell Membranes Requires Two Sequential 
Cleavages, One Within a Transmembrane Segment. Cell 85, 1037–1046. 
Sakai, J., Rawson, R.B., Espenshade, P.J., Cheng, D., Seegmiller, A.C., Goldstein, J.L., 
and Brown, M.S. (1998). Molecular Identification of the Sterol-Regulated Luminal 
Protease that Cleaves SREBPs and Controls Lipid Composition of Animal Cells. 
Molecular Cell 2, 505–514. 
Sanz, R.L., Ferraro, G.B., Girouard, M.-P., and Fournier, A.E. (2017). Ectodomain 
shedding of Limbic System-Associated Membrane Protein (LSAMP) by ADAM 
Metallopeptidases promotes neurite outgrowth in DRG neurons. Scientific Reports 7, 
7961. 
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., 
Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012). Fiji: an open-source 
platform for biological-image analysis. Nature Methods 9, 676–682. 
Schlombs, K., Wagner, T., and Scheel, J. (2003). Site-1 protease is required for cartilage 
development in zebrafish. PNAS 100, 14024–14029. 
Schubert, D., Herrera, F., Cumming, R., Read, J., Low, W., Maher, P., and Fischer, W.H. 
(2009). Neural cells secrete a unique repertoire of proteins. J. Neurochem. 109, 427–
435. 
Schwarting, G.A., Kostek, C., Ahmad, N., Dibble, C., Pays, L., and Püschel, A.W. 
(2000). Semaphorin 3A is required for guidance of olfactory axons in mice. J. Neurosci. 
20, 7691–7697. 
Schwarz, D.S., and Blower, M.D. (2016). The endoplasmic reticulum: structure, function 
and response to cellular signaling. Cell Mol Life Sci 73, 79–94. 
  129 
Selvaraj, B.T., Frank, N., Bender, F.L.P., Asan, E., and Sendtner, M. (2012). Local 
axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron 
disease. J Cell Biol 199, 437–451. 
Serafini, T., Colamarino, S.A., Leonardo, E.D., Wang, H., Beddington, R., Skarnes, 
W.C., and Tessier-Lavigne, M. (1996). Netrin-1 Is Required for Commissural Axon 
Guidance in the Developing Vertebrate Nervous System. Cell 87, 1001–1014. 
Shen, J., and Prywes, R. (2004). Dependence of Site-2 Protease Cleavage of ATF6 on 
Prior Site-1 Protease Digestion Is Determined by the Size of the Luminal Domain of 
ATF6. J. Biol. Chem. 279, 43046–43051. 
Sheng, Z., Li, L., Zhu, L.J., Smith, T.W., Demers, A., Ross, A.H., Moser, R.P., and 
Green, M.R. (2010). A genome-wide RNA interference screen reveals an essential 
CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic 
implications. Nat. Med. 16, 671–677. 
Shin, K., Lee, J., Guo, N., Kim, J., Lim, A., Qu, L., Mysorekar, I.U., and Beachy, P.A. 
(2011). Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem 
cells in bladder. Nature 472, 110–114. 
Simpson, J.H., Bland, K.S., Fetter, R.D., and Goodman, C.S. (2000). Short-range and 
long-range guidance by Slit and its Robo receptors: a combinatorial code of Robo 
receptors controls lateral position. Cell 103, 1019–1032. 
Singer, M., Nordlander, R.H., and Egar, M. (1979). Axonal guidance during 
embryogenesis and regeneration in the spinal cord of the newt: The blueprint hypothesis 
of neuronal pathway patterning. Journal of Comparative Neurology 185, 1–21. 
Smeyne, R.J., Klein, R., Schnapp, A., Long, L.K., Bryant, S., Lewin, A., Lira, S.A., and 
Barbacid, M. (1994). Severe sensory and sympathetic neuropathies in mice carrying a 
disrupted Trk/NGF receptor gene. Nature 368, 246–249. 
Sperry, R.W. (1963). Chemoaffinity in the Orderly Growth of Nerve Fiber Patterns and 
Connections. PNAS 50, 703–710. 
Stanton, B.Z., Peng, L.F., Maloof, N., Nakai, K., Wang, X., Duffner, J.L., Taveras, K.M., 
Hyman, J.M., Lee, S.W., Koehler, A.N., et al. (2009). A small molecule that binds 
Hedgehog and blocks its signaling in human cells. Nat. Chem. Biol. 5, 154–156. 
Stoeckli, E.T. (2018). Understanding axon guidance: are we nearly there yet? 
Development 145, dev151415. 
Stone, D.M., Hynes, M., Armanini, M., Swanson, T.A., Gu, Q., Johnson, R.L., Scott, 
M.P., Pennica, D., Goddard, A., Phillips, H., et al. (1996). The tumour-suppressor gene 
patched encodes a candidate receptor for Sonic hedgehog. Nature 384, 129. 
Storlazzi, C.T., Mertens, F., Nascimento, A., Isaksson, M., Wejde, J., Brosjö, O., 
Mandahl, N., and Panagopoulos, I. (2003). Fusion of the FUS and BBF2H7 genes in low 
grade fibromyxoid sarcoma. Hum Mol Genet 12, 2349–2358. 
  130 
van Straaten, H.W.M., and Hekking, J.W.M. (1991). Development of floor plate, neurons 
and axonal outgrowth pattern in the early spinal cord of the notochord-deficient chick 
embryo. Anat Embryol 184, 55–63. 
Sudhof, T.C. (2004). The synaptic vesicle cycle. Annu. Rev. Neurosci. 27, 509–547. 
Sun, X., Liu, J., Crary, J.F., Malagelada, C., Sulzer, D., Greene, L.A., and Levy, O.A. 
(2013). ATF4 protects against neuronal death in cellular PD models by maintaining 
levels of parkin. J Neurosci 33, 2398–2407. 
Tanegashima, K., Zhao, H., Rebbert, M.L., and Dawid, I.B. (2009). Coordinated 
activation of the secretory pathway during notochord formation in the Xenopus embryo. 
Development 136, 3543–3548. 
Taylor, A.M., Blurton-Jones, M., Rhee, S.W., Cribbs, D.H., Cotman, C.W., and Jeon, 
N.L. (2005). A microfluidic culture platform for CNS axonal injury, regeneration and 
transport. Nature Methods 2, 599–605. 
Taylor, A.M., Berchtold, N.C., Perreau, V.M., Tu, C.H., Li Jeon, N., and Cotman, C.W. 
(2009). Axonal mRNA in uninjured and regenerating cortical mammalian axons. J. 
Neurosci. 29, 4697–4707. 
Tenzen, T., Allen, B.L., Cole, F., Kang, J.-S., Krauss, R.S., and McMahon, A.P. (2006). 
The Cell Surface Membrane Proteins Cdo and Boc Are Components and Targets of the 
Hedgehog Signaling Pathway and Feedback Network in Mice. Developmental Cell 10, 
647–656. 
Thelen, K., Maier, B., Faber, M., Albrecht, C., Fischer, P., and Pollerberg, G.E. (2012). 
Translation of the cell adhesion molecule ALCAM in axonal growth cones – regulation 
and functional importance. J Cell Sci 125, 1003–1014. 
Tomoishi, S., Fukushima, S., Shinohara, K., Katada, T., and Saito, K. (2017). CREB3L2-
mediated expression of Sec23A/Sec24D is involved in hepatic stellate cell activation 
through ER-Golgi transport. Scientific Reports 7, 7992. 
Trousse, F., Martí, E., Gruss, P., Torres, M., and Bovolenta, P. (2001). Control of retinal 
ganglion cell axon growth: a new role for Sonic hedgehog. Development 128, 3927–
3936. 
Twelvetrees, A., Hendricks, A.G., and Holzbaur, E.L.F. (2012). SnapShot: Axonal 
Transport. Cell 149, 950-950.e1. 
Uhlén, M., Fagerberg, L., Hallström, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., 
Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015). Tissue-based map of 
the human proteome. Science 347, 1260419. 
Urra, H., Henriquez, D.R., Cánovas, J., Villarroel-Campos, D., Carreras-Sureda, A., 
Pulgar, E., Molina, E., Hazari, Y.M., Limia, C.M., Alvarez-Rojas, S., et al. (2018). IRE1α 
governs cytoskeleton remodelling and cell migration through a direct interaction with 
filamin A. Nature Cell Biology 20, 942. 
  131 
Varadarajan, S.G., Kong, J.H., Phan, K.D., Kao, T.-J., Panaitof, S.C., Cardin, J., 
Eltzschig, H., Kania, A., Novitch, B.G., and Butler, S.J. (2017). Netrin1 Produced by 
Neural Progenitors, Not Floor Plate Cells, Is Required for Axon Guidance in the Spinal 
Cord. Neuron 94, 790-799.e3. 
Varjosalo, M., and Taipale, J. (2008). Hedgehog: functions and mechanisms. Genes & 
Development 22, 2454–2472. 
Vattem, K.M., and Wek, R.C. (2004). Reinitiation involving upstream ORFs regulates 
ATF4 mRNA translation in mammalian cells. PNAS 101, 11269–11274. 
Villarin, J.M., McCurdy, E.P., Martínez, J.C., and Hengst, U. (2016). Local synthesis of 
dynein cofactors matches retrograde transport to acutely changing demands. Nat 
Commun 7, 13865. 
Vogelbaum, M.A., Tong, J.X., and Rich, K.M. (1998). Developmental Regulation of 
Apoptosis in Dorsal Root Ganglion Neurons. J. Neurosci. 18, 8928–8935. 
Walker, C.A., Randolph, L.K., Matute, C., Alberdi, E., Baleriola, J., and Hengst, U. 
(2018). Aβ1–42 triggers the generation of a retrograde signaling complex from sentinel 
mRNAs in axons. EMBO Reports 19, e45435. 
Wang, L., and Marquardt, T. (2013). What axons tell each other: axon–axon signaling in 
nerve and circuit assembly. Current Opinion in Neurobiology 23, 974–982. 
Webb, B.L.J., and Proud, C.G. (1997). Eukaryotic initiation factor 2B (eIF2B). The 
International Journal of Biochemistry & Cell Biology 29, 1127–1131. 
Weber, S., and Saftig, P. (2012). Ectodomain shedding and ADAMs in development. 
Development 139, 3693–3709. 
Wei, X., Howell, A.S., Dong, X., Taylor, C.A., Cooper, R.C., Zhang, J., Zou, W., 
Sherwood, D.R., and Shen, K. (2015). The unfolded protein response is required for 
dendrite morphogenesis. ELife 4. 
Weiss, P. (1936). Selectivity controlling the central-peripheral relations in the nervous 
system. Biological Reviews 11, 494–531. 
Weiss, P. (1945). Experiments on cell and axon orientation in vitro: The role of colloidal 
exudates in tissue organization. Journal of Experimental Zoology 100, 353–386. 
Wessels, H.P., and Spiess, M. (1988). Insertion of a multispanning membrane protein 
occurs sequentially and requires only one signal sequence. Cell 55, 61–70. 
Whalen, D.M., Malinauskas, T., Gilbert, R.J.C., and Siebold, C. (2013). Structural 
insights into proteoglycan-shaped Hedgehog signaling. PNAS 110, 16420–16425. 
Wichterle, H., Lieberam, I., Porter, J.A., and Jessell, T.M. (2002). Directed Differentiation 
of Embryonic Stem Cells into Motor Neurons. Cell 110, 385–397. 
  132 
Wijgerde, M., Ooms, M., Hoogerbrugge, J.W., and Grootegoed, J.A. (2005). Hedgehog 
Signaling in Mouse Ovary: Indian Hedgehog and Desert Hedgehog from Granulosa 
Cells Induce Target Gene Expression in Developing Theca Cells. Endocrinology 146, 
3558–3566. 
Williams, S.E., Mann, F., Erskine, L., Sakurai, T., Wei, S., Rossi, D.J., Gale, N.W., Holt, 
C.E., Mason, C.A., and Henkemeyer, M. (2003). Ephrin-B2 and EphB1 mediate retinal 
axon divergence at the optic chiasm. Neuron 39, 919–935. 
Wilson, N.H., and Stoeckli, E.T. (2013). Sonic hedgehog regulates its own receptor on 
postcrossing commissural axons in a glypican1-dependent manner. Neuron 79, 478–
491. 
Wolman, M.A., Liu, Y., Tawarayama, H., Shoji, W., and Halloran, M.C. (2004). Repulsion 
and Attraction of Axons by Semaphorin3D Are Mediated by Different Neuropilins In Vivo. 
J. Neurosci. 24, 8428–8435. 
Wortel, I.M.N., Meer, L.T. van der, Kilberg, M.S., and Leeuwen, F.N. van (2017). 
Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and 
Malignant Cells. Trends in Endocrinology & Metabolism 28, 794–806. 
Wu, K.Y., Hengst, U., Cox, L.J., Macosko, E.Z., Jeromin, A., Urquhart, E.R., and Jaffrey, 
S.R. (2005). Local translation of RhoA regulates growth cone collapse. Nature 436, 
1020. 
Wu, Y., Whiteus, C., Xu, C.S., Hayworth, K.J., Weinberg, R.J., Hess, H.F., and Camilli, 
P.D. (2017). Contacts between the endoplasmic reticulum and other membranes in 
neurons. PNAS 114, E4859–E4867. 
Yam, P.T., Langlois, S.D., Morin, S., and Charron, F. (2009). Sonic Hedgehog Guides 
Axons through a Noncanonical, Src-Family-Kinase-Dependent Signaling Pathway. 
Neuron 62, 349–362. 
Yam, P.T., Kent, C.B., Morin, S., Farmer, W.T., Alchini, R., Lepelletier, L., Colman, D.R., 
Tessier-Lavigne, M., Fournier, A.E., and Charron, F. (2012). 14-3-3 proteins regulate a 
cell-intrinsic switch from sonic hedgehog-mediated commissural axon attraction to 
repulsion after midline crossing. Neuron 76, 735–749. 
Yamada, T., Placzek, M., Tanaka, H., Dodd, J., and Jessell, T.M. (1991). Control of cell 
pattern in the developing nervous system: Polarizing activity of the floor plate and 
notochord. Cell 64, 635–647. 
Yan, D., and Lin, X. (2009). Shaping Morphogen Gradients by Proteoglycans. Cold 
Spring Harb Perspect Biol 1, a002493. 
Yao, J., Sasaki, Y., Wen, Z., Bassell, G.J., and Zheng, J.Q. (2006a). An essential role for 
β-actin mRNA localization and translation in Ca 2+ -dependent growth cone guidance. 
Nature Neuroscience 9, 1265. 
Yao, S., Lum, L., and Beachy, P. (2006b). The ihog cell-surface proteins bind Hedgehog 
and mediate pathway activation. Cell 125, 343–357. 
  133 
Ye, B., Zhang, Y., Song, W., Younger, S.H., Jan, L.Y., and Jan, Y.N. (2007). Growing 
dendrites and axons differ in their reliance on the secretory pathway. Cell 130, 717–729. 
Ye, J., Rawson, R.B., Komuro, R., Chen, X., Davé, U.P., Prywes, R., Brown, M.S., and 
Goldstein, J.L. (2000). ER Stress Induces Cleavage of Membrane-Bound ATF6 by the 
Same Proteases that Process SREBPs. Molecular Cell 6, 1355–1364. 
Ying, Z., Misra, V., and Verge, V.M.K. (2014). Sensing nerve injury at the axonal ER: 
Activated Luman/CREB3 serves as a novel axonally synthesized retrograde 
regeneration signal. Proceedings of the National Academy of Sciences 111, 16142–
16147. 
Ying, Z., Zhai, R., McLean, N.A., Johnston, J.M., Misra, V., and Verge, V.M.K. (2015). 
The Unfolded Protein Response and Cholesterol Biosynthesis Link Luman/CREB3 to 
Regenerative Axon Growth in Sensory Neurons. Journal of Neuroscience 35, 14557–
14570. 
Yokoyama, C., Wang, X., Briggs, M.R., Admon, A., Wu, J., Hua, X., Goldstein, J.L., and 
Brown, M.S. (1993). SREBP-1, a basic-helix-loop-helix-leucine zipper protein that 
controls transcription of the low density lipoprotein receptor gene. Cell 75, 187–197. 
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, K. (2001). XBP1 mRNA Is 
Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly 
Active Transcription Factor. Cell 107, 881–891. 
Yoshimura, K., and Takeda, S. (2012). Hedgehog signaling regulates myelination in the 
peripheral nervous system through primary cilia. Differentiation 83, S78-85. 
Zelenski, N.G., Rawson, R.B., Brown, M.S., and Goldstein, J.L. (1999). Membrane 
Topology of S2P, a Protein Required for Intramembranous Cleavage of Sterol 
Regulatory Element-binding Proteins. J. Biol. Chem. 274, 21973–21980. 
Zhang, K., Shen, X., Wu, J., Sakaki, K., Saunders, T., Rutkowski, D.T., Back, S.H., and 
Kaufman, R.J. (2006). Endoplasmic reticulum stress activates cleavage of CREBH to 
induce a systemic inflammatory response. Cell 124, 587–599. 
Zhang, X.M., Ramalho-Santos, M., and McMahon, A.P. (2001). Smoothened Mutants 
Reveal Redundant Roles for Shh and Ihh Signaling Including Regulation of L/R 
Asymmetry by the Mouse Node. Cell 105, 781–792. 
Zhou, J., Liu, C.Y., Back, S.H., Clark, R.L., Peisach, D., Xu, Z., and Kaufman, R.J. 
(2006). The crystal structure of human IRE1 luminal domain reveals a conserved 
dimerization interface required for activation of the unfolded protein response. PNAS 
103, 14343–14348. 
Ziel, A.M. van, Largo-Barrientos, P., Wolzak, K., Verhage, M., and Scheper, W. (2019). 
Unconventional secretion factor GRASP55 is increased by pharmacological unfolded 
protein response inducers in neurons. Scientific Reports 9, 1567. 
 


















































Received 1 Jul 2016 | Accepted 7 Nov 2016 | Published 21 Dec 2016
Local synthesis of dynein cofactors matches
retrograde transport to acutely changing demands
Joseph M. Villarin1, Ethan P. McCurdy2, Jose´ C. Martı´nez1 & Ulrich Hengst3,4
Cytoplasmic dynein mediates retrograde transport in axons, but it is unknown how its
transport characteristics are regulated to meet acutely changing demands. We find that
stimulus-induced retrograde transport of different cargos requires the local synthesis of
different dynein cofactors. Nerve growth factor (NGF)-induced transport of large vesicles
requires local synthesis of Lis1, while smaller signalling endosomes require both Lis1 and
p150Glued. Lis1 synthesis is also triggered by NGF withdrawal and required for the transport of
a death signal. Association of Lis1 transcripts with the microtubule plus-end tracking protein
APC is required for their translation in response to NGF stimulation but not for their axonal
recruitment and translation upon NGF withdrawal. These studies reveal a critical role for local
synthesis of dynein cofactors for the transport of specific cargos and identify association with
RNA-binding proteins as a mechanism to establish functionally distinct pools of a single
transcript species in axons.
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any cellular functions rely on the ordered transport
of macromolecules, proteins and organelles. Most
intracellular transport is an active process mediated
by motor protein complexes that move their cargos along
components of the cytoskeleton: myosins transport cargos along
actin filaments, while microtubule-based transport is facilitated
by two families of motors, the plus-end directed kinesins and
minus-end directed dynein1. In contrast to the great variety of
myosins and kinesins, there is only a single cytoplasmic dynein,
which is complemented by an array of regulatory proteins to fulfil
different functions2. These multifunctional proteins bind either to
the non-catalytic domains of dynein or directly to its force-
generating heavy chain, thereby changing the characteristics of
the dynein motor. For example, Lis1 (gene: PAFAH1B1) induces a
persistent force-producing state in microtubules-attached,
moving dynein by acting as a clutch linking the ATPase and
microtubules-binding domains3,4. It maintains the microtubule-
bound state of dynein5, and is required for moving large vesicles
through a constraint environment with high drag forces such as
kinked axons6. Together with NudE, it enhances the sustained
force produced by the dynein motor in a load induced manner7.
In addition, axonal Lis1 has been described as an initiation factor
for dynein-mediated transport8. Another dynein regulator,
dynactin, is a large complex of eleven protein subunits, with
p150Glued, encoded by DCTN1, being the largest and most
important. Among several described functions, dynactin acts by
increasing the processivity of the dynein motor9 and facilitates its
binding to different cargos10. Importantly, dynactin and Lis1
competitively bind the same domain of dynein11, suggesting a
mutually exclusive regulation of dynein by these adaptors. Thus,
cofactors or adaptor proteins such as dynactin or Lis1 regulate
dynein-dependent transport, but it remains unknown how their
association with dynein is controlled in a spatially precise and
temporally acute manner in response to extracellular signals. This
question is especially relevant in axons, where essentially all
microtubules are unidirectionally oriented with their plus-ends
facing the cellular periphery12, and dynein is anterogradely
transported as cargo by kinesins13,14. A potential solution to this
question is the on-demand, local synthesis of dynein cofactors
within distal axons and growth cones.
Intra-axonal protein synthesis is crucial for axon
development15–18, maintenance19, synapse formation20 and
axo-somatic communication21, as well as for axonal
regeneration22 and neurodegeneration23. From these studies,
a picture emerges in which local protein synthesis provides
short-lived and spatially precise bursts of locally translated
proteins, to react to extracellular cues, injurious insults or other
changes in an axon’s environment24. Therefore, it is especially
interesting that messenger RNAs (mRNAs) coding for dynein
regulators, including Lis1 and p150Glued, have repeatedly been
found in axons both in the central and peripheral nervous
system23,25,26.
Here we asked whether local synthesis of dynein regulators was
a mechanism to acutely match the intra-axonal retrograde
transport capabilities to changes in demand, as, for example, in
response to changes in extracellular trophic support. We report
that axonal synthesis of Lis1 and p150Glued is required for
the adjustment of retrograde transport to acutely changing
neurotrophin signalling in the periphery of neurons.
Results
NGF-induced changes in retrograde transport require translation.
To investigate whether changes in intra-axonal transport required
local protein synthesis, rat embryonic dorsal root ganglion (DRG)
were grown in tripartite microfluidic chambers that allow fluidic
isolation of distal axons from neuronal cell bodies and dendrites,
providing an experimental platform to study localized signalling
events in axons (Fig. 1a)17,27. We first investigated the requirement
of axonal protein synthesis for axonal retrograde transport in DRG
neurons kept at a low nerve growth factor (NGF) concentration of
5 ngml! 1 that is sufficient to support their survival. Application of
protein synthesis inhibitors, anisomycin or emetine, did not change
the proportion of retrogradely moving LysoTracker-positive
particles, which in axons are mainly late endosomes and
autophagosomes (Fig. 1b)28. Because transport in the 5 ngml! 1
NGF condition was protein synthesis independent, we decided to
use it as the baseline NGF concentration and to investigate whether
NGF withdrawal (0 ngml! 1) or stimulation (100ngml! 1)
changed the transport of LysoTracker-positive particles in a
protein synthesis-dependent manner. Upon NGF withdrawal or
stimulation, retrograde transport of LysoTracker-positive vesicles
was significantly increased with a corresponding decrease in the
proportion of stationary vesicles (Fig. 1c,d; Supplementary
Movies 1–5), while the percentages of anterogradely or
bidirectionally moving particles were not significantly changed
with either NGF concentration. Inhibition of protein synthesis
completely abolished the increases in retrograde transport upon
NGF stimulation and, surprisingly, upon NGF withdrawal.
Activation of protein synthesis had before only been described in
response to NGF stimulation17,18,21,29,30, but not depletion. To
investigate our finding that increased retrograde transport of
LysoTracker-positive vesicles in NGF-deprived axons was sensitive
to protein synthesis inhibition, we performed immunofluorescence
against a marker of active protein synthesis, the phosphorylated
form of 4EBP1 (Fig. 1e). The ratio of phosphorylated 4EBP1 was
significantly increased within distal axons upon 10min of NGF
stimulation as well was withdrawal. Inhibition of mTOR with
locally applied rapamycin completely abolished these changes.
To directly visualize local protein synthesis in response to changes
in NGF concentrations, we performed puromycylation assays.
Puromycin is a transfer RNA mimetic that gets incorporated into
nascent polypeptides and can be detected with specific
antibodies31. NGF withdrawal and stimulation significantly
increased the number of puromycylation events in axons in a
protein synthesis inhibitor-sensitive manner, confirming that local
protein synthesis is activated by both NGF stimulation and
depletion (Fig. 1f). Puromycylation in the cell bodies was not
affected by changes in NGF concentration or the addition of
protein synthesis inhibitors in the axon compartment further
proving the local nature of the NGF-induced changes in protein
synthesis (Fig. 1g). These results establish that while constitutive,
unstimulated retrograde transport does not require local protein
synthesis, rapid increases in dynein-dependent transport of
LysoTracker-positive particles in response to either NGF
stimulation or withdrawal are mediated by axonally produced
proteins.
NGF stimulation or withdrawal affect Lis1 and p150Glued.
mRNAs coding for regulators of cytoplasmic dynein have been
found in several axonal transcriptomes (Fig. 2a)23,25,26. To
investigate which proteins might be locally synthesized in
response to NGF stimulation or withdrawal, we focused on Lis1
and p150Glued. To directly visualize their mRNAs, Pafah1b1 and
Dctn1 within axons of DRG neurons, we used fluorescence in situ
hybridization (FISH). Both mRNAs were readily detectable in a
punctate pattern in axons and with significantly higher intensity
than the one obtained with a Gfp control probe (Fig. 2b). Using
quantitative immunofluorescence, we found that the axonal
abundance of Lis1 protein was significantly increased upon both
NGF stimulation and withdrawal for 10min (Fig. 2c), while in
contrast p150Glued levels were elevated only in response to NGF
stimulation (Fig. 2d). The levels of each protein were not changed
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by pre-incubation with protein synthesis inhibitors under
baseline conditions, but the increases in abundance upon NGF
stimulation (for both Lis1 and p150Glued) or withdrawal (Lis1
only) were abolished by the application of anisomycin or emetine
to the axonal compartment. Together, these data indicate that the
axonally localized transcripts of Lis1 and p150Glued might be
translated in response to changes in NGF signalling.
NGF signalling controls local Lis1 and p150Glued synthesis. To
directly test whether changes in axonal NGF signalling trigger the
local synthesis of Lis1 and p150Glued, we selectively transfected
axons with siRNAs targeting their mRNAs Pafah1b1 or Dctn1,
respectively, or with a non-targeting control siRNA. We had
validated the siRNAs by transfecting them into rat C6 glioma cells
and immunoblotting whole-cell lysates for Lis1 and p150Glued.
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Two siRNAs against each transcript were tested individually and
showed consistent phenotypes; the siRNAs were most efficacious
when used together (Supplementary Fig. 1). Previously, we have
demonstrated that the RNA interference (RNAi) pathway is
functional in developing axons32, and that it is possible to
selectively knockdown an mRNA in axons by local siRNA
transfection without causing a decrease of the transcript’s
abundance in cell bodies17,18,23,33. We confirmed that the
effects of the local siRNA transfections were indeed restricted
to axons by quantitative immunofluorescence against Lis1 and
p150Glued on cell bodies whose axons had been transfected with
siRNAs. No decrease of either protein was detectable in the
neuronal soma (Fig. 3a,b). In the siRNA-transfected axons, the
protein levels were not significantly reduced at our baseline NGF
concentration, again indicating that the mRNAs are not locally
translated under this condition (Fig. 3c,d). Conversely, the
significant increases in Lis1 abundance in response to NGF
stimulation or withdrawal were completely abolished by local
siRNA application, as was the increase in p150Glued levels in
NGF-stimulated axons. Together, these results demonstrate
that both transcripts can be locally translated in axons, but the
intra-axonal synthesis of these two dynein cofactors is
differentially regulated by changes in NGF signalling.
Lis1 synthesis is required for NGF-induced vesicle transport.
To determine whether the local synthesis of Lis1 and p150Glued in
response to changes in NGF concentration impacted retrograde
transport in axons, we incubated axons with LysoTracker and
scored the motility of labelled vesicles as before. Axonal knock-
down of Pafah1b1 or Dctn1 did not significantly affect retrograde
transport in the baseline condition (Fig. 4a), in line with our
finding that neither protein is locally synthesized under baseline
conditions. Axon-specific knockdown of Pafah1b1 abolished the
significant increase in the proportion of retrogradely moving
vesicles caused by NGF deprivation (Fig. 4b; Supplementary
Movie 6), and it caused a reduction of retrogradely moving
LysoTracker-positive particles below the baseline levels in the
NGF-stimulated condition (Fig. 4c; Supplementary Movie 7). In
contrast, knockdown of axonal Dctn1 mRNA did not affect the
movement of LysoTracker-positive vesicles upon either NGF
stimulation of withdrawal. Together, these results demonstrate
that locally synthesized Lis1 is required for induced retrograde
movement of these LysoTracker-labelled cargos, but p150Glued is
not. This observation is reminiscent of the finding that, globally,
high load retrograde transport requires Lis1 (ref. 6).
NGF–endosome transport requires Lis1 and p150Glued synthesis.
To investigate whether the requirement for local synthesis of
dynein cofactor varied between different cargos, we next visua-
lized the retrograde transport of NGF-signalling endosomes34.
Upon binding of NGF to its receptor TrkA, the receptor–ligand
complex is internalized, and the resulting endosome is
transported with downstream effector complexes to the soma
by a dynein–dynactin complex35. Mouse 2.5S NGF was linked
to red fluorescent quantum dots (QDs)36, selectively
applied to axons (100 ngml! 1), and movement of QD-labelled
NGF-signalling endosomes was measured by live-cell microscopy
(Fig. 4d). The proportion of retrogradely moving particles seen
under naive and control siRNA conditions (B27%) was
consistent with previous studies37,38. Axon-specific knockdown
of Pafah1b1 or Dctn1 significantly reduced the retrograde
movement of QD-positive particles and increased the
proportion of stationary particles. Together, these results
establish that NGF stimulation triggers local synthesis of Lis1
and p150Glued, and that the stimulated transport of different
cargos requires the local synthesis of different regulator proteins.
Transport of an axonal death signal requires Lis1 synthesis.
According to the signalling endosomes hypothesis, transport of
NGF bound to activated tyrosine receptor kinases in endosomes
from axons to the cell body is required for the survival of neurons
dependent upon target-derived neurotrophic support35,39, while
another model proposes that NGF acts by suppressing a
retrograde apoptotic signal, and that retrograde transport of
NGF-signalling endosomes is not required for survival40. Because
of the observed reduction in retrogradely moving, QD-labelled
NGF-signalling endosomes upon axon-specific knockdown of
Pafah1b1 or Dctn1 mRNAs, we next tested whether survival of
the DRG neurons was impaired as well. NGF was withheld from
both compartments or selectively applied (100 ngml! 1) to the
axonal compartment. To quench any residual NGF activity in the
deprivation conditions, a neutralizing anti-NGF antibody was
added. Contrary to what the signalling endosomes hypothesis
would predict but in line with a suppressive effect of NGF on an
axonal apoptotic signal in starved axons, in the NGF-replete
condition axonal knockdown of either Pafah1b1 or Dctn1 did not
induce apoptosis, as assessed by TUNEL-positive nuclei, nor did
it reduce the number of living neurons stained by calcein
acetoxymethyl (AM) (Fig. 5a,b). Moreover, in the NGF-starved
condition, knockdown of Pafah1b1 completely prevented the
induction of cell death by NGF deprivation. Knockdown of Dctn1
in the NGF-starved condition did not impact cell death,
consistent with our finding that NGF withdrawal does not
activate p150Glued synthesis.
Together, these results demonstrate that, although inhibition of
local Lis1 and p150Glued synthesis greatly reduced retrograde
transport of NGF-signalling endosomes, their local production is
Figure 1 | Local protein synthesis mediates NGF-regulated changes in axonal transport. (a) Representation of a microfluidic chamber used to isolate
axons. DRG neurons are seeded in the cell body compartment (green), and the axons extend through two microgroove barriers (blue) into the axonal
compartments (orange). All axon-specific treatments were applied to both axonal compartments, and analyses were performed in the distal most
compartment. (b –d) DRG neurons were cultured in microfluidic chambers for 3 DIV, at which point the NGF concentration in the axonal chamber
was changed to 5 ngml! 1 for 24 h. On DIV 4, axons were pretreated with protein synthesis inhibitors (anisomycin and emetine) or vehicle
(dimethylsulphoxide, DMSO) for 2 h before application of medium containing the inhibitors or DMSO and either 5 ngml! 1 NGF (b ), no NGF (c), or
100ngml! 1 NGF (d) and LysoTracker Green for 15min. Live-imaging time-lapse series of axonal fields were acquired, with images being taken every 13 s
for 4min. Kymographs of representative 100-mm-long axonal segments are shown. Scale bar, 10mm. LysoTracker-positive particles with diameters Z1mm
were scored as anterograde, retrograde, bidirectional or stationary. Percentage point differences to baseline condition are plotted. Data represent the
means±s.e.m. of nine fields per conditions (n¼ 3 biological replicates). *Pr0.05; **Pr0.01; ***Pr0.001. One-way ANOVA with Bonferroni’s multiple
comparison test. (e) DRG neurons were cultured as in b . After 10min of different NGF treatments, axonal levels of 4EBP1 and p-4EBP1 were determined by
immunofluorescence. Scale bar, 5 mm. Data represent the means±s.e.m. of 15 fields per conditions (n¼ 3 biological replicates). *Pr0.05; ***Pr0.001.
Two-way ANOVA with Dunnett’s multiple comparison test. (f,g) DRG neurons were cultured and axons were treated with NGF and inhibitors as in b .
Puromycin was added to all compartments of the chambers during the NGF treatment period. *Pr0.01; ***Pr0.001. Two-way ANOVA with Bonferroni’s
multiple comparison test. Scale bars, 10mm. NS, not significant.
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Figure 2 | NGF signalling differentially regulates Lis1 and p150Glued levels in axons. DRG neurons were cultured and treated as in Fig. 1. (a) Transcripts
coding for dynein regulators have been found in transcriptomes derived from embryonic rat DRG axons using microarray, embryonic mouse DRG using
RNAseq and embryonic rat hippocampal axons using RNAseq. Transcripts found in all three studies are highlighted in red, and Lis1 and p150Glued are
outlined in blue. (b) Pafah1b1 and Dctn1 levels were measured by quantitative FISH in axons kept for 12 h at the baseline NGF level (5 ngml! 1). Background
fluorescence was determined using a Gfp probe and subtracted. Means±s.e.m. of 15 optical fields per condition (n¼ 3 biological replicates). *Pr0.05;
**Pr0.01. Kruskal–Wallis test with Dunn’s multiple comparison test. (c) Axons were pretreated with protein synthesis inhibitors (anisomycin and emetine)
or vehicle, followed by exposure to different concentrations of NGF (0, 5 or 100ngml! 1) for 10min. Axonal Lis1 levels were measured by quantitative
immunofluorescence. Means±s.e.m. of 15–20 optical fields per conditions (n¼ 3–4 biological replicates). *Pr0.05. Two-way ANOVA with Dunnett’s
multiple comparison test. (d) Neurons were cultured and treated as in b. Axonal p150Glued levels were measured by quantitative immunofluorescence.
Means±s.e.m. of 15 optical fields per conditions (n¼ 3 biological replicates). *Pr0.05. Two-way ANOVA with Dunnett’s multiple comparison test.
Scale bars, 5mm. NS, not significant.
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Figure 3 | NGF induces local synthesis of Lis1 and p150Glued. DRG neurons were cultured in microfluidic chambers. On DIV 3, the NGF concentration in
the axonal chamber was changed to 5 ngml! 1, and axons were selectively transfected with a non-targeting control siRNA or siRNAs targeting Pafah1b1 or
Dctn1. (a,b) Twenty-four hours after transfection, axons were treated with 0, 5 or 100 ngml! 1 NGF for 10min, and Lis1 (a) and p150Glued (b) levels in the
cell bodies were determined by immunofluorescence. Means±s.e.m. of 15 optical fields per conditions (n¼ 3 biological replicates). No significant changes.
Two-way ANOVA with Dunnett’s multiple comparison test. Scale bars, 20mm. (c,d) Neurons were cultured and treated as before, and axonal Lis1 (c) and
p150Glued (d) levels were determined by immunofluorescence. Scale bars, 5 mm. Means±s.e.m. of 20–75 optical fields per conditions (n¼4–15 biological
replicates). *Pr0.05; **Pr0.01; ***Pr0.001. Two-way ANOVA with Dunnett’s multiple comparison test. See also Supplementary Fig. 1. NS, not
significant.
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not required for NGF-dependent survival. Rather, local Lis1
synthesis is necessary for the retrograde transport of a
pro-apoptotic signal of unknown identity that is generated in
NGF-deprived axons40,41. To further characterize this retrograde
death signal ,we first focused on protein kinases that have been
implicated in apoptotic cell death in neurons. Whole-cell
treatment with inhibitors of mixed lineage kinases or p38 MAP
kinase has previously been shown to prevent neuronal apoptosis
induced by neurotrophin deprivation42,43, but application of
these inhibitors to axons alone did not interfere with induction of
apoptosis in NGF-deprived DRGs, suggesting that these kinases
act centrally rather than in the periphery (Fig. 5c). GSK3b had
been proposed as a carrier of the axonally generated apoptotic
signal40. Application of two GSK3 inhibitors, LiCl or SB216763
(ref. 44), selectively to axons had no effect on cell death under
NGF-replete conditions, but completely prevented the induction
of apoptosis with NGF deprivation (Fig. 5c). Together, these
results indicate that the death signal, whose transport requires
local Lis1 production, involves active GSK3b.
NGF signalling regulates axonal Pafah1b1 and Dctn1 levels. In
regenerating DRG axons, neurotrophins regulate the abundance
of specific mRNAs through anterograde recruitment from the cell
body45. To investigate whether changes in neurotrophin
signalling not only differentially regulate the translation of
axonally localized Pafah1b1 and Dctn1 mRNAs but also their
abundance, we performed quantitative FISH on axons selectively
transfected with siRNAs and treated with different NGF
concentrations. As before, the effect of the siRNAs was
restricted to axons as neither mRNA’s abundance in the
neuronal cell bodies was changed upon axonal siRNA
transfection (Fig. 6a,b). Quantification of the axonal FISH
signals revealed that neither mRNA was recruited in response
to stimulation with NGF, but that NGF deprivation caused a
significant increase in Lis1 transcript levels (Fig. 6c,d). Similar
results were obtained for FISH against the transcripts of NudE
and its paralogue NudEL, two proteins can form a trimeric
complex with dynein and Lis1 (Supplementary Fig. 2)46,
indicating that NGF might co-regulate mRNAs of proteins that
frequently function in a complex. The FISH signal was specific for
the targeted mRNAs as transfection of axons with siRNAs
targeting either transcript reduced the FISH signal to background
levels. The results of the FISH experiments were confirmed by
quantitative real-time PCR with reverse transcription (RT–PCR)
performed on RNA collected from axonal compartments
(Fig. 6e). The siRNAs failed to reduce the levels of their target
transcripts under NGF conditions that do not trigger the
translation of these mRNAs (baseline for both mRNAs; NGF
withdrawal for Dctn1). This effect is likely due to the tight
packaging in RNA granules of silenced mRNAs in axons47
rendering them inaccessible for the RNAi machinery, an effect
we had observed previously23. Together, these results
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Figure 4 | NGF-induced changes in axonal trafficking require local
synthesis of Lis1 or p150Glued. DRG neurons were cultured in microfluidic
chambers. On DIV 3, the NGF concentration in the axonal chamber was
changed to 5 ngml! 1, and axons were selectively transfected with a
non-targeting control siRNA or siRNAs targeting Pafah1b1 or Dctn1.
(a–c) After 24 h, fresh medium was added to the axonal chamber
containing 5 ngml! 1 NGF, no NGF or 100ngml! 1 NGF together with
LysoTracker Green for 15min. Live-imaging time-lapse series of axonal fields
were acquired, with images being taken every 13 s for 4min. Kymographs of
representative 100-mm-long axonal segments are shown. Scale bar, 10mm.
LysoTracker-positive particles with diameters Z1mm were scored as
anterograde, retrograde, bidirectional or stationary. Means±s.e.m. of 12–18
optical fields per conditions (n¼ 3–6 biological replicates). **Pr0.01;
***Pr0.001. One-way ANOVA with Bonferroni’s multiple comparisons
test. (d) On DIV 4, axons were treated with 100 ngml! 1 QD-NGF for
15min and live imaged as above. QD-labelled particles o1-mm diameter
were scored as anterograde, retrograde, bidirectional or stationary.
Means±s.e.m. of nine optical fields per conditions (n¼ 3 biological
replicates). **Pr0.01; ***Pr0.001. Kruskal–Wallis test with Dunn’s
multiple comparison test. NS, not significant.
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cofactors Lis1 and p150Glued is differentially regulated both
translationally and through recruitment of their mRNAs.
APC-binding sorts Pafah1b1 into functionally distinct pools.
The finding that the one mRNA species, Pafah1b1, is locally
translated in response to both NGF stimulation and withdrawal,
and, further, is recruited into axons only upon NGF deprivation
but not stimulation, strongly suggested that distinct regulatory
mechanisms exist that control Pafah1b1 localization and
translation under different signalling conditions. Recently,
Pafah1b1 has been found to be part of the adenomatous polyposis
coli (APC) interactome48. APC is a microtubules plus-end
tracking protein, also referred to as þTIP49, and by binding a
specific subset of mRNAs, APC might provide a platform for the
local synthesis of dynein regulators, including Lis1, at the distal
end of axonal microtubules. Thus, we wondered whether
association with APC was required for Pafah1b1 regulation in
axons. To address this question, we used a locked nucleic acid
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Figure 5 | Pro-apoptotic signalling from NGF-deprived axons requires axonally synthesized Lis1 and active GSK3b. (a) DRG neurons were cultured and
transfected with siRNAs as in Fig. 4. On DIV 4, the medium in the somatic compartment was changed to NGF-free medium containing NGF-neutralizing
antibody, and axonal compartments were changed to 100ngml" 1 NGF or NGF-free medium with NGF-neutralizing antibody plus vehicle for 24 h. Cell
death was assessed by TUNEL assay. Means±s.e.m. of 15–25 optical fields per conditions (n¼ 3–5 biological replicates). ***Pr0.001. Two-way ANOVA
with Dunnett’s multiple comparison test. (b) Neurons were cultured and treated as in a. Survival was assessed by calcein AM staining. Means±s.e.m. of 15
optical fields per conditions (n¼ 3 biological replicates). ***Pr0.001. Two-way ANOVA with Dunnett’s multiple comparison test. (c) DRG neurons were
cultured as in Fig. 4. On DIV 4, the medium in the somatic compartment was changed to NGF-free medium containing NGF-neutralizing antibody, and the
medium in the axonal chamber was changed to 100ngml" 1 NGF or NGF-free medium with NGF-neutralizing antibody plus the mixed lineage kinase
inhibitor, CEP-1347, the p38 MAP kinase inhibitor, SB239063, or the GSK3b inhibitors, LiCl or SB216763, or vehicle for 24 h. Cell death was assessed by
TUNEL assay. Means±s.e.m. of 15–25 optical fields per conditions (n¼ 3–5 biological replicates). ***Pr0.001. Two-way ANOVA with Dunnett’s multiple
comparison test. Scale bars, 20mm. NS, not significant.
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Figure 6 | NGF signalling regulates axonal transcript levels of dynein regulators. (a–d) DRG neurons were cultured in microfluidic chambers for 3 DIV, at
which time the NGF concentration in the axonal chamber was changed to 5 ngml! 1, and axons were selectively transfected with a non-targeting control
siRNA or siRNAs targeting Pafah1b1 (a,c) or Dctn1 (b ,d). Twenty-four hours after the transfection, the NGF concentration in the axonal chamber was
adjusted to 0, 5 or 100ngml! 1 NGF for 12 h, and cell body Pafah1b1 (a) or Dctn1 (b ) or axonal Pafah1b1 (c) or Dctn1 (d) mRNA levels were determined by
FISH. Means±s.e.m. of 15–25 optical fields per condition (n¼ 3–5 biological replicates). *Pr0.05; **Pr0.01; ***Pr0.001. Two-way ANOVA. Scale bars,
20mm (a,b ); 5mm (c,d). (e) Neurons were cultured and axons treated with NGF in microfluidic chambers as before. Axonal RNAs were collected after the
12 h NGF treatment, and Pafah1b1 and Dctn1 levels were determined by quantitative real-time RT–PCR. Relative quantification with Gapdh as reference was
done using the 2!DDCTmethod. The means of the 5 ngml! 1 NGF conditions for Pafah1b1 and Dctn1 were defined as 1.0. Means±s.e.m. of 3–5 biological
replicates. *Pr0.05. Kruskal–Wallis test with Dunn’s multiple comparison test. NS, not significant.
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association by binding the putative APC-binding site, a CUGU
motif in the 30-untranslated region (UTR) of Pafah1b1 (ref. 48).
To determine which of the several CUGU motifs in the 30-UTR of
Pafah1b1 to target, reads from the APC-CLIP study48 were
collapse and quality-filtered50 and mapped to the mouse genome
(mm10). Mapped reads were analysed for cluster enrichment
using PIPE-CLIP51. Three clusters in the 30-UTR of Pafah1b1
were found to be significantly enriched in APC-binding, but only
two of these clusters had a significant fold change compared with
a control mRNA-seq data set. We chose the cluster with the
lowest P value (1.41! 10" 11), which also contained a CUGU
motif. A second LNA, binding Pafah1b1 13 bases upstream of the
CUGU LNA, was used as a control (Fig. 7a). To confirm whether
the CUGU LNA was able to interfere with APC–Pafah1b1
interaction, we transfected the LNAs in dissociated DRG and
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detectable in the precipitate and its abundance reduced in RIPs
from CUGU LNA-transfected DRGs (Fig. 7b). Next, the LNAs
were transfected in the cell body compartment, and mRNA levels
in axons were determined by quantitative FISH 12 h after
different NGF treatments as before (Fig. 7c). The control LNA
had no discernible effect compared with naive axons (two-way
analysis of variance (ANOVA) P¼ 0.7585), while transfection
with the CUGU LNA caused reduced Pafah1b1 levels in all
three conditions (P¼ 0.008). The differences in Pafah1b1
abundance at 5 and 0 ngml" 1 or 0 and 100 ngml" 1 NGF
were significant in both naive and CUGU LNA-transfected axons
and extremely similar (5 and 0 ngml" 1: 0.56 versus 0.50; 0 and
100 ngml" 1: 0.58 versus 0.68). These results indicate that APC
association is required for the axonal localization of a fixed
amount of Pafah1b1, but that the recruitment of additional
Pafah1b1 into axons in response to NGF withdrawal is APC-
independent.
To determine whether Lis1 protein levels in axons were
similarly affected by interference with Pafah1b1–APC binding,
we transfected DRGs with LNAs as before and performed
quantitative immunofluorescence against Lis1 (Fig. 7d). No
significant change in Lis1 abundance was detected at 5 ngml" 1
NGF, again confirming that it is not locally synthesized under this
condition. The increase in axonal Lis1 abundance in CUGU
LNA-transfected DRGs at 0 ngml" 1 was indistinguishable from
naive and control LNA neurons, while in NGF-stimulated axons
transfection with the CUGU LNA prevented the increase in Lis1
levels.
Finally, we investigated the requirement of Pafah1b1–APC
association for stimulation-induced retrograde transport of
LysoTracker-positive cargos. Transfection of the CUGU LNA
had no effect on transport at the baseline NGF condition or upon
NGF withdrawal, but completely prevented the increase in
retrograde transport triggered by NGF stimulation (Fig. 7e–g).
Together, the results from the LNA experiments reveal the
existence of two distinct modes of Pafah1b1 localization in axons:
one that is constitutively active and APC-dependent, and other
that is APC-independent and particularly responsive to NGF
deprivation (Supplementary Fig. 3). The transcripts that are
localized in the APC-dependent mode are translated in response
to stimulation with NGF, while the APC-independent pool is
locally translated with NGF withdrawal and is boosted by
recruitment into NGF-starved axons. Thus, the two diametrically
opposed triggers of axonal Lis1 synthesis, NGF withdrawal and
stimulation, act on two separate pools of Pafah1b1 mRNA that
each are solely responsible for the increase in local Lis1 levels
under either condition.
Discussion
Association with various accessory proteins allows cytoplasmic
dynein to fulfil a multitude of functions in cells and to transport a
wide variety of different cargos. Here we provide evidence that in
distal axons, stimulus-induced changes in dynein-dependent
transport are regulated through local synthesis of Lis1
and p150Glued. The unidirectional nature of microtubules in
axons poses special challenges for the acute regulation and
initiation of dynein-dependent transport, and local translation of
its cofactors can solve this problem. As the unidirectional
orientation of microtubules is not unique to axons but occurs
also in distal dendrites or during neuronal cell migration, it is
possible that this mechanism is utilized in these circumstances
as well. Meanwhile, local synthesis of motor complex proteins
might not be restricted to Lis1 and p150Glued. p150Glued is
only one of several subunits of dynactin. The transcript for
another subunit, p50, is also consistently found in transcriptomes,
while the localization of transcripts coding for other subunits is
less clear. It remains unknown whether the entire dynactin
complex can be locally synthesized or whether it locally assembles
upon on-demand synthesis of p150Glued and potentially p50.
Changes in intra-axonal transport have long been recognized
as hallmarks of many neurological and neurodegenerative
disorders52,53. In addition, alterations in neurotrophin signalling
have been implicated in neurodegenerative and psychiatric
disorders54. Therefore, it will be important to investigate
whether the processes uncovered here are disrupted in disease
and whether they might present novel targets for therapies. For
example, our previous finding that soluble oligomeric Ab1–42
upregulates protein synthesis in axons of mature hippocampal
neurons23 indicates the possibility that local translation has an
impact on dynein-dependent transport in Alzheimer’s disease
brain.
It is worth noting that axonal production is not merely
supplementary to global synthesis of these dynein cofactors.
Neuron-wide knockdown of Lis1 expression reduces retrograde
stimulation-independent transport of LysoTracker-positive
vesicles in axons55, while we found that axon-specific
knockdown of Lis1 or p150Glued prevented only induced
changes of transport. Why is induced but not constitutively
active transport dependent on local translation? A possible
explanation might be that in response to stimulation, previously
inactive dynein motor complexes get activated and coupled to
their cargos. We found that Lis1 synthesis in response to NGF
stimulation requires the association of Pafah1b1 with APC. As a
þTIP, APC is well situated to mediate the activation of dynein
through local production of regulatory proteins. In fact, the
Figure 7 | Association with APC separates axonally localized Lis1 transcripts into two functionally distinct pools. (a) Partial sequence of the 30-UTR of
rat Pafah1b1 starting at the stop codon (*). The binding regions of the CUGU and control LNAs are indicated in maroon and grey, respectively. The
CUGU element is underlined. (b ) Dissociated DRG were transfected with control and CUGU LNA, and 24h later, APC RNA immunoprecipitation was
performed. Pafah1b1 was quantified by RT–PCR. 2"DDCT values are reported relative to Tubb3 (positive control, binds APC but is not targeted by the LNAs).
Gfp was included as a control (no reads detected). Means±s.e.m. (n¼ 2 biological replicates with two technical replicates each). *Pr0.05. t-test. (c) DRG
neurons were cultured in microfluidic chambers. On DIV 3, the NGF concentration in the axonal chamber was changed to 5 ngml" 1, and cell bodies were
selectively transfected with the control or CUGU LNAs. Twenty-four hours after transfection, axons were treated with 0, 5 or 100ngml" 1 NGF for 12 h, and
axonal Pafah1b1 mRNA levels were determined by FISH. Background fluorescence was determined using a Gfp probe and subtracted. Means±s.e.m. of 15
optical fields per condition (n¼ 3 biological replicates). *Pr0.05. Two-way ANOVA with Fisher’s least significant difference test. Scale bar, 5mm. (d) DRG
neurons were cultured and transfected as in a. Twenty-four hours after transfection, axons were treated with 0, 5 or 100ngml" 1 NGF for 10min, and
axonal Lis1 protein levels were measured by quantitative immunofluorescence. Means±s.e.m. of 20–30 optical fields per conditions (n¼4–6 biological
replicates). *Pr0.05. Two-way ANOVA with Fisher’s LSD test. (e–g) DRG neurons were cultured and transfected as in a. Twenty-four hours after
transfection, transport of LysoTracker-positive particles was observed in axons at baseline NGF (e), without NGF (f) or stimulated with NGF (g). Live-
imaging time-lapse series of axonal fields were acquired, with images being taken every 13 s for 4min. LysoTracker-positive particles with diametersZ1mm
were scored as anterograde, retrograde, bidirectional or stationary. Means±s.e.m. of nine optical fields per conditions (n¼ 3 biological replicates).
**Pr0.01. One-way ANOVA with Bonferroni’s multiple comparisons test. NS, not significant.
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recruitment of dynactin by þTIPs has been found to be required
for the initiation of retrograde axonal transport of various
cargos56. In Aspergillus nidulans, the Lis1 homolog has also been
described as an initiation factor for dynein-mediated transport
that is absent from and is unnecessary for dynein–cargo
complexes once they are in motion8. Local synthesis of Lis1 or
p150Glued at very precise loci in axons or growth cones could,
therefore, be a tuning or initiation mechanism for dynein-based
transport.
In essentially all instances, intra-axonal protein synthesis has
been seen to be stimulus-dependent. Our finding that NGF
deprivation triggers axonal Lis1 synthesis within 10min leads to
the question as to how withdrawal of a ligand can be a stimulus
for translation. The extremely short time needed to induce
translation rules out that it might be a consequence of neuronal
degeneration caused by the lack of trophic support. Rather,
translation appears to be triggered by a signalling pathway that is
active in the absence of NGF and suppressed by NGF-TrkA
binding. For example, TrkA has been proposed to act as a
dependence receptor that triggers cell death in the absence of its
ligand57. Our study provides additional support for the
dependence receptor hypothesis and, further, an experimental
paradigm in which to dissect the underlying cell intrinsic death
pathway downstream of TrkA.
Our finding that association with APC establishes distinct
pools of axonally localized Pafah1b1 mRNA that differ as to
whether they are translated in response to NGF stimulation or
withdrawal provides mechanistic insight into the differential
regulation of axonally localized mRNAs. APC localizes mRNAs to
microtubule plus-ends, and spatially orchestrates protein synth-
esis in axons and growth cones48. It remains unknown how many
of these translational hubs exist in axons. The finding that the
netrin receptor DCC binds components of the protein synthesis
machinery and regulates local translation58 suggests that APC is
not unique. In the fungus Ustilago maydis, polysomes are actively
transported on the surface of early endosomes and likely
translationally active there59. If the same occurs in neurons, it
would suggest that cargos might be able to hitch a ride on dynein
by locally synthesizing adaptor proteins on their surface.
In conclusion, through these studies, we provide a mechanistic
explanation for how a unidirectional motor can be tuned to fulfil
changing transport needs far away from the cell soma, and we
further reveal that transcripts of the same gene exist in axons in
functionally distinct pools based on their association with
translational hubs.
Methods
Compartmentalized DRG culture. All reagents were from ThermoFisher
Scientific (Waltham, MA) unless otherwise noted. To apply NGF, inhibitors or
siRNAs specifically to distal axons and growth cones without affecting the cell
bodies, DRG neurons were prepared from Sprague-Dawley embryonic day 15 rat
embryos of both sexes. All work involving animals was performed in accordance
with the National Institutes of Health guidelines for the care and use of laboratory
animals, and was approved by the Institutional Animal Care and Use Committee of
Columbia University. Embryonic rat DRGs were grown in tripartite microfluidic
chambers composed of three compartments (width of middle compartment:
500mm; side compartments: 1,500 mm) connected by two microgroove barriers
(microgroove length: 500 mm, width: 10mm, height: 3 mm)17,27. Microfluidic
chambers were produced according to published protocols18,60. The microfluidic
chambers were coated with 100mgml" 1 poly-L-lysine (Trevigen, Gaithersburg,
MD). The plating medium (Neurobasal, 1# B27, 2mM glutamate, 20mM
50-fluorodeoxyuridine, 100 ngml" 1 NGF) was completely exchanged for
5 ngml" 1 NGF in both axonal compartments after 48 h. siRNA transfection in the
axonal compartments or LNA transfection in the somatic compartment
was performed on DIV 3, and all experiments were performed on DIV 4.
Whenever stated, the axonal compartments only were treated with anisomycin
(1mM, Sigma-Aldrich), emetine (2mM, EMD Millipore), rapamycin (10 nM,
Sigma-Aldrich), CEP-1347 (0.5 mM, Sigma-Aldrich), SB239063 (1 mM,
Sigma-Aldrich), lithium chloride (15mM) or SB216763 (10 mM, Sigma-Aldrich).
Live imaging of axonal cargos. Axonal transport of various cargos was visualized
using an Axio Observer.Z1 inverted microscope equipped with an AxioCam MRm
Rev. 3 camera (Zeiss, Thornwood, NY). To assay the effects of acute changes in
NGF signalling on axonal trafficking, 50 nM LysoTracker Green DND-26 was
added to axons when the axonal medium was changed to the experimental NGF
concentrations (0, 5 or 100 ngml" 1), 15min before the start of imaging. For
imaging transport of NGF-containing endosomes, QD-NGF was prepared by
mixing mouse NGF 2.5S-Biotin (Alomone Labs, Jerusalem) and Qdot 585
Streptavidin Conjugate in a 1:1.2 molar ratio, and incubating them together at 4 !C
with continuous inversion for 24 h. QD-NGF was diluted to 100 ngml" 1 and
added to axons with a medium change 15min before imaging. During imaging,
neurons were kept in a CO2- and humidity-controlled incubation chamber
maintained at 37 !C. Images were acquired every 13 s over a total 4-min time
period, with three fields of axons imaged per replicate. For motility analysis,
LysoTracker-positive particles were scored only if they were Z1 mm in diameter,
thereby allowing the identification and tracing of individual particles, whereas the
much scarcer and smaller QD-NGF particles were included only if they were
r0.5 mm in diameter. Particles were scored as stationary, anterograde, retrograde
or bidirectional according the following definitions: stationary if they travelled a
distance o1 mm during the observation period; anterograde or retrograde if they
displaced 43 mm in one direction; and bidirectional if they travelled 43 mm in
both directions.
Puromycylation assay. To visualized locally synthesized proteins, puromycin
(1.8 mM) was added to axons or cell bodies for 10min. Incorporation of
puromycin into nascent polypeptide chains was determined by quantitative
immunofluorescence and quantified as the numbers of puromycin-positive puncta
in axons or relative intensity of the puromycin immunofluorescence signal.
Fluorescence in situ hybridization. Antisense riboprobes were transcribed in vitro
from sense oligonucleotides containing a T7 promoter site (50-GCCCTATAGTG
AGTCGTATTAC-30) at their 30-end using the MEGAshortscript T7 Transcription
kit and digoxigenin-conjugated UTP (Roche, Indianapolis, IN). A mix of five
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FISH was performed as described previously17. Neurons grown in microfluidic
chambers were fixed in 4% paraformaldehyde in PBS for 20min at room
temperature. Following three washes with PBS, the cells were permeabilized with
0.5% Triton X-100 in PBS and washed twice more with PBS. The coverslips were
incubated with a total of 100 ng digoxigenin-labelled riboprobes (20 ng each of five
distinct riboprobes) in 30ml hybridization buffer (50% formamide, 2! SSC, 0.2%
bovine serum albumin (BSA), 1mgml" 1 E. coli transfer RNA and 1mgml" 1
salmon sperm DNA) overnight at 37 !C. The coverslips were washed with constant
agitation at 37 !C, first with 50% formamide in 2! SSC for 30min followed by
50% formamide in 1! SSC for another 30min. An additional three washes were
done at room temperature with 1! SSC for 15min each. The coverslips were
washed three times with PBS containing 0.1% Tween-20 for 5min each, blocked
with 3% BSA in PBST for 30min, and incubated with anti-digoxin (Sigma-Aldrich,
DI-22; 1:500) and anti-b-III tubulin (Abcam, ab41489; 1:1,000) antibodies in
blocking solution overnight at 4 !C. The coverslips were washed three times with
PBST and incubated with fluorophore-conjugated Alexa secondary antibodies
(1:2,000) for 1 h at room temperature, and washed and mounted with ProLong
Gold antifade reagent. b-III tubulin staining was used to generate a mask within
which the intensity of the FISH signal was quantified. Average fluorescence
intensity of axonal fields that were incubated with a Gfp probe was subtracted from
the fluorescence intensities resulting from hybridization with Pafah1b1 or Dctn1
riboprobes.
Quantitative immunofluorescence imaging. Axons of neurons grown in
microfluidic chambers were exposed to 0, 5 or 100 ngml" 1 NGF for 10min, either
in the presence of protein synthesis inhibitors or after pretreatment with siRNAs.
Neurons were fixed with 4% paraformaldehyde/4% sucrose in PBS for 20min at
room temperature. The coverslips were washed three times in PBS, blocked for 1 h
with BGT buffer (3% BSA, 0.25% Triton X-100 and 100mM glycine) and
incubated with primary antibodies against b-III tubulin (Abcam, ab7751; 1:500),
4EBP1, p-4EBP1 (Cell Signaling Technology, 1:1,000), puromycin (Millipore,
MABE343; 1:250), Lis1 (Sigma-Aldrich, SAB3500302, 1:400) or p150Glued (Abcam,
ab11806, 1:500). Images of distal axons or growth cones were acquired in Z-stacks
using a Plan-Apochromat ! 63/1.40 oil objective.
siRNA and LNA transfection. Axon-specific silencing of Pafah1b1 and Dctn1
mRNAs was achieved by transfecting siRNAs into axons concomitant with the
axonal medium change on DIV 3 using NeuroPORTER (Genlantis, San Diego, CA)
as the transfection reagent. The following siRNAs were used to target rat Pafah1b1
(NM_031763.3): 50-CCUUUGACCACAGUGGCAAACUCUU-30 and 50-GGA
UUUCCAUAAGACGGCACCCUAU-30; and Dctn1 (NM_024130.1): 50-GAGCGC
UCCUUAGAUUUCCUCAUCG-30 and 50-GACAUCCGUCAGUUCUGCAAGA
AGA-30. Negative control siRNA was purchased from ThermoFisher Scientific
(Stealth RNAi siRNA Negative Control Med GC Duplex #3).
LNAs were transfected into the cell body compartment on DIV 3 using
NeuroPORTER. The following high-performance liquid chromatography-purified
LNAs (Exiqon, Woburn, MA) were used to target bases 1,878–1,891 (control LNA)
or 1,905–1,921 (targeting the CUGU motif APC-binding site) of rat Pafah1b1
mRNA: 50-CAþTGAAþTACTTþTGT-30 and 50-AþTTTAþCAGTA
þTACAAþTT-30 , respectively; preposedþ signifies LNA base.
Immunoblot. The efficacy of each siRNA employed was validated by western
blotting of endogenous protein from rat C6 glioma cells transfected at 50–80%
confluence and cultured for 72 h to allow time for effective knockdown. Cells were
lysed in RIPA buffer and proteins were resolved by 4–12% SDS–polyacrylamide gel
electrophoresis on NuPAGE Bis-Tris gels, electrotransferred to Immobilon-P
PVDF membranes (Millipore), blocked with 5% (w/v) nonfat milk, probed with
primary antibodies followed by incubation with horseradish peroxidase-conjugated
secondary antibodies (Pierce) and visualized with SuperSignal West Pico
Chemiluminescent substrate (Pierce). Protein quantification was performed using
ImageJ (NIH) software. The primary antibodies used for loading controls were:
b-actin (1:10,000, Millipore) and cofilin (1:1,000, Cell Signaling Technology).
horseradish peroxidase-conjugated secondary antibodies were used at 1:2,000.
Images have been cropped for presentation. Full-size images are presented in
Supplementary Fig. 4.
TUNEL and calcein AM staining. TUNEL was performed on fixed samples using
the DeadEnd Fluorometric TUNEL System (Promega, Madison, WI), and nuclei
were counterstained with 4,6-diamidino-2-phenylindole. Survival was analysed
using calcein staining in living cells. Cell bodies were incubated with 4.17 mgml" 1
calcein AM dye in dimethylsulphoxide for 40–60min at 37 !C. Calcein was
quenched with 15mgml" 1 bovine haemoglobin (Sigma-Aldrich), and nuclei
were labelled with Hoechst stain. Cells were live imaged inside the microscope
incubation chamber kept at 37 !C and 5% CO2. TUNEL-positive nuclei and
calcein-positive cells were scored in five fields per replicate that were proximal to
the microgrooves.
Real-time RT–PCR. RNA was purified from the axonal compartments of
microfluidic chambers using the PrepEase RNA Isolation kit (Affymetrix, Santa
Clara, CA) and concentrated using the RNeasy MinElute Cleanup kit (Qiagen,
Valencia, CA). A total amount ofB2 ng was generally isolated from axonal lysates,
which was concentrated into 10 ml for reverse transcription. Reverse transcription
was performed using SuperScript III First-Strand Synthesis SuperMix for
qRT–PCR. Real-time RT–PCR was performed with TaqMan Gene Expression
master mix in a StepOnePlus Real-Time PCR instrument using the following
conditions: an initial denaturation step at 95 !C for 10min, followed by 40 cycles of
denaturation at 95 !C for 15 s and extension at 60 !C for 1min. Pafah1b1 and
Dctn1 levels were normalized to Gapdh.
RNA immunoprecipitation. CUGU and control LNAs were transfected into
dissociated DRGs and 24 h later the DRGs were lysed in RIP buffer (150mM KCl,
25mM Tris-HCl, 5mM EDTA, 0.5mM dithiothreitol, 0.5% NP40,þ protease
inhibitors). The cleared lysate was incubated with an APC antibody (Santa Cruz
Biotechnology, sc-896; 1:500) overnight at 4 !C. Antibody–protein–RNA
complexes were precipitate by incubation under agitation with Dynabeads for 1 h
at 4 !C. The beads were washed five times in ice-cold RIP buffer. RNAzol RT was
added to the beads, RNA was purified using the Direct-zol RNA MicroPrep kit
(Zymo Research) with DNaseI treatment. Complementary was synthesized using
the iScript Reverse Transcript Supermix for RT–qPCR. RT–PCR was run according
to the guidelines for TaqMan Fast Advance Master Mix.
Statistical analyses. All experiments were performed in at least three biological
replicates to gain sufficient power for meaningful statically analyses. Two means
were compared by t-tests, whereas multiple means were compared using one-way
ANOVAs with multiple comparisons testing. When comparing multiple groups in
experiments with more than one variable, two-way ANOVA was performed. For all
comparisons, normal distribution and variance were determined and appropriate
statistical tests chosen.
Data availability. Data supporting the findings of this study are available within
the article (and its Supplementary Information files) and from the corresponding
author on reasonable request.
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Figure 5.1: CREB3L2 is locally translated in axons in response to Aβ1-42. (A) Hippocampal 
neurons were cultured in microfluidics and treated with vehicle (control) or oligomerized Aβ1-
42 for 12 hours in the axonal compartment. Following treatment, 1.8 µM puromycin was 
supplemented into the axonal media for 15 minutes to label locally synthesized proteins. As a 
technical control, 40 µM anisomycin was supplemented concomitant with puromycin to 
suppress protein translation for 2 biological replicates. PLA was performed between 
puromycin and N-terminal CREB3L2. (B) Quantification of the experiments performed in (A). 
Means ± SEM of 20–30 axonal fields per condition (4 biological replicates, 2 biological 
replicates anisomycin). Kruskal-Wallis test with Dunn’s multiple comparison test, ***P ≤  
0.001. Scale bar, 20 µm. 
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Figure 5.2: CREB3L2 is cleaved by S2P. (A) HEK293T cells were transfected with 
CREB3L2 with GFP fused to the N-terminus, and S1P or S2P. Lysates were probed 
for GFP and a loading control. (B) Immunofluorescence of HEK293T cells 
transfected with GFP-CREB3L2 or S2P as described in (A). Experiment performed 
by Cláudio Gouveia Roque. 
A B 


















Figure 5.3: Axonal inhibition of S2P prevents induction of CHOP by Aβ1-42. (A) Hippocampal neurons 
were cultured in microfluidic devices and treated with vehicle (control) or Aβ1-42 for 12 hours. After 12 
hours, 15 uM nelfinavir or an equal volume of DMSO was supplemented into the axonal compartment 
for an additional 24 hours. In total, axons were treated with vehicle or Aβ1-42 for 36 hours. Afterwards 
the neurons were fixed and CHOP levels were assessed by immunofluorescence. (B) Quantification of 
the experiments performed in (A). Means ± SEM of 5–15 axonal fields per condition (3 biological 
replicates). Kruskal-Wallis test with Dunn’s multiple comparison test, *P ≤  0.05. Scale bar, 20 µm. (C) 
Axonal inhibition of S2P prevents cell death by Aβ1-42. Hippocampal neurons were cultured in 
microfluidics and treated as described in (A). 15 uM nelfinavir, 10 uM 3,4-Dichloroisocoumarin, or an 
equal volume of DMSO was supplemented into the axonal compartment after 12 hours of treatment 
with vehicle or Aβ1-42. After 36 hours total treatment with vehicle or Aβ1-42, the neurons were fixed and 
cell death was assessed by the TUNEL assay. (D) Quantification of the experiments performed in (C). 
Means ± SEM of 10–25 axonal fields per condition (4 biological replicates, 2 biological replicates with 
3,4-Dichloroisocoumarin). Kruskal-Wallis test with Dunn’s multiple comparison test, ***P ≤  0.001. 
Scale bar, 20 µm. 
 




















Figure 5.4: Axonal inhibition of S2P prevents accumulation of somatic ATF4-CREB3L2 complexes and 
instead restricts their formation to the axon. (A) Hippocampal neurons were cultured in microfluidic 
devices and treated with vehicle (control) or Aβ1-42 for 12 hours. After 12 hours, 15 uM nelfinavir or an 
equal volume of DMSO was supplemented into the axonal compartment for an additional 24 hours. 
Neurons were fixed and prepared for PLA between ATF4 and N-terminal CREB3L2. (B) and (C) 
Quantification of experiments in (A). (B) There was a significant increase in the number of positive PLA 
complexes in cell bodies following axonal treatment with Aβ1-42 that was prevented with treatment with 
nelfinavir. (C) Similar differences between Aβ1-42 and nelfinavir treatments were also detected in the 
nuclei of cell bodies that were positive for PLA puncta. Means ± SEM of 10–20 somatic fields per 
condition (4 biological replicates). Kruskal-Wallis test with Dunn’s multiple comparison test, *P ≤ 0.05, ** 
P ≤ 0.01, ***P ≤  0.001. Scale bar, 10 µm. (D) Assessment of PLA complexes of hippocampal cultures 
prepared in (A). (E) Quantification of (D).  Means ± SEM of 10–15 axonal fields per condition (4 















Figure 5.5: Diagram summarizing our understanding of the roles for N- and C-terminal CREB3L2 in 
neurons. 
 
